Title: F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
Official Title: F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
Number of Sections: 1
Source: versions - H 309 Filed
Media Type: application/pdf
Strikethrough Detection: 57 sections found

================================================================================

Section 1:
HB 309 2026
1 A bill to be entitled
2 An act relating to controlled substances; amending s.
3 893.03, F.S.; adding to the list of Schedule I
4 controlled substances 7-Hydroxymitragynine
5 concentrated at a level above 400 parts per million on
6 a dry-weight basis; excepting from the list of
7 Schedule I controlled substances certain xylazine
8 animal drug products approved by the United States
9 Food and Drug Administration and used for certain
10 purposes; amending s. 893.13, F.S.; providing criminal
11 penalties and requiring a mandatory minimum term of
12 imprisonment if a person sells, manufactures, or
13 delivers or possesses with intent to sell,
14 manufacture, or deliver xylazine; amending s. 893.131,
15 F.S.; conforming a cross-reference; amending s.
16 893.135, F.S.; creating the offense of trafficking in
17 xylazine; providing criminal penalties and requiring a
18 mandatory minimum term of imprisonment and fines based
19 on the quantity of the controlled substance involved
20 in the offense; providing effective dates.
21
22 Be It Enacted by the Legislature of the State of Florida:
23
24 Section 1. Effective July 1, 2026, paragraphs (a) and (c)
25 of subsection (1) of section 893.03, Florida Statutes, are
Page 1 of 57
CODING: Words stricken are deletions; words underlined are additions.
hb309-00
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
HB 309 2026
26 amended to read:
27 893.03 Standards and schedules.—The substances enumerated
28 in this section are controlled by this chapter. The controlled
29 substances listed or to be listed in Schedules I, II, III, IV,
30 and V are included by whatever official, common, usual,
31 chemical, trade name, or class designated. The provisions of
32 this section shall not be construed to include within any of the
33 schedules contained in this section any excluded drugs listed
34 within the purview of 21 C.F.R. s. 1308.22, styled "Excluded
35 Substances"; 21 C.F.R. s. 1308.24, styled "Exempt Chemical
36 Preparations"; 21 C.F.R. s. 1308.32, styled "Exempted
37 Prescription Products"; or 21 C.F.R. s. 1308.34, styled "Exempt
38 Anabolic Steroid Products."
39 (1) SCHEDULE I.—A substance in Schedule I has a high
40 potential for abuse and has no currently accepted medical use in
41 treatment in the United States and in its use under medical
42 supervision does not meet accepted safety standards. The
43 following substances are controlled in Schedule I:
44 (a) Unless specifically excepted or unless listed in
45 another schedule, any of the following substances, including
46 their isomers, esters, ethers, salts, and salts of isomers,
47 esters, and ethers, whenever the existence of such isomers,
48 esters, ethers, and salts is possible within the specific
49 chemical designation:
50 1. Acetyl-alpha-methylfentanyl.
Page 2 of 57
CODING: Words stricken are deletions; words underlined are additions.
hb309-00
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
HB 309 2026
51 2. Acetylmethadol.
52 3. Allylprodine.
53 4. Alphacetylmethadol (except levo-alphacetylmethadol,
54 also known as levo-alpha-acetylmethadol, levomethadyl acetate,
55 or LAAM).
56 5. Alphamethadol.
57 6. Alpha-methylfentanyl (N-[1-(alpha-methyl-betaphenyl)
58 ethyl-4-piperidyl] propionanilide; 1-(1-methyl-2-phenylethyl)-4-
59 (N-propanilido) piperidine).
60 7. Alpha-methylthiofentanyl.
61 8. Alphameprodine.
62 9. Benzethidine.
63 10. Benzylfentanyl.
64 11. Betacetylmethadol.
65 12. Beta-hydroxyfentanyl.
66 13. Beta-hydroxy-3-methylfentanyl.
67 14. Betameprodine.
68 15. Betamethadol.
69 16. Betaprodine.
70 17. Clonitazene.
71 18. Dextromoramide.
72 19. Diampromide.
73 20. Diethylthiambutene.
74 21. Difenoxin.
75 22. Dimenoxadol.
Page 3 of 57
CODING: Words stricken are deletions; words underlined are additions.
hb309-00
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
HB 309 2026
76 23. Dimepheptanol.
77 24. Dimethylthiambutene.
78 25. Dioxaphetyl butyrate.
79 26. Dipipanone.
80 27. Ethylmethylthiambutene.
81 28. Etonitazene.
82 29. Etoxeridine.
83 30. Flunitrazepam.
84 31. Furethidine.
85 32. 7-Hydroxymitragynine concentrated at a level above 400
86 parts per million on a dry-weight basis.
87 33.32. Hydroxypethidine.
88 34.33. Ketobemidone.
89 35.34. Levomoramide.
90 36.35. Levophenacylmorphan.
91 37.36. Desmethylprodine (1-Methyl-4-Phenyl-4-
92 Propionoxypiperidine).
93 38.37. 3-Methylfentanyl (N-[3-methyl-1-(2-phenylethyl)-4-
94 piperidyl]-N-phenylpropanamide).
95 39.38. 3-Methylthiofentanyl.
96 40.39. Morpheridine.
97 41.40. Noracymethadol.
98 42.41. Norlevorphanol.
99 43.42. Normethadone.
100 44.43. Norpipanone.
Page 4 of 57
CODING: Words stricken are deletions; words underlined are additions.
hb309-00
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
HB 309 2026
101 45.44. Para-Fluorofentanyl.
102 46.45. Phenadoxone.
103 47.46. Phenampromide.
104 48.47. Phenomorphan.
105 49.48. Phenoperidine.
106 50.49. PEPAP (1-(2-Phenylethyl)-4-Phenyl-4-
107 Acetyloxypiperidine).
108 51.50. Piritramide.
109 52.51. Proheptazine.
110 53.52. Properidine.
111 54.53. Propiram.
112 55.54. Racemoramide.
113 56.55. Thenylfentanyl.
114 57.56. Thiofentanyl.
115 58.57. Tianeptine.
116 59.58. Tilidine.
117 60.59. Trimeperidine.
118 61.60. Acetylfentanyl.
119 62.61. Butyrylfentanyl.
120 63.62. Beta-Hydroxythiofentanyl.
121 64.63. Fentanyl derivatives. Unless specifically excepted,
122 listed in another schedule, or contained within a pharmaceutical
123 product approved by the United States Food and Drug
124 Administration, any material, compound, mixture, or preparation,
125 including its salts, isomers, esters, or ethers, and salts of
Page 5 of 57
CODING: Words stricken are deletions; words underlined are additions.
hb309-00
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
HB 309 2026
126 isomers, esters, or ethers, whenever the existence of such salts
127 is possible within any of the following specific chemical
128 designations containing a 4-anilidopiperidine structure:
129 a. With or without substitution at the carbonyl of the
130 aniline moiety with alkyl, alkenyl, carboalkoxy, cycloalkyl,
131 methoxyalkyl, cyanoalkyl, or aryl groups, or furanyl,
132 dihydrofuranyl, benzyl moiety, or rings containing heteroatoms
133 sulfur, oxygen, or nitrogen;
134 b. With or without substitution at the piperidine amino
135 moiety with a phenethyl, benzyl, alkylaryl (including
136 heteroaromatics), alkyltetrazolyl ring, or an alkyl or
137 carbomethoxy group, whether or not further substituted in the
138 ring or group;
139 c. With or without substitution or addition to the
140 piperdine ring to any extent with one or more methyl,
141 carbomethoxy, methoxy, methoxymethyl, aryl, allyl, or ester
142 groups;
143 d. With or without substitution of one or more hydrogen
144 atoms for halogens, or methyl, alkyl, or methoxy groups, in the
145 aromatic ring of the anilide moiety;
146 e. With or without substitution at the alpha or beta
147 position of the piperidine ring with alkyl, hydroxyl, or methoxy
148 groups;
149 f. With or without substitution of the benzene ring of the
150 anilide moiety for an aromatic heterocycle; and
Page 6 of 57
CODING: Words stricken are deletions; words underlined are additions.
hb309-00
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
HB 309 2026
151 g. With or without substitution of the piperidine ring for
152 a pyrrolidine ring, perhydroazepine ring, or azepine ring;
153 excluding, Alfentanil, Carfentanil, Fentanyl, and Sufentanil;
154 including, but not limited to:
155 (I) Acetyl-alpha-methylfentanyl.
156 (II) Alpha-methylfentanyl (N-[1-(alpha-methyl-betaphenyl)
157 ethyl-4-piperidyl] propionanilide; 1-(1-methyl-2-phenylethyl)-4-
158 (N-propanilido) piperidine).
159 (III) Alpha-methylthiofentanyl.
160 (IV) Benzylfentanyl.
161 (V) Beta-hydroxyfentanyl.
162 (VI) Beta-hydroxy-3-methylfentanyl.
163 (VII) 3-Methylfentanyl (N-[3-methyl-1-(2-phenylethyl)-4-
164 piperidyl]-N-phenylpropanamide).
165 (VIII) 3-Methylthiofentanyl.
166 (IX) Para-Fluorofentanyl.
167 (X) Thenylfentanyl or Thienyl fentanyl.
168 (XI) Thiofentanyl.
169 (XII) Acetylfentanyl.
170 (XIII) Butyrylfentanyl.
171 (XIV) Beta-Hydroxythiofentanyl.
172 (XV) Lofentanil.
173 (XVI) Ocfentanil.
174 (XVII) Ohmfentanyl.
175 (XVIII) Benzodioxolefentanyl.
Page 7 of 57
CODING: Words stricken are deletions; words underlined are additions.
hb309-00
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
HB 309 2026
176 (XIX) Furanyl fentanyl.
177 (XX) Pentanoyl fentanyl.
178 (XXI) Cyclopentyl fentanyl.
179 (XXII) Isobutyryl fentanyl.
180 (XXIII) Remifentanil.
181 65.64. Nitazene derivatives. Unless specifically excepted,
182 listed in another schedule, or contained within a pharmaceutical
183 product approved by the United States Food and Drug
184 Administration, any material, compound, mixture, or preparation,
185 including its salts, isomers, esters, or ethers, and salts of
186 isomers, esters, or ethers, whenever the existence of such salts
187 is possible within any of the following specific chemical
188 designations containing a benzimidazole ring with an ethylamine
189 substitution at the 1-position and a benzyl ring substitution at
190 the 2-position structure:
191 a. With or without substitution on the benzimidazole ring
192 with alkyl, alkoxy, carboalkoxy, amino, nitro, or aryl groups,
193 or halogens;
194 b. With or without substitution at the ethylamine amino
195 moiety with alkyl, dialkyl, acetyl, or benzyl groups, whether or
196 not further substituted in the ring system;
197 c. With or without inclusion of the ethylamine amino
198 moiety in a cyclic structure;
199 d. With or without substitution of the benzyl ring; or
200 e. With or without replacement of the benzyl ring with an
Page 8 of 57
CODING: Words stricken are deletions; words underlined are additions.
hb309-00
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
HB 309 2026
201 aromatic ring, including, but not limited to:
202 (I) Butonitazene.
203 (II) Clonitazene.
204 (III) Etodesnitazene.
205 (IV) Etonitazene.
206 (V) Flunitazene.
207 (VI) Isotodesnitazene.
208 (VII) Isotonitazene.
209 (VIII) Metodesnitazene.
210 (IX) Metonitazene.
211 (X) Nitazene.
212 (XI) N-Desethyl Etonitazene.
213 (XII) N-Desethyl Isotonitazene.
214 (XIII) N-Piperidino Etonitazene.
215 (XIV) N-Pyrrolidino Etonitazene.
216 (XV) Protonitazene.
217 (c) Unless specifically excepted or unless listed in
218 another schedule, any material, compound, mixture, or
219 preparation that contains any quantity of the following
220 hallucinogenic substances or that contains any of their salts,
221 isomers, including optical, positional, or geometric isomers,
222 homologues, nitrogen-heterocyclic analogs, esters, ethers, and
223 salts of isomers, homologues, nitrogen-heterocyclic analogs,
224 esters, or ethers, if the existence of such salts, isomers, and
225 salts of isomers is possible within the specific chemical
Page 9 of 57
CODING: Words stricken are deletions; words underlined are additions.
hb309-00
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
HB 309 2026
226 designation or class description:
227 1. Alpha-Ethyltryptamine.
228 2. 4-Methylaminorex (2-Amino-4-methyl-5-phenyl-2-
229 oxazoline).
230 3. Aminorex (2-Amino-5-phenyl-2-oxazoline).
231 4. DOB (4-Bromo-2,5-dimethoxyamphetamine).
232 5. 2C-B (4-Bromo-2,5-dimethoxyphenethylamine).
233 6. Bufotenine.
234 7. Cannabis.
235 8. Cathinone.
236 9. DET (Diethyltryptamine).
237 10. 2,5-Dimethoxyamphetamine.
238 11. DOET (4-Ethyl-2,5-Dimethoxyamphetamine).
239 12. DMT (Dimethyltryptamine).
240 13. PCE (N-Ethyl-1-phenylcyclohexylamine) (Ethylamine
241 analog of phencyclidine).
242 14. JB-318 (N-Ethyl-3-piperidyl benzilate).
243 15. N-Ethylamphetamine.
244 16. Fenethylline.
245 17. 3,4-Methylenedioxy-N-hydroxyamphetamine.
246 18. Ibogaine.
247 19. LSD (Lysergic acid diethylamide).
248 20. Mescaline.
249 21. Methcathinone.
250 22. 5-Methoxy-3,4-methylenedioxyamphetamine.
Page 10 of 57
CODING: Words stricken are deletions; words underlined are additions.
hb309-00
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
HB 309 2026
251 23. PMA (4-Methoxyamphetamine).
252 24. PMMA (4-Methoxymethamphetamine).
253 25. DOM (4-Methyl-2,5-dimethoxyamphetamine).
254 26. MDEA (3,4-Methylenedioxy-N-ethylamphetamine).
255 27. MDA (3,4-Methylenedioxyamphetamine).
256 28. JB-336 (N-Methyl-3-piperidyl benzilate).
257 29. N,N-Dimethylamphetamine.
258 30. Parahexyl.
259 31. Peyote.
260 32. PCPY (N-(1-Phenylcyclohexyl)-pyrrolidine) (Pyrrolidine
261 analog of phencyclidine).
262 33. Psilocybin.
263 34. Psilocyn.
264 35. Salvia divinorum, except for any drug product approved
265 by the United States Food and Drug Administration which contains
266 Salvia divinorum or its isomers, esters, ethers, salts, and
267 salts of isomers, esters, and ethers, if the existence of such
268 isomers, esters, ethers, and salts is possible within the
269 specific chemical designation.
270 36. Salvinorin A, except for any drug product approved by
271 the United States Food and Drug Administration which contains
272 Salvinorin A or its isomers, esters, ethers, salts, and salts of
273 isomers, esters, and ethers, if the existence of such isomers,
274 esters, ethers, and salts is possible within the specific
275 chemical designation.
Page 11 of 57
CODING: Words stricken are deletions; words underlined are additions.
hb309-00
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
HB 309 2026
276 37. Xylazine, except for a xylazine animal drug product
277 approved by the United States Food and Drug Administration and
278 the use of which conforms to the approved application or is
279 authorized under 21 U.S.C. s. 360b(a)(4). The manufacture,
280 importation, distribution, prescribing, or sale of xylazine for
281 human use is not subject to this exception.
282 38. TCP (1-[1-(2-Thienyl)-cyclohexyl]-piperidine)
283 (Thiophene analog of phencyclidine).
284 39. 3,4,5-Trimethoxyamphetamine.
285 40. Methylone (3,4-Methylenedioxymethcathinone).
286 41. MDPV (3,4-Methylenedioxypyrovalerone).
287 42. Methylmethcathinone.
288 43. Methoxymethcathinone.
289 44. Fluoromethcathinone.
290 45. Methylethcathinone.
291 46. CP 47,497 (2-(3-Hydroxycyclohexyl)-5-(2-methyloctan-2-
292 yl)phenol) and its dimethyloctyl (C8) homologue.
293 47. HU-210 [(6aR,10aR)-9-(Hydroxymethyl)-6,6-dimethyl-3-
294 (2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-
295 ol].
296 48. JWH-018 (1-Pentyl-3-(1-naphthoyl)indole).
297 49. JWH-073 (1-Butyl-3-(1-naphthoyl)indole).
298 50. JWH-200 (1-[2-(4-Morpholinyl)ethyl]-3-(1-
299 naphthoyl)indole).
300 51. BZP (Benzylpiperazine).
Page 12 of 57
CODING: Words stricken are deletions; words underlined are additions.
hb309-00
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
HB 309 2026
301 52. Fluorophenylpiperazine.
302 53. Methylphenylpiperazine.
303 54. Chlorophenylpiperazine.
304 55. Methoxyphenylpiperazine.
305 56. DBZP (1,4-Dibenzylpiperazine).
306 57. TFMPP (Trifluoromethylphenylpiperazine).
307 58. MBDB (Methylbenzodioxolylbutanamine) or (3,4-
308 Methylenedioxy-N-methylbutanamine).
309 59. 5-Hydroxy-AMT (5-Hydroxy-alpha-methyltryptamine).
310 60. 5-Hydroxy-N-methyltryptamine.
311 61. 5-MeO-MiPT (5-Methoxy-N-methyl-N-isopropyltryptamine).
312 62. 5-MeO-AMT (5-Methoxy-alpha-methyltryptamine).
313 63. Methyltryptamine.
314 64. 5-MeO-DMT (5-Methoxy-N,N-dimethyltryptamine).
315 65. 5-Me-DMT (5-Methyl-N,N-dimethyltryptamine).
316 66. Tyramine (4-Hydroxyphenethylamine).
317 67. 5-MeO-DiPT (5-Methoxy-N,N-Diisopropyltryptamine).
318 68. DiPT (N,N-Diisopropyltryptamine).
319 69. DPT (N,N-Dipropyltryptamine).
320 70. 4-Hydroxy-DiPT (4-Hydroxy-N,N-diisopropyltryptamine).
321 71. 5-MeO-DALT (5-Methoxy-N,N-Diallyltryptamine).
322 72. DOI (4-Iodo-2,5-dimethoxyamphetamine).
323 73. DOC (4-Chloro-2,5-dimethoxyamphetamine).
324 74. 2C-E (4-Ethyl-2,5-dimethoxyphenethylamine).
325 75. 2C-T-4 (4-Isopropylthio-2,5-dimethoxyphenethylamine).
Page 13 of 57
CODING: Words stricken are deletions; words underlined are additions.
hb309-00
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
HB 309 2026
326 76. 2C-C (4-Chloro-2,5-dimethoxyphenethylamine).
327 77. 2C-T (4-Methylthio-2,5-dimethoxyphenethylamine).
328 78. 2C-T-2 (4-Ethylthio-2,5-dimethoxyphenethylamine).
329 79. 2C-T-7 (4-(n)-Propylthio-2,5-dimethoxyphenethylamine).
330 80. 2C-I (4-Iodo-2,5-dimethoxyphenethylamine).
331 81. Butylone (3,4-Methylenedioxy-alpha-
332 methylaminobutyrophenone).
333 82. Ethcathinone.
334 83. Ethylone (3,4-Methylenedioxy-N-ethylcathinone).
335 84. Naphyrone (Naphthylpyrovalerone).
336 85. Dimethylone (3,4-Methylenedioxy-N,N-
337 dimethylcathinone).
338 86. 3,4-Methylenedioxy-N,N-diethylcathinone.
339 87. 3,4-Methylenedioxy-propiophenone.
340 88. 3,4-Methylenedioxy-alpha-bromopropiophenone.
341 89. 3,4-Methylenedioxy-propiophenone-2-oxime.
342 90. 3,4-Methylenedioxy-N-acetylcathinone.
343 91. 3,4-Methylenedioxy-N-acetylmethcathinone.
344 92. 3,4-Methylenedioxy-N-acetylethcathinone.
345 93. Bromomethcathinone.
346 94. Buphedrone (alpha-Methylamino-butyrophenone).
347 95. Eutylone (3,4-Methylenedioxy-alpha-
348 ethylaminobutyrophenone).
349 96. Dimethylcathinone.
350 97. Dimethylmethcathinone.
Page 14 of 57
CODING: Words stricken are deletions; words underlined are additions.
hb309-00
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
HB 309 2026
351 98. Pentylone (3,4-Methylenedioxy-alpha-
352 methylaminovalerophenone).
353 99. MDPPP (3,4-Methylenedioxy-alpha-
354 pyrrolidinopropiophenone).
355 100. MDPBP (3,4-Methylenedioxy-alpha-
356 pyrrolidinobutyrophenone).
357 101. MOPPP (Methoxy-alpha-pyrrolidinopropiophenone).
358 102. MPHP (Methyl-alpha-pyrrolidinohexanophenone).
359 103. BTCP (Benzothiophenylcyclohexylpiperidine) or BCP
360 (Benocyclidine).
361 104. F-MABP (Fluoromethylaminobutyrophenone).
362 105. MeO-PBP (Methoxypyrrolidinobutyrophenone).
363 106. Et-PBP (Ethylpyrrolidinobutyrophenone).
364 107. 3-Me-4-MeO-MCAT (3-Methyl-4-Methoxymethcathinone).
365 108. Me-EABP (Methylethylaminobutyrophenone).
366 109. Etizolam.
367 110. PPP (Pyrrolidinopropiophenone).
368 111. PBP (Pyrrolidinobutyrophenone).
369 112. PVP (Pyrrolidinovalerophenone) or
370 (Pyrrolidinopentiophenone).
371 113. MPPP (Methyl-alpha-pyrrolidinopropiophenone).
372 114. JWH-007 (1-Pentyl-2-methyl-3-(1-naphthoyl)indole).
373 115. JWH-015 (1-Propyl-2-methyl-3-(1-naphthoyl)indole).
374 116. JWH-019 (1-Hexyl-3-(1-naphthoyl)indole).
375 117. JWH-020 (1-Heptyl-3-(1-naphthoyl)indole).
Page 15 of 57
CODING: Words stricken are deletions; words underlined are additions.
hb309-00
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
HB 309 2026
376 118. JWH-072 (1-Propyl-3-(1-naphthoyl)indole).
377 119. JWH-081 (1-Pentyl-3-(4-methoxy-1-naphthoyl)indole).
378 120. JWH-122 (1-Pentyl-3-(4-methyl-1-naphthoyl)indole).
379 121. JWH-133 ((6aR,10aR)-6,6,9-Trimethyl-3-(2-
380 methylpentan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromene).
381 122. JWH-175 (1-Pentyl-3-(1-naphthylmethyl)indole).
382 123. JWH-201 (1-Pentyl-3-(4-methoxyphenylacetyl)indole).
383 124. JWH-203 (1-Pentyl-3-(2-chlorophenylacetyl)indole).
384 125. JWH-210 (1-Pentyl-3-(4-ethyl-1-naphthoyl)indole).
385 126. JWH-250 (1-Pentyl-3-(2-methoxyphenylacetyl)indole).
386 127. JWH-251 (1-Pentyl-3-(2-methylphenylacetyl)indole).
387 128. JWH-302 (1-Pentyl-3-(3-methoxyphenylacetyl)indole).
388 129. JWH-398 (1-Pentyl-3-(4-chloro-1-naphthoyl)indole).
389 130. HU-211 ((6aS,10aS)-9-(Hydroxymethyl)-6,6-dimethyl-3-
390 (2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-
391 ol).
392 131. HU-308 ([(1R,2R,5R)-2-[2,6-Dimethoxy-4-(2-
393 methyloctan-2-yl)phenyl]-7,7-dimethyl-4-bicyclo[3.1.1]hept-3-
394 enyl] methanol).
395 132. HU-331 (3-Hydroxy-2-[(1R,6R)-3-methyl-6-(1-
396 methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-2,5-cyclohexadiene-
397 1,4-dione).
398 133. CB-13 (4-Pentyloxy-1-(1-naphthoyl)naphthalene).
399 134. CB-25 (N-Cyclopropyl-11-(3-hydroxy-5-pentylphenoxy)-
400 undecanamide).
Page 16 of 57
CODING: Words stricken are deletions; words underlined are additions.
hb309-00
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
HB 309 2026
401 135. CB-52 (N-Cyclopropyl-11-(2-hexyl-5-hydroxyphenoxy)-
402 undecanamide).
403 136. CP 55,940 (2-[3-Hydroxy-6-propanol-cyclohexyl]-5-(2-
404 methyloctan-2-yl)phenol).
405 137. AM-694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl)indole).
406 138. AM-2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl)indole).
407 139. RCS-4 (1-Pentyl-3-(4-methoxybenzoyl)indole).
408 140. RCS-8 (1-(2-Cyclohexylethyl)-3-(2-
409 methoxyphenylacetyl)indole).
410 141. WIN55,212-2 ((R)-(+)-[2,3-Dihydro-5-methyl-3-(4-
411 morpholinylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]-1-
412 naphthalenylmethanone).
413 142. WIN55,212-3 ([(3S)-2,3-Dihydro-5-methyl-3-(4-
414 morpholinylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]-1-
415 naphthalenylmethanone).
416 143. Pentedrone (alpha-Methylaminovalerophenone).
417 144. Fluoroamphetamine.
418 145. Fluoromethamphetamine.
419 146. Methoxetamine.
420 147. Methiopropamine.
421 148. Methylbuphedrone (Methyl-alpha-
422 methylaminobutyrophenone).
423 149. APB ((2-Aminopropyl)benzofuran).
424 150. APDB ((2-Aminopropyl)-2,3-dihydrobenzofuran).
425 151. UR-144 (1-Pentyl-3-(2,2,3,3-
Page 17 of 57
CODING: Words stricken are deletions; words underlined are additions.
hb309-00
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
HB 309 2026
426 tetramethylcyclopropanoyl)indole).
427 152. XLR11 (1-(5-Fluoropentyl)-3-(2,2,3,3-
428 tetramethylcyclopropanoyl)indole).
429 153. Chloro UR-144 (1-(Chloropentyl)-3-(2,2,3,3-
430 tetramethylcyclopropanoyl)indole).
431 154. AKB48 (N-Adamant-1-yl 1-pentylindazole-3-
432 carboxamide).
433 155. AM-2233(1-[(N-Methyl-2-piperidinyl)methyl]-3-(2-
434 iodobenzoyl)indole).
435 156. STS-135 (N-Adamant-1-yl 1-(5-fluoropentyl)indole-3-
436 carboxamide).
437 157. URB-597 ((3′-(Aminocarbonyl)[1,1′-biphenyl]-3-yl)-
438 cyclohexylcarbamate).
439 158. URB-602 ([1,1′-Biphenyl]-3-yl-carbamic acid,
440 cyclohexyl ester).
441 159. URB-754 (6-Methyl-2-[(4-methylphenyl)amino]-1-
442 benzoxazin-4-one).
443 160. 2C-D (4-Methyl-2,5-dimethoxyphenethylamine).
444 161. 2C-H (2,5-Dimethoxyphenethylamine).
445 162. 2C-N (4-Nitro-2,5-dimethoxyphenethylamine).
446 163. 2C-P (4-(n)-Propyl-2,5-dimethoxyphenethylamine).
447 164. 25I-NBOMe (4-Iodo-2,5-dimethoxy-[N-(2-
448 methoxybenzyl)]phenethylamine).
449 165. MDMA (3,4-Methylenedioxymethamphetamine).
450 166. PB-22 (8-Quinolinyl 1-pentylindole-3-carboxylate).
Page 18 of 57
CODING: Words stricken are deletions; words underlined are additions.
hb309-00
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
HB 309 2026
451 167. Fluoro PB-22 (8-Quinolinyl 1-(fluoropentyl)indole-3-
452 carboxylate).
453 168. BB-22 (8-Quinolinyl 1-(cyclohexylmethyl)indole-3-
454 carboxylate).
455 169. Fluoro AKB48 (N-Adamant-1-yl 1-
456 (fluoropentyl)indazole-3-carboxamide).
457 170. AB-PINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-
458 pentylindazole-3-carboxamide).
459 171. AB-FUBINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-
460 (4-fluorobenzyl)indazole-3-carboxamide).
461 172. ADB-PINACA (N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-
462 1-pentylindazole-3-carboxamide).
463 173. Fluoro ADBICA (N-(1-Amino-3,3-dimethyl-1-oxobutan-2-
464 yl)-1-(fluoropentyl)indole-3-carboxamide).
465 174. 25B-NBOMe (4-Bromo-2,5-dimethoxy-[N-(2-
466 methoxybenzyl)]phenethylamine).
467 175. 25C-NBOMe (4-Chloro-2,5-dimethoxy-[N-(2-
468 methoxybenzyl)]phenethylamine).
469 176. AB-CHMINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-
470 (cyclohexylmethyl)indazole-3-carboxamide).
471 177. FUB-PB-22 (8-Quinolinyl 1-(4-fluorobenzyl)indole-3-
472 carboxylate).
473 178. Fluoro-NNEI (N-Naphthalen-1-yl 1-
474 (fluoropentyl)indole-3-carboxamide).
475 179. Fluoro-AMB (N-(1-Methoxy-3-methyl-1-oxobutan-2-yl)-1-
Page 19 of 57
CODING: Words stricken are deletions; words underlined are additions.
hb309-00
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
HB 309 2026
476 (fluoropentyl)indazole-3-carboxamide).
477 180. THJ-2201 (1-(5-Fluoropentyl)-3-(1-
478 naphthoyl)indazole).
479 181. AM-855 ((4aR,12bR)-8-Hexyl-2,5,5-trimethyl-
480 1,4,4a,8,9,10,11,12b-octahydronaphtho[3,2-c]isochromen-12-ol).
481 182. AM-905 ((6aR,9R,10aR)-3-[(E)-Hept-1-enyl]-9-
482 (hydroxymethyl)-6,6-dimethyl-6a,7,8,9,10,10a-
483 hexahydrobenzo[c]chromen-1-ol).
484 183. AM-906 ((6aR,9R,10aR)-3-[(Z)-Hept-1-enyl]-9-
485 (hydroxymethyl)-6,6-dimethyl-6a,7,8,9,10,10a-
486 hexahydrobenzo[c]chromen-1-ol).
487 184. AM-2389 ((6aR,9R,10aR)-3-(1-Hexyl-cyclobut-1-yl)-
488 6a,7,8,9,10,10a-hexahydro-6,6-dimethyl-6H-dibenzo[b,d]pyran-1,9
489 diol).
490 185. HU-243 ((6aR,8S,9S,10aR)-9-(Hydroxymethyl)-6,6-
491 dimethyl-3-(2-methyloctan-2-yl)-8,9-ditritio-7,8,10,10a-
492 tetrahydro-6aH-benzo[c]chromen-1-ol).
493 186. HU-336 ((6aR,10aR)-6,6,9-Trimethyl-3-pentyl-
494 6a,7,10,10a-tetrahydro-1H-benzo[c]chromene-1,4(6H)-dione).
495 187. MAPB ((2-Methylaminopropyl)benzofuran).
496 188. 5-IT (2-(1H-Indol-5-yl)-1-methyl-ethylamine).
497 189. 6-IT (2-(1H-Indol-6-yl)-1-methyl-ethylamine).
498 190. Synthetic Cannabinoids.—Unless specifically excepted
499 or unless listed in another schedule or contained within a
500 pharmaceutical product approved by the United States Food and
Page 20 of 57
CODING: Words stricken are deletions; words underlined are additions.
hb309-00
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
HB 309 2026
501 Drug Administration, any material, compound, mixture, or
502 preparation that contains any quantity of a synthetic
503 cannabinoid found to be in any of the following chemical class
504 descriptions, or homologues, nitrogen-heterocyclic analogs,
505 isomers (including optical, positional, or geometric), esters,
506 ethers, salts, and salts of homologues, nitrogen-heterocyclic
507 analogs, isomers, esters, or ethers, whenever the existence of
508 such homologues, nitrogen-heterocyclic analogs, isomers, esters,
509 ethers, salts, and salts of isomers, esters, or ethers is
510 possible within the specific chemical class or designation.
511 Since nomenclature of these synthetically produced cannabinoids
512 is not internationally standardized and may continually evolve,
513 these structures or the compounds of these structures shall be
514 included under this subparagraph, regardless of their specific
515 numerical designation of atomic positions covered, if it can be
516 determined through a recognized method of scientific testing or
517 analysis that the substance contains properties that fit within
518 one or more of the following categories:
519 a. Tetrahydrocannabinols.—Any tetrahydrocannabinols
520 naturally contained in a plant of the genus Cannabis, the
521 synthetic equivalents of the substances contained in the plant
522 or in the resinous extracts of the genus Cannabis, or synthetic
523 substances, derivatives, and their isomers with similar chemical
524 structure and pharmacological activity, including, but not
525 limited to, Delta 9 tetrahydrocannabinols and their optical
Page 21 of 57
CODING: Words stricken are deletions; words underlined are additions.
hb309-00
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
HB 309 2026
526 isomers, Delta 8 tetrahydrocannabinols and their optical
527 isomers, Delta 6a,10a tetrahydrocannabinols and their optical
528 isomers, or any compound containing a tetrahydrobenzo[c]chromene
529 structure with substitution at either or both the 3-position or
530 9-position, with or without substitution at the 1-position with
531 hydroxyl or alkoxy groups, including, but not limited to:
532 (I) Tetrahydrocannabinol.
533 (II) HU-210 ((6aR,10aR)-9-(Hydroxymethyl)-6,6-dimethyl-3-
534 (2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-
535 ol).
536 (III) HU-211 ((6aS,10aS)-9-(Hydroxymethyl)-6,6-dimethyl-3-
537 (2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-
538 ol).
539 (IV) JWH-051 ((6aR,10aR)-9-(Hydroxymethyl)-6,6-dimethyl-3-
540 (2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromene).
541 (V) JWH-133 ((6aR,10aR)-6,6,9-Trimethyl-3-(2-methylpentan-
542 2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromene).
543 (VI) JWH-057 ((6aR,10aR)-6,6,9-Trimethyl-3-(2-methyloctan-
544 2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromene).
545 (VII) JWH-359 ((6aR,10aR)-1-Methoxy-6,6,9-trimethyl-3-
546 (2,3-dimethylpentan-2-yl)-6a,7,10,10a-
547 tetrahydrobenzo[c]chromene).
548 (VIII) AM-087 ((6aR,10aR)-3-(2-Methyl-6-bromohex-2-yl)-
549 6,6,9-trimethyl-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol).
550 (IX) AM-411 ((6aR,10aR)-3-(1-Adamantyl)-6,6,9-trimethyl-
Page 22 of 57
CODING: Words stricken are deletions; words underlined are additions.
hb309-00
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
HB 309 2026
551 6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol).
552 (X) Parahexyl.
553 b. Naphthoylindoles, Naphthoylindazoles,
554 Naphthoylcarbazoles, Naphthylmethylindoles,
555 Naphthylmethylindazoles, and Naphthylmethylcarbazoles.—Any
556 compound containing a naphthoylindole, naphthoylindazole,
557 naphthoylcarbazole, naphthylmethylindole,
558 naphthylmethylindazole, or naphthylmethylcarbazole structure,
559 with or without substitution on the indole, indazole, or
560 carbazole ring to any extent, whether or not substituted on the
561 naphthyl ring to any extent, including, but not limited to:
562 (I) JWH-007 (1-Pentyl-2-methyl-3-(1-naphthoyl)indole).
563 (II) JWH-011 (1-(1-Methylhexyl)-2-methyl-3-(1-
564 naphthoyl)indole).
565 (III) JWH-015 (1-Propyl-2-methyl-3-(1-naphthoyl)indole).
566 (IV) JWH-016 (1-Butyl-2-methyl-3-(1-naphthoyl)indole).
567 (V) JWH-018 (1-Pentyl-3-(1-naphthoyl)indole).
568 (VI) JWH-019 (1-Hexyl-3-(1-naphthoyl)indole).
569 (VII) JWH-020 (1-Heptyl-3-(1-naphthoyl)indole).
570 (VIII) JWH-022 (1-(4-Pentenyl)-3-(1-naphthoyl)indole).
571 (IX) JWH-071 (1-Ethyl-3-(1-naphthoyl)indole).
572 (X) JWH-072 (1-Propyl-3-(1-naphthoyl)indole).
573 (XI) JWH-073 (1-Butyl-3-(1-naphthoyl)indole).
574 (XII) JWH-080 (1-Butyl-3-(4-methoxy-1-naphthoyl)indole).
575 (XIII) JWH-081 (1-Pentyl-3-(4-methoxy-1-naphthoyl)indole).
Page 23 of 57
CODING: Words stricken are deletions; words underlined are additions.
hb309-00
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
HB 309 2026
576 (XIV) JWH-098 (1-Pentyl-2-methyl-3-(4-methoxy-1-
577 naphthoyl)indole).
578 (XV) JWH-116 (1-Pentyl-2-ethyl-3-(1-naphthoyl)indole).
579 (XVI) JWH-122 (1-Pentyl-3-(4-methyl-1-naphthoyl)indole).
580 (XVII) JWH-149 (1-Pentyl-2-methyl-3-(4-methyl-1-
581 naphthoyl)indole).
582 (XVIII) JWH-164 (1-Pentyl-3-(7-methoxy-1-
583 naphthoyl)indole).
584 (XIX) JWH-175 (1-Pentyl-3-(1-naphthylmethyl)indole).
585 (XX) JWH-180 (1-Propyl-3-(4-propyl-1-naphthoyl)indole).
586 (XXI) JWH-182 (1-Pentyl-3-(4-propyl-1-naphthoyl)indole).
587 (XXII) JWH-184 (1-Pentyl-3-[(4-methyl)-1-
588 naphthylmethyl]indole).
589 (XXIII) JWH-193 (1-[2-(4-Morpholinyl)ethyl]-3-(4-methyl-1-
590 naphthoyl)indole).
591 (XXIV) JWH-198 (1-[2-(4-Morpholinyl)ethyl]-3-(4-methoxy-1-
592 naphthoyl)indole).
593 (XXV) JWH-200 (1-[2-(4-Morpholinyl)ethyl]-3-(1-
594 naphthoyl)indole).
595 (XXVI) JWH-210 (1-Pentyl-3-(4-ethyl-1-naphthoyl)indole).
596 (XXVII) JWH-387 (1-Pentyl-3-(4-bromo-1-naphthoyl)indole).
597 (XXVIII) JWH-398 (1-Pentyl-3-(4-chloro-1-
598 naphthoyl)indole).
599 (XXIX) JWH-412 (1-Pentyl-3-(4-fluoro-1-naphthoyl)indole).
600 (XXX) JWH-424 (1-Pentyl-3-(8-bromo-1-naphthoyl)indole).
Page 24 of 57
CODING: Words stricken are deletions; words underlined are additions.
hb309-00
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
HB 309 2026
601 (XXXI) AM-1220 (1-[(1-Methyl-2-piperidinyl)methyl]-3-(1-
602 naphthoyl)indole).
603 (XXXII) AM-1235 (1-(5-Fluoropentyl)-6-nitro-3-(1-
604 naphthoyl)indole).
605 (XXXIII) AM-2201 (1-(5-Fluoropentyl)-3-(1-
606 naphthoyl)indole).
607 (XXXIV) Chloro JWH-018 (1-(Chloropentyl)-3-(1-
608 naphthoyl)indole).
609 (XXXV) Bromo JWH-018 (1-(Bromopentyl)-3-(1-
610 naphthoyl)indole).
611 (XXXVI) AM-2232 (1-(4-Cyanobutyl)-3-(1-naphthoyl)indole).
612 (XXXVII) THJ-2201 (1-(5-Fluoropentyl)-3-(1-
613 naphthoyl)indazole).
614 (XXXVIII) MAM-2201 (1-(5-Fluoropentyl)-3-(4-methyl-1-
615 naphthoyl)indole).
616 (XXXIX) EAM-2201 (1-(5-Fluoropentyl)-3-(4-ethyl-1-
617 naphthoyl)indole).
618 (XL) EG-018 (9-Pentyl-3-(1-naphthoyl)carbazole).
619 (XLI) EG-2201 (9-(5-Fluoropentyl)-3-(1-
620 naphthoyl)carbazole).
621 c. Naphthoylpyrroles.—Any compound containing a
622 naphthoylpyrrole structure, with or without substitution on the
623 pyrrole ring to any extent, whether or not substituted on the
624 naphthyl ring to any extent, including, but not limited to:
625 (I) JWH-030 (1-Pentyl-3-(1-naphthoyl)pyrrole).
Page 25 of 57
CODING: Words stricken are deletions; words underlined are additions.
hb309-00
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
HB 309 2026
626 (II) JWH-031 (1-Hexyl-3-(1-naphthoyl)pyrrole).
627 (III) JWH-145 (1-Pentyl-5-phenyl-3-(1-naphthoyl)pyrrole).
628 (IV) JWH-146 (1-Heptyl-5-phenyl-3-(1-naphthoyl)pyrrole).
629 (V) JWH-147 (1-Hexyl-5-phenyl-3-(1-naphthoyl)pyrrole).
630 (VI) JWH-307 (1-Pentyl-5-(2-fluorophenyl)-3-(1-
631 naphthoyl)pyrrole).
632 (VII) JWH-309 (1-Pentyl-5-(1-naphthalenyl)-3-(1-
633 naphthoyl)pyrrole).
634 (VIII) JWH-368 (1-Pentyl-5-(3-fluorophenyl)-3-(1-
635 naphthoyl)pyrrole).
636 (IX) JWH-369 (1-Pentyl-5-(2-chlorophenyl)-3-(1-
637 naphthoyl)pyrrole).
638 (X) JWH-370 (1-Pentyl-5-(2-methylphenyl)-3-(1-
639 naphthoyl)pyrrole).
640 d. Naphthylmethylenindenes.—Any compound containing a
641 naphthylmethylenindene structure, with or without substitution
642 at the 3-position of the indene ring to any extent, whether or
643 not substituted on the naphthyl ring to any extent, including,
644 but not limited to, JWH-176 (3-Pentyl-1-
645 (naphthylmethylene)indene).
646 e. Phenylacetylindoles and Phenylacetylindazoles.—Any
647 compound containing a phenylacetylindole or phenylacetylindazole
648 structure, with or without substitution on the indole or
649 indazole ring to any extent, whether or not substituted on the
650 phenyl ring to any extent, including, but not limited to:
Page 26 of 57
CODING: Words stricken are deletions; words underlined are additions.
hb309-00
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
HB 309 2026
651 (I) JWH-167 (1-Pentyl-3-(phenylacetyl)indole).
652 (II) JWH-201 (1-Pentyl-3-(4-methoxyphenylacetyl)indole).
653 (III) JWH-203 (1-Pentyl-3-(2-chlorophenylacetyl)indole).
654 (IV) JWH-250 (1-Pentyl-3-(2-methoxyphenylacetyl)indole).
655 (V) JWH-251 (1-Pentyl-3-(2-methylphenylacetyl)indole).
656 (VI) JWH-302 (1-Pentyl-3-(3-methoxyphenylacetyl)indole).
657 (VII) Cannabipiperidiethanone.
658 (VIII) RCS-8 (1-(2-Cyclohexylethyl)-3-(2-
659 methoxyphenylacetyl)indole).
660 f. Cyclohexylphenols.—Any compound containing a
661 cyclohexylphenol structure, with or without substitution at the
662 5-position of the phenolic ring to any extent, whether or not
663 substituted on the cyclohexyl ring to any extent, including, but
664 not limited to:
665 (I) CP 47,497 (2-(3-Hydroxycyclohexyl)-5-(2-methyloctan-2-
666 yl)phenol).
667 (II) Cannabicyclohexanol (CP 47,497 dimethyloctyl (C8)
668 homologue).
669 (III) CP-55,940 (2-(3-Hydroxy-6-propanol-cyclohexyl)-5-(2-
670 methyloctan-2-yl)phenol).
671 g. Benzoylindoles and Benzoylindazoles.—Any compound
672 containing a benzoylindole or benzoylindazole structure, with or
673 without substitution on the indole or indazole ring to any
674 extent, whether or not substituted on the phenyl ring to any
675 extent, including, but not limited to:
Page 27 of 57
CODING: Words stricken are deletions; words underlined are additions.
hb309-00
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
HB 309 2026
676 (I) AM-679 (1-Pentyl-3-(2-iodobenzoyl)indole).
677 (II) AM-694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl)indole).
678 (III) AM-1241 (1-[(N-Methyl-2-piperidinyl)methyl]-3-(2-
679 iodo-5-nitrobenzoyl)indole).
680 (IV) Pravadoline (1-[2-(4-Morpholinyl)ethyl]-2-methyl-3-
681 (4-methoxybenzoyl)indole).
682 (V) AM-2233 (1-[(N-Methyl-2-piperidinyl)methyl]-3-(2-
683 iodobenzoyl)indole).
684 (VI) RCS-4 (1-Pentyl-3-(4-methoxybenzoyl)indole).
685 (VII) RCS-4 C4 homologue (1-Butyl-3-(4-
686 methoxybenzoyl)indole).
687 (VIII) AM-630 (1-[2-(4-Morpholinyl)ethyl]-2-methyl-6-iodo-
688 3-(4-methoxybenzoyl)indole).
689 h. Tetramethylcyclopropanoylindoles and
690 Tetramethylcyclopropanoylindazoles.—Any compound containing a
691 tetramethylcyclopropanoylindole or
692 tetramethylcyclopropanoylindazole structure, with or without
693 substitution on the indole or indazole ring to any extent,
694 whether or not substituted on the tetramethylcyclopropyl group
695 to any extent, including, but not limited to:
696 (I) UR-144 (1-Pentyl-3-(2,2,3,3-
697 tetramethylcyclopropanoyl)indole).
698 (II) XLR11 (1-(5-Fluoropentyl)-3-(2,2,3,3-
699 tetramethylcyclopropanoyl)indole).
700 (III) Chloro UR-144 (1-(Chloropentyl)-3-(2,2,3,3-
Page 28 of 57
CODING: Words stricken are deletions; words underlined are additions.
hb309-00
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
HB 309 2026
701 tetramethylcyclopropanoyl)indole).
702 (IV) A-796,260 (1-[2-(4-Morpholinyl)ethyl]-3-(2,2,3,3-
703 tetramethylcyclopropanoyl)indole).
704 (V) A-834,735 (1-[4-(Tetrahydropyranyl)methyl]-3-(2,2,3,3-
705 tetramethylcyclopropanoyl)indole).
706 (VI) M-144 (1-(5-Fluoropentyl)-2-methyl-3-(2,2,3,3-
707 tetramethylcyclopropanoyl)indole).
708 (VII) FUB-144 (1-(4-Fluorobenzyl)-3-(2,2,3,3-
709 tetramethylcyclopropanoyl)indole).
710 (VIII) FAB-144 (1-(5-Fluoropentyl)-3-(2,2,3,3-
711 tetramethylcyclopropanoyl)indazole).
712 (IX) XLR12 (1-(4,4,4-Trifluorobutyl)-3-(2,2,3,3-
713 tetramethylcyclopropanoyl)indole).
714 (X) AB-005 (1-[(1-Methyl-2-piperidinyl)methyl]-3-(2,2,3,3-
715 tetramethylcyclopropanoyl)indole).
716 i. Adamantoylindoles, Adamantoylindazoles, Adamantylindole
717 carboxamides, and Adamantylindazole carboxamides.—Any compound
718 containing an adamantoyl indole, adamantoyl indazole, adamantyl
719 indole carboxamide, or adamantyl indazole carboxamide structure,
720 with or without substitution on the indole or indazole ring to
721 any extent, whether or not substituted on the adamantyl ring to
722 any extent, including, but not limited to:
723 (I) AKB48 (N-Adamant-1-yl 1-pentylindazole-3-carboxamide).
724 (II) Fluoro AKB48 (N-Adamant-1-yl 1-
725 (fluoropentyl)indazole-3-carboxamide).
Page 29 of 57
CODING: Words stricken are deletions; words underlined are additions.
hb309-00
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
HB 309 2026
726 (III) STS-135 (N-Adamant-1-yl 1-(5-fluoropentyl)indole-3-
727 carboxamide).
728 (IV) AM-1248 (1-(1-Methylpiperidine)methyl-3-(1-
729 adamantoyl)indole).
730 (V) AB-001 (1-Pentyl-3-(1-adamantoyl)indole).
731 (VI) APICA (N-Adamant-1-yl 1-pentylindole-3-carboxamide).
732 (VII) Fluoro AB-001 (1-(Fluoropentyl)-3-(1-
733 adamantoyl)indole).
734 j. Quinolinylindolecarboxylates,
735 Quinolinylindazolecarboxylates, Quinolinylindolecarboxamides,
736 and Quinolinylindazolecarboxamides.—Any compound containing a
737 quinolinylindole carboxylate, quinolinylindazole carboxylate,
738 isoquinolinylindole carboxylate, isoquinolinylindazole
739 carboxylate, quinolinylindole carboxamide, quinolinylindazole
740 carboxamide, isoquinolinylindole carboxamide, or
741 isoquinolinylindazole carboxamide structure, with or without
742 substitution on the indole or indazole ring to any extent,
743 whether or not substituted on the quinoline or isoquinoline ring
744 to any extent, including, but not limited to:
745 (I) PB-22 (8-Quinolinyl 1-pentylindole-3-carboxylate).
746 (II) Fluoro PB-22 (8-Quinolinyl 1-(fluoropentyl)indole-3-
747 carboxylate).
748 (III) BB-22 (8-Quinolinyl 1-(cyclohexylmethyl)indole-3-
749 carboxylate).
750 (IV) FUB-PB-22 (8-Quinolinyl 1-(4-fluorobenzyl)indole-3-
Page 30 of 57
CODING: Words stricken are deletions; words underlined are additions.
hb309-00
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
HB 309 2026
751 carboxylate).
752 (V) NPB-22 (8-Quinolinyl 1-pentylindazole-3-carboxylate).
753 (VI) Fluoro NPB-22 (8-Quinolinyl 1-(fluoropentyl)indazole-
754 3-carboxylate).
755 (VII) FUB-NPB-22 (8-Quinolinyl 1-(4-fluorobenzyl)indazole-
756 3-carboxylate).
757 (VIII) THJ (8-Quinolinyl 1-pentylindazole-3-carboxamide).
758 (IX) Fluoro THJ (8-Quinolinyl 1-(fluoropentyl)indazole-3-
759 carboxamide).
760 k. Naphthylindolecarboxylates and
761 Naphthylindazolecarboxylates.—Any compound containing a
762 naphthylindole carboxylate or naphthylindazole carboxylate
763 structure, with or without substitution on the indole or
764 indazole ring to any extent, whether or not substituted on the
765 naphthyl ring to any extent, including, but not limited to:
766 (I) NM-2201 (1-Naphthalenyl 1-(5-fluoropentyl)indole-3-
767 carboxylate).
768 (II) SDB-005 (1-Naphthalenyl 1-pentylindazole-3-
769 carboxylate).
770 (III) Fluoro SDB-005 (1-Naphthalenyl 1-
771 (fluoropentyl)indazole-3-carboxylate).
772 (IV) FDU-PB-22 (1-Naphthalenyl 1-(4-fluorobenzyl)indole-3-
773 carboxylate).
774 (V) 3-CAF (2-Naphthalenyl 1-(2-fluorophenyl)indazole-3-
775 carboxylate).
Page 31 of 57
CODING: Words stricken are deletions; words underlined are additions.
hb309-00
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
HB 309 2026
776 l. Naphthylindole carboxamides and Naphthylindazole
777 carboxamides.—Any compound containing a naphthylindole
778 carboxamide or naphthylindazole carboxamide structure, with or
779 without substitution on the indole or indazole ring to any
780 extent, whether or not substituted on the naphthyl ring to any
781 extent, including, but not limited to:
782 (I) NNEI (N-Naphthalen-1-yl 1-pentylindole-3-carboxamide).
783 (II) Fluoro-NNEI (N-Naphthalen-1-yl 1-
784 (fluoropentyl)indole-3-carboxamide).
785 (III) Chloro-NNEI (N-Naphthalen-1-yl 1-
786 (chloropentyl)indole-3-carboxamide).
787 (IV) MN-18 (N-Naphthalen-1-yl 1-pentylindazole-3-
788 carboxamide).
789 (V) Fluoro MN-18 (N-Naphthalen-1-yl 1-
790 (fluoropentyl)indazole-3-carboxamide).
791 m. Alkylcarbonyl indole carboxamides, Alkylcarbonyl
792 indazole carboxamides, Alkylcarbonyl indole carboxylates, and
793 Alkylcarbonyl indazole carboxylates.—Any compound containing an
794 alkylcarbonyl group, including 1-amino-3-methyl-1-oxobutan-2-yl,
795 1-methoxy-3-methyl-1-oxobutan-2-yl, 1-amino-1-oxo-3-
796 phenylpropan-2-yl, 1-methoxy-1-oxo-3-phenylpropan-2-yl, with an
797 indole carboxamide, indazole carboxamide, indole carboxylate, or
798 indazole carboxylate, with or without substitution on the indole
799 or indazole ring to any extent, whether or not substituted on
800 the alkylcarbonyl group to any extent, including, but not
Page 32 of 57
CODING: Words stricken are deletions; words underlined are additions.
hb309-00
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
HB 309 2026
801 limited to:
802 (I) ADBICA, (N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-
803 pentylindole-3-carboxamide).
804 (II) Fluoro ADBICA (N-(1-Amino-3,3-dimethyl-1-oxobutan-2-
805 yl)-1-(fluoropentyl)indole-3-carboxamide).
806 (III) Fluoro ABICA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-
807 1-(fluoropentyl)indole-3-carboxamide).
808 (IV) AB-PINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-
809 pentylindazole-3-carboxamide).
810 (V) Fluoro AB-PINACA (N-(1-Amino-3-methyl-1-oxobutan-2-
811 yl)-1-(fluoropentyl)indazole-3-carboxamide).
812 (VI) ADB-PINACA (N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-
813 1-pentylindazole-3-carboxamide).
814 (VII) Fluoro ADB-PINACA (N-(1-Amino-3,3-dimethyl-1-
815 oxobutan-2-yl)-1-(fluoropentyl)indazole-3-carboxamide).
816 (VIII) AB-FUBINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-
817 1-(4-fluorobenzyl)indazole-3-carboxamide).
818 (IX) ADB-FUBINACA (N-(1-Amino-3,3-dimethyl-1-oxobutan-2-
819 yl)-1-(4-fluorobenzyl)indazole-3-carboxamide).
820 (X) AB-CHMINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-
821 (cyclohexylmethyl)indazole-3-carboxamide).
822 (XI) MA-CHMINACA (N-(1-Methoxy-3-methyl-1-oxobutan-2-yl)-
823 1-(cyclohexylmethyl)indazole-3-carboxamide).
824 (XII) MAB-CHMINACA (N-(1-Amino-3,3-dimethyl-1-oxobutan-2-
825 yl)-1-(cyclohexylmethyl)indazole-3-carboxamide).
Page 33 of 57
CODING: Words stricken are deletions; words underlined are additions.
hb309-00
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
HB 309 2026
826 (XIII) AMB (N-(1-Methoxy-3-methyl-1-oxobutan-2-yl)-1-
827 pentylindazole-3-carboxamide).
828 (XIV) Fluoro-AMB (N-(1-Methoxy-3-methyl-1-oxobutan-2-yl)-
829 1-(fluoropentyl)indazole-3-carboxamide).
830 (XV) FUB-AMB (N-(1-Methoxy-3-methyl-1-oxobutan-2-yl)-1-(4-
831 fluorobenzyl)indazole-3-carboxamide).
832 (XVI) MDMB-CHMINACA (N-(1-Methoxy-3,3-dimethyl-1-oxobutan-
833 2-yl)-1-(cyclohexylmethyl)indazole-3-carboxamide).
834 (XVII) MDMB-FUBINACA (N-(1-Methoxy-3,3-dimethyl-1-
835 oxobutan-2-yl)-1-(4-fluorobenzyl)indazole-3-carboxamide).
836 (XVIII) MDMB-CHMICA (N-(1-Methoxy-3,3-dimethyl-1-oxobutan-
837 2-yl)-1-(cyclohexylmethyl)indole-3-carboxamide).
838 (XIX) PX-1 (N-(1-Amino-1-oxo-3-phenylpropan-2-yl)-1-(5-
839 fluoropentyl)indole-3-carboxamide).
840 (XX) PX-2 (N-(1-Amino-1-oxo-3-phenylpropan-2-yl)-1-(5-
841 fluoropentyl)indazole-3-carboxamide).
842 (XXI) PX-3 (N-(1-Amino-1-oxo-3-phenylpropan-2-yl)-1-
843 (cyclohexylmethyl)indazole-3-carboxamide).
844 (XXII) PX-4 (N-(1-Amino-1-oxo-3-phenylpropan-2-yl)-1-(4-
845 fluorobenzyl)indazole-3-carboxamide).
846 (XXIII) MO-CHMINACA (N-(1-Methoxy-3,3-dimethyl-1-oxobutan-
847 2-yl)-1-(cyclohexylmethyl)indazole-3-carboxylate).
848 n. Cumylindolecarboxamides and Cumylindazolecarboxamides.—
849 Any compound containing a N-(2-phenylpropan-2-yl) indole
850 carboxamide or N-(2-phenylpropan-2-yl) indazole carboxamide
Page 34 of 57
CODING: Words stricken are deletions; words underlined are additions.
hb309-00
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
HB 309 2026
851 structure, with or without substitution on the indole or
852 indazole ring to any extent, whether or not substituted on the
853 phenyl ring of the cumyl group to any extent, including, but not
854 limited to:
855 (I) CUMYL-PICA (N-(2-Phenylpropan-2-yl)-1-pentylindole-3-
856 carboxamide).
857 (II) Fluoro CUMYL-PICA (N-(2-Phenylpropan-2-yl)-1-
858 (fluoropentyl)indole-3-carboxamide).
859 o. Other Synthetic Cannabinoids.—Any material, compound,
860 mixture, or preparation that contains any quantity of a
861 Synthetic Cannabinoid, as described in sub-subparagraphs a.-n.:
862 (I) With or without modification or replacement of a
863 carbonyl, carboxamide, alkylene, alkyl, or carboxylate linkage
864 between either two core rings, or linkage between a core ring
865 and group structure, with or without the addition of a carbon or
866 replacement of a carbon;
867 (II) With or without replacement of a core ring or group
868 structure, whether or not substituted on the ring or group
869 structures to any extent; and
870 (III) Is a cannabinoid receptor agonist, unless
871 specifically excepted or unless listed in another schedule or
872 contained within a pharmaceutical product approved by the United
873 States Food and Drug Administration.
874 191. Substituted Cathinones.—Unless specifically excepted,
875 listed in another schedule, or contained within a pharmaceutical
Page 35 of 57
CODING: Words stricken are deletions; words underlined are additions.
hb309-00
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
HB 309 2026
876 product approved by the United States Food and Drug
877 Administration, any material, compound, mixture, or preparation,
878 including its salts, isomers, esters, or ethers, and salts of
879 isomers, esters, or ethers, whenever the existence of such salts
880 is possible within any of the following specific chemical
881 designations:
882 a. Any compound containing a 2-amino-1-phenyl-1-propanone
883 structure;
884 b. Any compound containing a 2-amino-1-naphthyl-1-
885 propanone structure; or
886 c. Any compound containing a 2-amino-1-thiophenyl-1-
887 propanone structure, whether or not the compound is further
888 modified:
889 (I) With or without substitution on the ring system to any
890 extent with alkyl, alkylthio, thio, fused alkylenedioxy, alkoxy,
891 haloalkyl, hydroxyl, nitro, fused furan, fused benzofuran, fused
892 dihydrofuran, fused tetrahydropyran, fused alkyl ring, or halide
893 substituents;
894 (II) With or without substitution at the 3-propanone
895 position with an alkyl substituent or removal of the methyl
896 group at the 3-propanone position;
897 (III) With or without substitution at the 2-amino nitrogen
898 atom with alkyl, dialkyl, acetyl, or benzyl groups, whether or
899 not further substituted in the ring system; or
900 (IV) With or without inclusion of the 2-amino nitrogen
Page 36 of 57
CODING: Words stricken are deletions; words underlined are additions.
hb309-00
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
HB 309 2026
901 atom in a cyclic structure, including, but not limited to:
902 (A) Methcathinone.
903 (B) Ethcathinone.
904 (C) Methylone (3,4-Methylenedioxymethcathinone).
905 (D) 2,3-Methylenedioxymethcathinone.
906 (E) MDPV (3,4-Methylenedioxypyrovalerone).
907 (F) Methylmethcathinone.
908 (G) Methoxymethcathinone.
909 (H) Fluoromethcathinone.
910 (I) Methylethcathinone.
911 (J) Butylone (3,4-Methylenedioxy-alpha-
912 methylaminobutyrophenone).
913 (K) Ethylone (3,4-Methylenedioxy-N-ethylcathinone).
914 (L) BMDP (3,4-Methylenedioxy-N-benzylcathinone).
915 (M) Naphyrone (Naphthylpyrovalerone).
916 (N) Bromomethcathinone.
917 (O) Buphedrone (alpha-Methylaminobutyrophenone).
918 (P) Eutylone (3,4-Methylenedioxy-alpha-
919 ethylaminobutyrophenone).
920 (Q) Dimethylcathinone.
921 (R) Dimethylmethcathinone.
922 (S) Pentylone (3,4-Methylenedioxy-alpha-
923 methylaminovalerophenone).
924 (T) Pentedrone (alpha-Methylaminovalerophenone).
925 (U) MDPPP (3,4-Methylenedioxy-alpha-
Page 37 of 57
CODING: Words stricken are deletions; words underlined are additions.
hb309-00
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
HB 309 2026
926 pyrrolidinopropiophenone).
927 (V) MDPBP (3,4-Methylenedioxy-alpha-
928 pyrrolidinobutyrophenone).
929 (W) MPPP (Methyl-alpha-pyrrolidinopropiophenone).
930 (X) PPP (Pyrrolidinopropiophenone).
931 (Y) PVP (Pyrrolidinovalerophenone) or
932 (Pyrrolidinopentiophenone).
933 (Z) MOPPP (Methoxy-alpha-pyrrolidinopropiophenone).
934 (AA) MPHP (Methyl-alpha-pyrrolidinohexanophenone).
935 (BB) F-MABP (Fluoromethylaminobutyrophenone).
936 (CC) Me-EABP (Methylethylaminobutyrophenone).
937 (DD) PBP (Pyrrolidinobutyrophenone).
938 (EE) MeO-PBP (Methoxypyrrolidinobutyrophenone).
939 (FF) Et-PBP (Ethylpyrrolidinobutyrophenone).
940 (GG) 3-Me-4-MeO-MCAT (3-Methyl-4-Methoxymethcathinone).
941 (HH) Dimethylone (3,4-Methylenedioxy-N,N-
942 dimethylcathinone).
943 (II) 3,4-Methylenedioxy-N,N-diethylcathinone.
944 (JJ) 3,4-Methylenedioxy-N-acetylcathinone.
945 (KK) 3,4-Methylenedioxy-N-acetylmethcathinone.
946 (LL) 3,4-Methylenedioxy-N-acetylethcathinone.
947 (MM) Methylbuphedrone (Methyl-alpha-
948 methylaminobutyrophenone).
949 (NN) Methyl-alpha-methylaminohexanophenone.
950 (OO) N-Ethyl-N-methylcathinone.
Page 38 of 57
CODING: Words stricken are deletions; words underlined are additions.
hb309-00
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
HB 309 2026
951 (PP) PHP (Pyrrolidinohexanophenone).
952 (QQ) PV8 (Pyrrolidinoheptanophenone).
953 (RR) Chloromethcathinone.
954 (SS) 4-Bromo-2,5-dimethoxy-alpha-aminoacetophenone.
955 192. Substituted Phenethylamines.—Unless specifically
956 excepted or unless listed in another schedule, or contained
957 within a pharmaceutical product approved by the United States
958 Food and Drug Administration, any material, compound, mixture,
959 or preparation, including its salts, isomers, esters, or ethers,
960 and salts of isomers, esters, or ethers, whenever the existence
961 of such salts is possible within any of the following specific
962 chemical designations, any compound containing a phenethylamine
963 structure, without a beta-keto group, and without a benzyl group
964 attached to the amine group, whether or not the compound is
965 further modified with or without substitution on the phenyl ring
966 to any extent with alkyl, alkylthio, nitro, alkoxy, thio,
967 halide, fused alkylenedioxy, fused furan, fused benzofuran,
968 fused dihydrofuran, or fused tetrahydropyran substituents,
969 whether or not further substituted on a ring to any extent, with
970 or without substitution at the alpha or beta position by any
971 alkyl substituent, with or without substitution at the nitrogen
972 atom, and with or without inclusion of the 2-amino nitrogen atom
973 in a cyclic structure, including, but not limited to:
974 a. 2C-B (4-Bromo-2,5-dimethoxyphenethylamine).
975 b. 2C-E (4-Ethyl-2,5-dimethoxyphenethylamine).
Page 39 of 57
CODING: Words stricken are deletions; words underlined are additions.
hb309-00
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
HB 309 2026
976 c. 2C-T-4 (4-Isopropylthio-2,5-dimethoxyphenethylamine).
977 d. 2C-C (4-Chloro-2,5-dimethoxyphenethylamine).
978 e. 2C-T (4-Methylthio-2,5-dimethoxyphenethylamine).
979 f. 2C-T-2 (4-Ethylthio-2,5-dimethoxyphenethylamine).
980 g. 2C-T-7 (4-(n)-Propylthio-2,5-dimethoxyphenethylamine).
981 h. 2C-I (4-Iodo-2,5-dimethoxyphenethylamine).
982 i. 2C-D (4-Methyl-2,5-dimethoxyphenethylamine).
983 j. 2C-H (2,5-Dimethoxyphenethylamine).
984 k. 2C-N (4-Nitro-2,5-dimethoxyphenethylamine).
985 l. 2C-P (4-(n)-Propyl-2,5-dimethoxyphenethylamine).
986 m. MDMA (3,4-Methylenedioxymethamphetamine).
987 n. MBDB (Methylbenzodioxolylbutanamine) or (3,4-
988 Methylenedioxy-N-methylbutanamine).
989 o. MDA (3,4-Methylenedioxyamphetamine).
990 p. 2,5-Dimethoxyamphetamine.
991 q. Fluoroamphetamine.
992 r. Fluoromethamphetamine.
993 s. MDEA (3,4-Methylenedioxy-N-ethylamphetamine).
994 t. DOB (4-Bromo-2,5-dimethoxyamphetamine).
995 u. DOC (4-Chloro-2,5-dimethoxyamphetamine).
996 v. DOET (4-Ethyl-2,5-dimethoxyamphetamine).
997 w. DOI (4-Iodo-2,5-dimethoxyamphetamine).
998 x. DOM (4-Methyl-2,5-dimethoxyamphetamine).
999 y. PMA (4-Methoxyamphetamine).
1000 z. N-Ethylamphetamine.
Page 40 of 57
CODING: Words stricken are deletions; words underlined are additions.
hb309-00
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
HB 309 2026
1001 aa. 3,4-Methylenedioxy-N-hydroxyamphetamine.
1002 bb. 5-Methoxy-3,4-methylenedioxyamphetamine.
1003 cc. PMMA (4-Methoxymethamphetamine).
1004 dd. N,N-Dimethylamphetamine.
1005 ee. 3,4,5-Trimethoxyamphetamine.
1006 ff. 4-APB (4-(2-Aminopropyl)benzofuran).
1007 gg. 5-APB (5-(2-Aminopropyl)benzofuran).
1008 hh. 6-APB (6-(2-Aminopropyl)benzofuran).
1009 ii. 7-APB (7-(2-Aminopropyl)benzofuran).
1010 jj. 4-APDB (4-(2-Aminopropyl)-2,3-dihydrobenzofuran).
1011 kk. 5-APDB (5-(2-Aminopropyl)-2,3-dihydrobenzofuran).
1012 ll. 6-APDB (6-(2-Aminopropyl)-2,3-dihydrobenzofuran).
1013 mm. 7-APDB (7-(2-Aminopropyl)-2,3-dihydrobenzofuran).
1014 nn. 4-MAPB (4-(2-Methylaminopropyl)benzofuran).
1015 oo. 5-MAPB (5-(2-Methylaminopropyl)benzofuran).
1016 pp. 6-MAPB (6-(2-Methylaminopropyl)benzofuran).
1017 qq. 7-MAPB (7-(2-Methylaminopropyl)benzofuran).
1018 rr. 5-EAPB (5-(2-Ethylaminopropyl)benzofuran).
1019 ss. 5-MAPDB (5-(2-Methylaminopropyl)-2,3-
1020 dihydrobenzofuran),
1021
1022 which does not include phenethylamine, mescaline as described in
1023 subparagraph 20., substituted cathinones as described in
1024 subparagraph 191., N-Benzyl phenethylamine compounds as
1025 described in subparagraph 193., or methamphetamine as described
Page 41 of 57
CODING: Words stricken are deletions; words underlined are additions.
hb309-00
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
HB 309 2026
1026 in subparagraph (2)(c)5.
1027 193. N-Benzyl Phenethylamine Compounds.—Unless
1028 specifically excepted or unless listed in another schedule, or
1029 contained within a pharmaceutical product approved by the United
1030 States Food and Drug Administration, any material, compound,
1031 mixture, or preparation, including its salts, isomers, esters,
1032 or ethers, and salts of isomers, esters, or ethers, whenever the
1033 existence of such salts is possible within any of the following
1034 specific chemical designations, any compound containing a
1035 phenethylamine structure without a beta-keto group, with
1036 substitution on the nitrogen atom of the amino group with a
1037 benzyl substituent, with or without substitution on the phenyl
1038 or benzyl ring to any extent with alkyl, alkoxy, thio,
1039 alkylthio, halide, fused alkylenedioxy, fused furan, fused
1040 benzofuran, or fused tetrahydropyran substituents, whether or
1041 not further substituted on a ring to any extent, with or without
1042 substitution at the alpha position by any alkyl substituent,
1043 including, but not limited to:
1044 a. 25B-NBOMe (4-Bromo-2,5-dimethoxy-[N-(2-
1045 methoxybenzyl)]phenethylamine).
1046 b. 25B-NBOH (4-Bromo-2,5-dimethoxy-[N-(2-
1047 hydroxybenzyl)]phenethylamine).
1048 c. 25B-NBF (4-Bromo-2,5-dimethoxy-[N-(2-
1049 fluorobenzyl)]phenethylamine).
1050 d. 25B-NBMD (4-Bromo-2,5-dimethoxy-[N-(2,3-
Page 42 of 57
CODING: Words stricken are deletions; words underlined are additions.
hb309-00
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
HB 309 2026
1051 methylenedioxybenzyl)]phenethylamine).
1052 e. 25I-NBOMe (4-Iodo-2,5-dimethoxy-[N-(2-
1053 methoxybenzyl)]phenethylamine).
1054 f. 25I-NBOH (4-Iodo-2,5-dimethoxy-[N-(2-
1055 hydroxybenzyl)]phenethylamine).
1056 g. 25I-NBF (4-Iodo-2,5-dimethoxy-[N-(2-
1057 fluorobenzyl)]phenethylamine).
1058 h. 25I-NBMD (4-Iodo-2,5-dimethoxy-[N-(2,3-
1059 methylenedioxybenzyl)]phenethylamine).
1060 i. 25T2-NBOMe (4-Methylthio-2,5-dimethoxy-[N-(2-
1061 methoxybenzyl)]phenethylamine).
1062 j. 25T4-NBOMe (4-Isopropylthio-2,5-dimethoxy-[N-(2-
1063 methoxybenzyl)]phenethylamine).
1064 k. 25T7-NBOMe (4-(n)-Propylthio-2,5-dimethoxy-[N-(2-
1065 methoxybenzyl)]phenethylamine).
1066 l. 25C-NBOMe (4-Chloro-2,5-dimethoxy-[N-(2-
1067 methoxybenzyl)]phenethylamine).
1068 m. 25C-NBOH (4-Chloro-2,5-dimethoxy-[N-(2-
1069 hydroxybenzyl)]phenethylamine).
1070 n. 25C-NBF (4-Chloro-2,5-dimethoxy-[N-(2-
1071 fluorobenzyl)]phenethylamine).
1072 o. 25C-NBMD (4-Chloro-2,5-dimethoxy-[N-(2,3-
1073 methylenedioxybenzyl)]phenethylamine).
1074 p. 25H-NBOMe (2,5-Dimethoxy-[N-(2-
1075 methoxybenzyl)]phenethylamine).
Page 43 of 57
CODING: Words stricken are deletions; words underlined are additions.
hb309-00
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
HB 309 2026
1076 q. 25H-NBOH (2,5-Dimethoxy-[N-(2-
1077 hydroxybenzyl)]phenethylamine).
1078 r. 25H-NBF (2,5-Dimethoxy-[N-(2-
1079 fluorobenzyl)]phenethylamine).
1080 s. 25D-NBOMe (4-Methyl-2,5-dimethoxy-[N-(2-
1081 methoxybenzyl)]phenethylamine),
1082
1083 which does not include substituted cathinones as described in
1084 subparagraph 191.
1085 194. Substituted Tryptamines.—Unless specifically excepted
1086 or unless listed in another schedule, or contained within a
1087 pharmaceutical product approved by the United States Food and
1088 Drug Administration, any material, compound, mixture, or
1089 preparation containing a 2-(1H-indol-3-yl)ethanamine, for
1090 example tryptamine, structure with or without mono- or di-
1091 substitution of the amine nitrogen with alkyl or alkenyl groups,
1092 or by inclusion of the amino nitrogen atom in a cyclic
1093 structure, whether or not substituted at the alpha position with
1094 an alkyl group, whether or not substituted on the indole ring to
1095 any extent with any alkyl, alkoxy, halo, hydroxyl, or acetoxy
1096 groups, including, but not limited to:
1097 a. Alpha-Ethyltryptamine.
1098 b. Bufotenine.
1099 c. DET (Diethyltryptamine).
1100 d. DMT (Dimethyltryptamine).
Page 44 of 57
CODING: Words stricken are deletions; words underlined are additions.
hb309-00
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
HB 309 2026
1101 e. MET (N-Methyl-N-ethyltryptamine).
1102 f. DALT (N,N-Diallyltryptamine).
1103 g. EiPT (N-Ethyl-N-isopropyltryptamine).
1104 h. MiPT (N-Methyl-N-isopropyltryptamine).
1105 i. 5-Hydroxy-AMT (5-Hydroxy-alpha-methyltryptamine).
1106 j. 5-Hydroxy-N-methyltryptamine.
1107 k. 5-MeO-MiPT (5-Methoxy-N-methyl-N-isopropyltryptamine).
1108 l. 5-MeO-AMT (5-Methoxy-alpha-methyltryptamine).
1109 m. Methyltryptamine.
1110 n. 5-MeO-DMT (5-Methoxy-N,N-dimethyltryptamine).
1111 o. 5-Me-DMT (5-Methyl-N,N-dimethyltryptamine).
1112 p. 5-MeO-DiPT (5-Methoxy-N,N-Diisopropyltryptamine).
1113 q. DiPT (N,N-Diisopropyltryptamine).
1114 r. DPT (N,N-Dipropyltryptamine).
1115 s. 4-Hydroxy-DiPT (4-Hydroxy-N,N-diisopropyltryptamine).
1116 t. 5-MeO-DALT (5-Methoxy-N,N-Diallyltryptamine).
1117 u. 4-AcO-DMT (4-Acetoxy-N,N-dimethyltryptamine).
1118 v. 4-AcO-DiPT (4-Acetoxy-N,N-diisopropyltryptamine).
1119 w. 4-Hydroxy-DET (4-Hydroxy-N,N-diethyltryptamine).
1120 x. 4-Hydroxy-MET (4-Hydroxy-N-methyl-N-ethyltryptamine).
1121 y. 4-Hydroxy-MiPT (4-Hydroxy-N-methyl-N-
1122 isopropyltryptamine).
1123 z. Methyl-alpha-ethyltryptamine.
1124 aa. Bromo-DALT (Bromo-N,N-diallyltryptamine),
1125
Page 45 of 57
CODING: Words stricken are deletions; words underlined are additions.
hb309-00
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
HB 309 2026
1126 which does not include tryptamine, psilocyn as described in
1127 subparagraph 34., or psilocybin as described in subparagraph 33.
1128 195. Substituted Phenylcyclohexylamines.—Unless
1129 specifically excepted or unless listed in another schedule, or
1130 contained within a pharmaceutical product approved by the United
1131 States Food and Drug Administration, any material, compound,
1132 mixture, or preparation containing a phenylcyclohexylamine
1133 structure, with or without any substitution on the phenyl ring,
1134 any substitution on the cyclohexyl ring, any replacement of the
1135 phenyl ring with a thiophenyl or benzothiophenyl ring, with or
1136 without substitution on the amine with alkyl, dialkyl, or alkoxy
1137 substituents, inclusion of the nitrogen in a cyclic structure,
1138 or any combination of the above, including, but not limited to:
1139 a. BTCP (Benzothiophenylcyclohexylpiperidine) or BCP
1140 (Benocyclidine).
1141 b. PCE (N-Ethyl-1-phenylcyclohexylamine)(Ethylamine analog
1142 of phencyclidine).
1143 c. PCPY (N-(1-Phenylcyclohexyl)-pyrrolidine)(Pyrrolidine
1144 analog of phencyclidine).
1145 d. PCPr (Phenylcyclohexylpropylamine).
1146 e. TCP (1-[1-(2-Thienyl)-cyclohexyl]-piperidine)(Thiophene
1147 analog of phencyclidine).
1148 f. PCEEA (Phenylcyclohexyl(ethoxyethylamine)).
1149 g. PCMPA (Phenylcyclohexyl(methoxypropylamine)).
1150 h. Methoxetamine.
Page 46 of 57
CODING: Words stricken are deletions; words underlined are additions.
hb309-00
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
HB 309 2026
1151 i. 3-Methoxy-PCE ((3-Methoxyphenyl)cyclohexylethylamine).
1152 j. Bromo-PCP ((Bromophenyl)cyclohexylpiperidine).
1153 k. Chloro-PCP ((Chlorophenyl)cyclohexylpiperidine).
1154 l. Fluoro-PCP ((Fluorophenyl)cyclohexylpiperidine).
1155 m. Hydroxy-PCP ((Hydroxyphenyl)cyclohexylpiperidine).
1156 n. Methoxy-PCP ((Methoxyphenyl)cyclohexylpiperidine).
1157 o. Methyl-PCP ((Methylphenyl)cyclohexylpiperidine).
1158 p. Nitro-PCP ((Nitrophenyl)cyclohexylpiperidine).
1159 q. Oxo-PCP ((Oxophenyl)cyclohexylpiperidine).
1160 r. Amino-PCP ((Aminophenyl)cyclohexylpiperidine).
1161 196. W-15, 4-chloro-N-[1-(2-phenylethyl)-2-
1162 piperidinylidene]-benzenesulfonamide.
1163 197. W-18, 4-chloro-N-[1-[2-(4-nitrophenyl)ethyl]-2-
1164 piperidinylidene]-benzenesulfonamide.
1165 198. AH-7921, 3,4-dichloro-N-[[1-
1166 (dimethylamino)cyclohexyl]methyl]-benzamide.
1167 199. U47700, trans-3,4-dichloro-N-[2-
1168 (dimethylamino)cyclohexyl]-N-methyl-benzamide.
1169 200. MT-45, 1-cyclohexyl-4-(1,2-diphenylethyl)-piperazine,
1170 dihydrochloride.
1171 Section 2. Paragraph (i) of subsection (1) of section
1172 893.13, Florida Statutes, is amended to read:
1173 893.13 Prohibited acts; penalties.—
1174 (1)
1175 (i) Except as authorized by this chapter, a person commits
Page 47 of 57
CODING: Words stricken are deletions; words underlined are additions.
hb309-00
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
HB 309 2026
1176 a felony of the first degree, punishable as provided in s.
1177 775.082, s. 775.083, or s. 775.084, and must be sentenced to a
1178 mandatory minimum term of imprisonment of 3 years, if:
1179 1. The person sells, manufactures, or delivers, or
1180 possesses with intent to sell, manufacture, or deliver, any of
1181 the following:
1182 a. Alfentanil, as described in s. 893.03(2)(b)1.;
1183 b. Carfentanil, as described in s. 893.03(2)(b)6.;
1184 c. Fentanyl, as described in s. 893.03(2)(b)9.;
1185 d. Sufentanil, as described in s. 893.03(2)(b)30.;
1186 e. A fentanyl derivative, as described in s.
1187 893.03(1)(a)64. s. 893.03(1)(a)63.;
1188 f. Xylazine, as described in s. 893.03(1)(c)37.;
1189 g.f. A controlled substance analog, as described in s.
1190 893.0356, of any substance described in sub-subparagraphs a.-f.
1191 sub-subparagraphs a.-e.; or
1192 h.g. A mixture containing any substance described in sub-
1193 subparagraphs a.-g. sub-subparagraphs a.-f.; and
1194 2. The substance or mixture listed in subparagraph 1. is
1195 in a form that resembles, or is mixed, granulated, absorbed,
1196 spray-dried, or aerosolized as or onto, coated on, in whole or
1197 in part, or solubilized with or into, a product, when such
1198 product or its packaging further has at least one of the
1199 following attributes:
1200 a. Resembles the trade dress of a branded food product,
Page 48 of 57
CODING: Words stricken are deletions; words underlined are additions.
hb309-00
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
HB 309 2026
1201 consumer food product, or logo food product;
1202 b. Incorporates an actual or fake registered copyright,
1203 service mark, or trademark;
1204 c. Resembles candy, cereal, a gummy, a vitamin, or a
1205 chewable product, such as a gum or gelatin-based product; or
1206 d. Contains a cartoon character imprint.
1207 Section 3. Paragraph (a) of subsection (2) of section
1208 893.131, Florida Statutes, is amended to read:
1209 893.131 Distribution of controlled substances resulting in
1210 overdose or serious bodily injury.—
1211 (2)(a) Except as provided in paragraph (b), a person 18
1212 years of age or older who unlawfully distributes:
1213 1. Heroin, as described in s. 893.03(1)(b)11.;
1214 2. Alfentanil, as described in s. 893.03(2)(b)1.;
1215 3. Carfentanil, as described in s. 893.03(2)(b)6.;
1216 4. Fentanyl, as described in s. 893.03(2)(b)9.;
1217 5. Sufentanil, as described in s. 893.03(2)(b)30.;
1218 6. Fentanyl derivatives, as described in s.
1219 893.03(1)(a)64. s. 893.03(1)(a)63.;
1220 7. A controlled substance analog, as described in s.
1221 893.0356, of any substance specified in subparagraphs 1.-6.; or
1222 8. A mixture containing any substance specified in
1223 subparagraphs 1.-7.,
1224
1225 and an overdose or serious bodily injury of the user results,
Page 49 of 57
CODING: Words stricken are deletions; words underlined are additions.
hb309-00
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
HB 309 2026
1226 commits a felony of the second degree, punishable as provided in
1227 s. 775.082, s. 775.083, or s. 775.084, when such substance or
1228 mixture is proven to have caused or been a substantial factor in
1229 causing the overdose or serious bodily injury of the user.
1230 Section 4. Paragraph (c) of subsection (1) of section
1231 893.135, Florida Statutes, is amended to read:
1232 893.135 Trafficking; mandatory sentences; suspension or
1233 reduction of sentences; conspiracy to engage in trafficking.—
1234 (1) Except as authorized in this chapter or in chapter 499
1235 and notwithstanding the provisions of s. 893.13:
1236 (c)1. A person who knowingly sells, purchases,
1237 manufactures, delivers, or brings into this state, or who is
1238 knowingly in actual or constructive possession of, 4 grams or
1239 more of any morphine, opium, hydromorphone, or any salt,
1240 derivative, isomer, or salt of an isomer thereof, including
1241 heroin, as described in s. 893.03(1)(b), (2)(a), (3)(c)3., or
1242 (3)(c)4., or 4 grams or more of any mixture containing any such
1243 substance, but less than 30 kilograms of such substance or
1244 mixture, commits a felony of the first degree, which felony
1245 shall be known as "trafficking in illegal drugs," punishable as
1246 provided in s. 775.082, s. 775.083, or s. 775.084. If the
1247 quantity involved:
1248 a. Is 4 grams or more, but less than 14 grams, such person
1249 shall be sentenced to a mandatory minimum term of imprisonment
1250 of 3 years and shall be ordered to pay a fine of $50,000.
Page 50 of 57
CODING: Words stricken are deletions; words underlined are additions.
hb309-00
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
HB 309 2026
1251 b. Is 14 grams or more, but less than 28 grams, such
1252 person shall be sentenced to a mandatory minimum term of
1253 imprisonment of 15 years and shall be ordered to pay a fine of
1254 $100,000.
1255 c. Is 28 grams or more, but less than 30 kilograms, such
1256 person shall be sentenced to a mandatory minimum term of
1257 imprisonment of 25 years and shall be ordered to pay a fine of
1258 $500,000.
1259 2. A person who knowingly sells, purchases, manufactures,
1260 delivers, or brings into this state, or who is knowingly in
1261 actual or constructive possession of, 28 grams or more of
1262 hydrocodone, as described in s. 893.03(2)(a)1.k., codeine, as
1263 described in s. 893.03(2)(a)1.g., or any salt thereof, or 28
1264 grams or more of any mixture containing any such substance,
1265 commits a felony of the first degree, which felony shall be
1266 known as "trafficking in hydrocodone," punishable as provided in
1267 s. 775.082, s. 775.083, or s. 775.084. If the quantity involved:
1268 a. Is 28 grams or more, but less than 50 grams, such
1269 person shall be sentenced to a mandatory minimum term of
1270 imprisonment of 3 years and shall be ordered to pay a fine of
1271 $50,000.
1272 b. Is 50 grams or more, but less than 100 grams, such
1273 person shall be sentenced to a mandatory minimum term of
1274 imprisonment of 7 years and shall be ordered to pay a fine of
1275 $100,000.
Page 51 of 57
CODING: Words stricken are deletions; words underlined are additions.
hb309-00
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
HB 309 2026
1276 c. Is 100 grams or more, but less than 300 grams, such
1277 person shall be sentenced to a mandatory minimum term of
1278 imprisonment of 15 years and shall be ordered to pay a fine of
1279 $500,000.
1280 d. Is 300 grams or more, but less than 30 kilograms, such
1281 person shall be sentenced to a mandatory minimum term of
1282 imprisonment of 25 years and shall be ordered to pay a fine of
1283 $750,000.
1284 3. A person who knowingly sells, purchases, manufactures,
1285 delivers, or brings into this state, or who is knowingly in
1286 actual or constructive possession of, 7 grams or more of
1287 oxycodone, as described in s. 893.03(2)(a)1.q., or any salt
1288 thereof, or 7 grams or more of any mixture containing any such
1289 substance, commits a felony of the first degree, which felony
1290 shall be known as "trafficking in oxycodone," punishable as
1291 provided in s. 775.082, s. 775.083, or s. 775.084. If the
1292 quantity involved:
1293 a. Is 7 grams or more, but less than 14 grams, such person
1294 shall be sentenced to a mandatory minimum term of imprisonment
1295 of 3 years and shall be ordered to pay a fine of $50,000.
1296 b. Is 14 grams or more, but less than 25 grams, such
1297 person shall be sentenced to a mandatory minimum term of
1298 imprisonment of 7 years and shall be ordered to pay a fine of
1299 $100,000.
1300 c. Is 25 grams or more, but less than 100 grams, such
Page 52 of 57
CODING: Words stricken are deletions; words underlined are additions.
hb309-00
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
HB 309 2026
1301 person shall be sentenced to a mandatory minimum term of
1302 imprisonment of 15 years and shall be ordered to pay a fine of
1303 $500,000.
1304 d. Is 100 grams or more, but less than 30 kilograms, such
1305 person shall be sentenced to a mandatory minimum term of
1306 imprisonment of 25 years and shall be ordered to pay a fine of
1307 $750,000.
1308 4.a. A person who knowingly sells, purchases,
1309 manufactures, delivers, or brings into this state, or who is
1310 knowingly in actual or constructive possession of, 4 grams or
1311 more of:
1312 (I) Alfentanil, as described in s. 893.03(2)(b)1.;
1313 (II) Carfentanil, as described in s. 893.03(2)(b)6.;
1314 (III) Fentanyl, as described in s. 893.03(2)(b)9.;
1315 (IV) Sufentanil, as described in s. 893.03(2)(b)30.;
1316 (V) A fentanyl derivative, as described in s.
1317 893.03(1)(a)64. s. 893.03(1)(a)63.;
1318 (VI) A controlled substance analog, as described in s.
1319 893.0356, of any substance described in sub-sub-subparagraphs
1320 (I)-(V); or
1321 (VII) A mixture containing any substance described in sub-
1322 sub-subparagraphs (I)-(VI),
1323
1324 commits a felony of the first degree, which felony shall be
1325 known as "trafficking in dangerous fentanyl or fentanyl
Page 53 of 57
CODING: Words stricken are deletions; words underlined are additions.
hb309-00
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
HB 309 2026
1326 analogues," punishable as provided in s. 775.082, s. 775.083, or
1327 s. 775.084.
1328 b. If the quantity involved under sub-subparagraph a.:
1329 (I) Is 4 grams or more, but less than 14 grams, such
1330 person shall be sentenced to a mandatory minimum term of
1331 imprisonment of 7 years, and shall be ordered to pay a fine of
1332 $50,000.
1333 (II) Is 14 grams or more, but less than 28 grams, such
1334 person shall be sentenced to a mandatory minimum term of
1335 imprisonment of 20 years, and shall be ordered to pay a fine of
1336 $100,000.
1337 (III) Is 28 grams or more, such person shall be sentenced
1338 to a mandatory minimum term of imprisonment of 25 years, and
1339 shall be ordered to pay a fine of $500,000.
1340 c. A person 18 years of age or older who violates sub-
1341 subparagraph a. by knowingly selling or delivering to a minor at
1342 least 4 grams of a substance or mixture listed in sub-
1343 subparagraph a. shall be sentenced to a mandatory minimum term
1344 of not less than 25 years and not exceeding life imprisonment,
1345 and shall be ordered to pay a fine of $1 million if the
1346 substance or mixture listed in sub-subparagraph a. is in a form
1347 that resembles, or is mixed, granulated, absorbed, spray-dried,
1348 or aerosolized as or onto, coated on, in whole or in part, or
1349 solubilized with or into, a product, when such product or its
1350 packaging further has at least one of the following attributes:
Page 54 of 57
CODING: Words stricken are deletions; words underlined are additions.
hb309-00
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
HB 309 2026
1351 (I) Resembles the trade dress of a branded food product,
1352 consumer food product, or logo food product;
1353 (II) Incorporates an actual or fake registered copyright,
1354 service mark, or trademark;
1355 (III) Resembles candy, cereal, a gummy, a vitamin, or a
1356 chewable product, such as a gum or gelatin-based product; or
1357 (IV) Contains a cartoon character imprint.
1358 5. A person who knowingly sells, purchases, manufactures,
1359 delivers, or brings into this state, or who is knowingly in
1360 actual or constructive possession of, 30 kilograms or more of
1361 any morphine, opium, oxycodone, hydrocodone, codeine,
1362 hydromorphone, or any salt, derivative, isomer, or salt of an
1363 isomer thereof, including heroin, as described in s.
1364 893.03(1)(b), (2)(a), (3)(c)3., or (3)(c)4., or 30 kilograms or
1365 more of any mixture containing any such substance, commits the
1366 first degree felony of trafficking in illegal drugs. A person
1367 who has been convicted of the first degree felony of trafficking
1368 in illegal drugs under this subparagraph shall be punished by
1369 life imprisonment and is ineligible for any form of
1370 discretionary early release except pardon or executive clemency
1371 or conditional medical release under s. 947.149. However, if the
1372 court determines that, in addition to committing any act
1373 specified in this paragraph:
1374 a. The person intentionally killed an individual or
1375 counseled, commanded, induced, procured, or caused the
Page 55 of 57
CODING: Words stricken are deletions; words underlined are additions.
hb309-00
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
HB 309 2026
1376 intentional killing of an individual and such killing was the
1377 result; or
1378 b. The person's conduct in committing that act led to a
1379 natural, though not inevitable, lethal result,
1380
1381 such person commits the capital felony of trafficking in illegal
1382 drugs, punishable as provided in ss. 775.082 and 921.142. A
1383 person sentenced for a capital felony under this paragraph shall
1384 also be sentenced to pay the maximum fine provided under
1385 subparagraph 1.
1386 6. A person who knowingly brings into this state 60
1387 kilograms or more of any morphine, opium, oxycodone,
1388 hydrocodone, codeine, hydromorphone, or any salt, derivative,
1389 isomer, or salt of an isomer thereof, including heroin, as
1390 described in s. 893.03(1)(b), (2)(a), (3)(c)3., or (3)(c)4., or
1391 60 kilograms or more of any mixture containing any such
1392 substance, and who knows that the probable result of such
1393 importation would be the death of a person, commits capital
1394 importation of illegal drugs, a capital felony punishable as
1395 provided in ss. 775.082 and 921.142. A person sentenced for a
1396 capital felony under this paragraph shall also be sentenced to
1397 pay the maximum fine provided under subparagraph 1.
1398 7. A person who knowingly sells, purchases, manufactures,
1399 delivers, or brings into this state, or who is knowingly in
1400 actual or constructive possession of, 28 grams or more of
Page 56 of 57
CODING: Words stricken are deletions; words underlined are additions.
hb309-00
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
HB 309 2026
1401 xylazine, as described in s. 893.03(1)(c)37., or any salt
1402 thereof, or 28 grams or more of any mixture containing any such
1403 substance, commits a felony of the first degree, which felony
1404 shall be known as "trafficking in xylazine," punishable as
1405 provided in s. 775.082, s. 775.083, or s. 775.084. If the
1406 quantity involved:
1407 a. Is 28 grams or more, but less than 100 grams, such
1408 person shall be sentenced to a mandatory minimum term of
1409 imprisonment of 3 years and shall be ordered to pay a fine of
1410 $50,000.
1411 b. Is 100 grams or more, but less than 200 grams, such
1412 person shall be sentenced to a mandatory minimum term of
1413 imprisonment of 7 years and shall be ordered to pay a fine of
1414 $100,000.
1415 c. Is 200 grams or more, such person shall be sentenced to
1416 a mandatory minimum term of imprisonment of 25 years and shall
1417 be ordered to pay a fine of $500,000.
1418 Section 5. Except as otherwise expressly provided in this
1419 act and except for this section, which shall take effect upon
1420 this act becoming a law, this act shall take effect October 1,
1421 2026.
Page 57 of 57
CODING: Words stricken are deletions; words underlined are additions.
hb309-00
[DELETED:  92 LORIDA HOUSE OF REPRESENTATIVES A A 8 c c a S a F p p i d m F 8 x m o i  B S]
[DELETED:  92 LORIDA HOUSE OF REPRESENTATIVES   8 i s a c t s w S P P A  ( p t s f  ( a t e e c  1]
[DELETED:  92 LORIDA HOUSE OF REPRESENTATIVES  2  3  4 a o  5  6 e (  7  8  9  1  1  1  1  1  1  1  1  1  1  2  2  2]
[DELETED:  92 LORIDA HOUSE OF REPRESENTATIVES  2  2  2  2  2  2  2  3  3  3 p  3  3  3  3  3 P  3 p  3  4  4  4  4  4]
[DELETED:  92 LORIDA HOUSE OF REPRESENTATIVES  4  4  4  4  4  5 A  5  5  5  5  5  5  5  5  5  6  6  6  6  6 l p A i]
[DELETED:  92 LORIDA HOUSE OF REPRESENTATIVES i i d  a a m d s  b m h c r  c p c g  d a a  e p g  f a]
[DELETED:  92 LORIDA HOUSE OF REPRESENTATIVES  g a e i  (  ( e (  (  (  (  (  ( p  (  (  (  (  (  (  (  (  (  (  (]
[DELETED:  92 LORIDA HOUSE OF REPRESENTATIVES  (  (  (  (  (  6 l p A i i i d s t  a w o  b m n  c m  d  e]
[DELETED:  92 LORIDA HOUSE OF REPRESENTATIVES a  (  (  (  (  (  (  (  (  (  (  (  (  (  (  (  ( a p h i h s e s]
[DELETED:  92 LORIDA HOUSE OF REPRESENTATIVES d  1  2 o  3  4  5  6  7  8  9  1  1  1  1 a  1  1  1  1  1  1  2  2  2]
[DELETED:  92 LORIDA HOUSE OF REPRESENTATIVES  2  2  2  2  2  2  2  3  3  3 a  3  3  3 b S s i s  3 t S i e c]
[DELETED:  92 LORIDA HOUSE OF REPRESENTATIVES  3 a t a i h  3 (  3  4  4  4  4  4  4  4 y  4 ( o  4  4  5 n  5]
[DELETED:  92 LORIDA HOUSE OF REPRESENTATIVES  5  5  5  5  5  5  5 M  5  6  6  6  6  6  6  6  6  6  6  7  7  7  7  7  7]
[DELETED:  92 LORIDA HOUSE OF REPRESENTATIVES  7  7  7  7  8  8 m  8  8  8  8 d  8  8  8  8  9  9  9  9  9  9 e  9  9]
[DELETED:  92 LORIDA HOUSE OF REPRESENTATIVES  9 m  9 p  1 p  1  1  1 (  1  1  1  1  1  1  1  1  1 (  1  1  1  1  1]
[DELETED:  92 LORIDA HOUSE OF REPRESENTATIVES  1  1  1  1 m  1  1  1  1  1  1  1  1  1 ( o  1 m e  1 m 1  1  1 u]
[DELETED:  92 LORIDA HOUSE OF REPRESENTATIVES  1 u  1 m  1  1  1  1 m  1 m n  1 m n  1  1  1  1  1  1 m  1  1  1]
[DELETED:  92 LORIDA HOUSE OF REPRESENTATIVES t  1 t  1 t  1 c  1 i  1 c  1 c  1 c  1 b  1  1  1  1  1 m  1  1]
[DELETED:  92 LORIDA HOUSE OF REPRESENTATIVES  1 c  1 c  1 (  1 p  1 (  1 1  1 y  1 m  1 m  1 (  1 c  1 (  1]
[DELETED:  92 LORIDA HOUSE OF REPRESENTATIVES (  1 n  1 1  1 ( h  1 ( h  1 6 d  1 d t  1 6  1  1  1  1 o p]
[DELETED:  92 LORIDA HOUSE OF REPRESENTATIVES D p c d i e a s e p S i t i n d a o  a n s o s s l]
[DELETED:  92 LORIDA HOUSE OF REPRESENTATIVES i i i s 9 h  (  ( ( o  ( ( o  ( (  ( 2  ( 2  ( ( t  ( 6  (]
[DELETED:  92 LORIDA HOUSE OF REPRESENTATIVES 6  (  b N N c n n w c n  (  ( n  (  (  (  (  (  (  (  (  (  (  (]
[DELETED:  92 LORIDA HOUSE OF REPRESENTATIVES  ( n  (  (  ( n  ( n  (  (  (  ( n  ( n  ( n  ( n  (  (  ( n  (  (]
[DELETED:  92 LORIDA HOUSE OF REPRESENTATIVES  ( n  ( n  ( n  ( n  ( n  (  ( n  ( n  ( n  (  ( n  c n p n  (]
[DELETED:  92 LORIDA HOUSE OF REPRESENTATIVES  (  (  (  (  ( n  ( n  ( n  ( n  ( n  d n a n b (  e c s i p]
[DELETED:  92 LORIDA HOUSE OF REPRESENTATIVES  (  (  (  (  (  (  (  ( m  f c 5 s n  ( y  ( h  ( m  g c w e e]
[DELETED:  92 LORIDA HOUSE OF REPRESENTATIVES  (  (  ( i  ( (  ( i  (  ( m  ( 3  h T t t s w t  ( t  ( t  (]
[DELETED:  92 LORIDA HOUSE OF REPRESENTATIVES t  ( t  ( t  ( t  ( t  ( t  ( t  ( t  i c c i w a a  (  ( (]
[DELETED:  92 LORIDA HOUSE OF REPRESENTATIVES  ( c  ( a  (  (  ( a  j Q a q i c c i s w t  (  ( c  ( c  (]
[DELETED:  92 LORIDA HOUSE OF REPRESENTATIVES c  (  ( 3  ( 3  (  ( c  k N n s i n  ( c  ( c  ( (  ( c  ( c]
[DELETED:  92 LORIDA HOUSE OF REPRESENTATIVES  l c c w e e  (  ( (  ( (  ( c  ( (  m i A a 1 p i i o t]
[DELETED:  92 LORIDA HOUSE OF REPRESENTATIVES l  ( p  ( y  ( 1  ( p  ( y  ( 1  ( o  ( 1  ( y  ( (  ( 1  ( y]
[DELETED:  92 LORIDA HOUSE OF REPRESENTATIVES  ( p  ( 1  ( f  ( 2  ( o  ( 2  ( f  ( f  ( (  ( f  ( 2  n A c]
[DELETED:  92 LORIDA HOUSE OF REPRESENTATIVES s i p l  ( c  ( (  o m S  ( c b a r  ( s s  ( s c S  1 l]
[DELETED:  92 LORIDA HOUSE OF REPRESENTATIVES p A i i i d  a s  b p  c p m  ( e h d s  ( p g  ( a n  (]
[DELETED:  92 LORIDA HOUSE OF REPRESENTATIVES a  (  (  (  (  (  (  (  (  (  ( m  (  (  (  (  (  ( e  (  (  ( m  (  (]
[DELETED:  92 LORIDA HOUSE OF REPRESENTATIVES p  ( p  (  (  ( (  (  (  (  (  (  (  (  (  ( d  (  (  (  (  ( m  (  (]
[DELETED:  92 LORIDA HOUSE OF REPRESENTATIVES  (  (  (  (  1 e w F o a o c s a f t h f w o a a i  a  b]
[DELETED:  92 LORIDA HOUSE OF REPRESENTATIVES  c  d  e  f  g  h  i  j  k  l  m  n M  o  p  q  r  s  t  u  v  w  x  y  z]
[DELETED:  92 LORIDA HOUSE OF REPRESENTATIVES  a  b  c  d  e  f  g  h  i  j  k  l  m  n  o  p  q  r  s d  w s s d]
[DELETED:  92 LORIDA HOUSE OF REPRESENTATIVES i  1 s c S m o e s p s b o a b n s i  a m  b h  c f  d]
[DELETED:  92 LORIDA HOUSE OF REPRESENTATIVES m  e m  f h  g f  h m  i m  j m  k m  l m  m h  n f  o m  p m]
[DELETED:  92 LORIDA HOUSE OF REPRESENTATIVES  q h  r f  s m  w s  1 o p D p e s o s a a g  a  b  c  d]
[DELETED:  92 LORIDA HOUSE OF REPRESENTATIVES  e  f  g  h  i  j  k  l  m  n  o  p  q  r  s  t  u  v  w  x  y i  z  a ]
[DELETED:  92 LORIDA HOUSE OF REPRESENTATIVES w s  1 s c S m s a p w s o  a (  b o  c a  d  e a  f  g  h]
[DELETED:  92 LORIDA HOUSE OF REPRESENTATIVES  i  j  k  l  m  n  o  p  q  r  1 p  1 p  1 (  1 (  2 dS   8  (  (]
[DELETED:  92 LORIDA HOUSE OF REPRESENTATIVES a 7 m  1 p t  a  b  c  d  e 8  f  g 8 s  h s  2 i s i p f  a]
[DELETED:  92 LORIDA HOUSE OF REPRESENTATIVES c  b s  c c  dS   8 o  ( y  1  2  3  4  5  6 8  7 8  8 s  a]
[DELETED:  92 LORIDA HOUSE OF REPRESENTATIVES c s m cS   8 r  ( a  ( m k m d h ( s m s p q  a s o]
[DELETED:  92 LORIDA HOUSE OF REPRESENTATIVES  b p i $  c p i $  2 d a h d g c k s  a p i $  b p i $]
[DELETED:  92 LORIDA HOUSE OF REPRESENTATIVES  c p i $  d p i $  3 d a o t s s p q  a s o  b p i $  c]
[DELETED:  92 LORIDA HOUSE OF REPRESENTATIVES p i $  d p i $  4 m k m  (  (  (  (  ( 8  ( 8 (  ( s  c k]
[DELETED:  92 LORIDA HOUSE OF REPRESENTATIVES a s  b  ( p i $  ( p i $  ( t s  c s l s o a s t o s p]
[DELETED:  92 LORIDA HOUSE OF REPRESENTATIVES  ( c  ( s  ( c  (  5 d a a h i 8 m f w i l d o c s  a c]
[DELETED:  92 LORIDA HOUSE OF REPRESENTATIVES i r  b n  s d p a s  6 k h i d 6 s i i p c p  7 d a]
[DELETED:  92 LORIDA HOUSE OF REPRESENTATIVES x t s s p q  a p i $  b p i $  c a bS   a t 2]


================================================================================

Raw Text:
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
HB 309 2026
1 A bill to be entitled
2 An act relating to controlled substances; amending s.
3 893.03, F.S.; adding to the list of Schedule I
4 controlled substances 7-Hydroxymitragynine
5 concentrated at a level above 400 parts per million on
6 a dry-weight basis; excepting from the list of
7 Schedule I controlled substances certain xylazine
8 animal drug products approved by the United States
9 Food and Drug Administration and used for certain
10 purposes; amending s. 893.13, F.S.; providing criminal
11 penalties and requiring a mandatory minimum term of
12 imprisonment if a person sells, manufactures, or
13 delivers or possesses with intent to sell,
14 manufacture, or deliver xylazine; amending s. 893.131,
15 F.S.; conforming a cross-reference; amending s.
16 893.135, F.S.; creating the offense of trafficking in
17 xylazine; providing criminal penalties and requiring a
18 mandatory minimum term of imprisonment and fines based
19 on the quantity of the controlled substance involved
20 in the offense; providing effective dates.
21
22 Be It Enacted by the Legislature of the State of Florida:
23
24 Section 1. Effective July 1, 2026, paragraphs (a) and (c)
25 of subsection (1) of section 893.03, Florida Statutes, are
Page 1 of 57
CODING: Words stricken are deletions; words underlined are additions.
hb309-00

F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
HB 309 2026
26 amended to read:
27 893.03 Standards and schedules.—The substances enumerated
28 in this section are controlled by this chapter. The controlled
29 substances listed or to be listed in Schedules I, II, III, IV,
30 and V are included by whatever official, common, usual,
31 chemical, trade name, or class designated. The provisions of
32 this section shall not be construed to include within any of the
33 schedules contained in this section any excluded drugs listed
34 within the purview of 21 C.F.R. s. 1308.22, styled "Excluded
35 Substances"; 21 C.F.R. s. 1308.24, styled "Exempt Chemical
36 Preparations"; 21 C.F.R. s. 1308.32, styled "Exempted
37 Prescription Products"; or 21 C.F.R. s. 1308.34, styled "Exempt
38 Anabolic Steroid Products."
39 (1) SCHEDULE I.—A substance in Schedule I has a high
40 potential for abuse and has no currently accepted medical use in
41 treatment in the United States and in its use under medical
42 supervision does not meet accepted safety standards. The
43 following substances are controlled in Schedule I:
44 (a) Unless specifically excepted or unless listed in
45 another schedule, any of the following substances, including
46 their isomers, esters, ethers, salts, and salts of isomers,
47 esters, and ethers, whenever the existence of such isomers,
48 esters, ethers, and salts is possible within the specific
49 chemical designation:
50 1. Acetyl-alpha-methylfentanyl.
Page 2 of 57
CODING: Words stricken are deletions; words underlined are additions.
hb309-00

F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
HB 309 2026
51 2. Acetylmethadol.
52 3. Allylprodine.
53 4. Alphacetylmethadol (except levo-alphacetylmethadol,
54 also known as levo-alpha-acetylmethadol, levomethadyl acetate,
55 or LAAM).
56 5. Alphamethadol.
57 6. Alpha-methylfentanyl (N-[1-(alpha-methyl-betaphenyl)
58 ethyl-4-piperidyl] propionanilide; 1-(1-methyl-2-phenylethyl)-4-
59 (N-propanilido) piperidine).
60 7. Alpha-methylthiofentanyl.
61 8. Alphameprodine.
62 9. Benzethidine.
63 10. Benzylfentanyl.
64 11. Betacetylmethadol.
65 12. Beta-hydroxyfentanyl.
66 13. Beta-hydroxy-3-methylfentanyl.
67 14. Betameprodine.
68 15. Betamethadol.
69 16. Betaprodine.
70 17. Clonitazene.
71 18. Dextromoramide.
72 19. Diampromide.
73 20. Diethylthiambutene.
74 21. Difenoxin.
75 22. Dimenoxadol.
Page 3 of 57
CODING: Words stricken are deletions; words underlined are additions.
hb309-00

F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
HB 309 2026
76 23. Dimepheptanol.
77 24. Dimethylthiambutene.
78 25. Dioxaphetyl butyrate.
79 26. Dipipanone.
80 27. Ethylmethylthiambutene.
81 28. Etonitazene.
82 29. Etoxeridine.
83 30. Flunitrazepam.
84 31. Furethidine.
85 32. 7-Hydroxymitragynine concentrated at a level above 400
86 parts per million on a dry-weight basis.
87 33.32. Hydroxypethidine.
88 34.33. Ketobemidone.
89 35.34. Levomoramide.
90 36.35. Levophenacylmorphan.
91 37.36. Desmethylprodine (1-Methyl-4-Phenyl-4-
92 Propionoxypiperidine).
93 38.37. 3-Methylfentanyl (N-[3-methyl-1-(2-phenylethyl)-4-
94 piperidyl]-N-phenylpropanamide).
95 39.38. 3-Methylthiofentanyl.
96 40.39. Morpheridine.
97 41.40. Noracymethadol.
98 42.41. Norlevorphanol.
99 43.42. Normethadone.
100 44.43. Norpipanone.
Page 4 of 57
CODING: Words stricken are deletions; words underlined are additions.
hb309-00

F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
HB 309 2026
101 45.44. Para-Fluorofentanyl.
102 46.45. Phenadoxone.
103 47.46. Phenampromide.
104 48.47. Phenomorphan.
105 49.48. Phenoperidine.
106 50.49. PEPAP (1-(2-Phenylethyl)-4-Phenyl-4-
107 Acetyloxypiperidine).
108 51.50. Piritramide.
109 52.51. Proheptazine.
110 53.52. Properidine.
111 54.53. Propiram.
112 55.54. Racemoramide.
113 56.55. Thenylfentanyl.
114 57.56. Thiofentanyl.
115 58.57. Tianeptine.
116 59.58. Tilidine.
117 60.59. Trimeperidine.
118 61.60. Acetylfentanyl.
119 62.61. Butyrylfentanyl.
120 63.62. Beta-Hydroxythiofentanyl.
121 64.63. Fentanyl derivatives. Unless specifically excepted,
122 listed in another schedule, or contained within a pharmaceutical
123 product approved by the United States Food and Drug
124 Administration, any material, compound, mixture, or preparation,
125 including its salts, isomers, esters, or ethers, and salts of
Page 5 of 57
CODING: Words stricken are deletions; words underlined are additions.
hb309-00

F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
HB 309 2026
126 isomers, esters, or ethers, whenever the existence of such salts
127 is possible within any of the following specific chemical
128 designations containing a 4-anilidopiperidine structure:
129 a. With or without substitution at the carbonyl of the
130 aniline moiety with alkyl, alkenyl, carboalkoxy, cycloalkyl,
131 methoxyalkyl, cyanoalkyl, or aryl groups, or furanyl,
132 dihydrofuranyl, benzyl moiety, or rings containing heteroatoms
133 sulfur, oxygen, or nitrogen;
134 b. With or without substitution at the piperidine amino
135 moiety with a phenethyl, benzyl, alkylaryl (including
136 heteroaromatics), alkyltetrazolyl ring, or an alkyl or
137 carbomethoxy group, whether or not further substituted in the
138 ring or group;
139 c. With or without substitution or addition to the
140 piperdine ring to any extent with one or more methyl,
141 carbomethoxy, methoxy, methoxymethyl, aryl, allyl, or ester
142 groups;
143 d. With or without substitution of one or more hydrogen
144 atoms for halogens, or methyl, alkyl, or methoxy groups, in the
145 aromatic ring of the anilide moiety;
146 e. With or without substitution at the alpha or beta
147 position of the piperidine ring with alkyl, hydroxyl, or methoxy
148 groups;
149 f. With or without substitution of the benzene ring of the
150 anilide moiety for an aromatic heterocycle; and
Page 6 of 57
CODING: Words stricken are deletions; words underlined are additions.
hb309-00

F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
HB 309 2026
151 g. With or without substitution of the piperidine ring for
152 a pyrrolidine ring, perhydroazepine ring, or azepine ring;
153 excluding, Alfentanil, Carfentanil, Fentanyl, and Sufentanil;
154 including, but not limited to:
155 (I) Acetyl-alpha-methylfentanyl.
156 (II) Alpha-methylfentanyl (N-[1-(alpha-methyl-betaphenyl)
157 ethyl-4-piperidyl] propionanilide; 1-(1-methyl-2-phenylethyl)-4-
158 (N-propanilido) piperidine).
159 (III) Alpha-methylthiofentanyl.
160 (IV) Benzylfentanyl.
161 (V) Beta-hydroxyfentanyl.
162 (VI) Beta-hydroxy-3-methylfentanyl.
163 (VII) 3-Methylfentanyl (N-[3-methyl-1-(2-phenylethyl)-4-
164 piperidyl]-N-phenylpropanamide).
165 (VIII) 3-Methylthiofentanyl.
166 (IX) Para-Fluorofentanyl.
167 (X) Thenylfentanyl or Thienyl fentanyl.
168 (XI) Thiofentanyl.
169 (XII) Acetylfentanyl.
170 (XIII) Butyrylfentanyl.
171 (XIV) Beta-Hydroxythiofentanyl.
172 (XV) Lofentanil.
173 (XVI) Ocfentanil.
174 (XVII) Ohmfentanyl.
175 (XVIII) Benzodioxolefentanyl.
Page 7 of 57
CODING: Words stricken are deletions; words underlined are additions.
hb309-00

F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
HB 309 2026
176 (XIX) Furanyl fentanyl.
177 (XX) Pentanoyl fentanyl.
178 (XXI) Cyclopentyl fentanyl.
179 (XXII) Isobutyryl fentanyl.
180 (XXIII) Remifentanil.
181 65.64. Nitazene derivatives. Unless specifically excepted,
182 listed in another schedule, or contained within a pharmaceutical
183 product approved by the United States Food and Drug
184 Administration, any material, compound, mixture, or preparation,
185 including its salts, isomers, esters, or ethers, and salts of
186 isomers, esters, or ethers, whenever the existence of such salts
187 is possible within any of the following specific chemical
188 designations containing a benzimidazole ring with an ethylamine
189 substitution at the 1-position and a benzyl ring substitution at
190 the 2-position structure:
191 a. With or without substitution on the benzimidazole ring
192 with alkyl, alkoxy, carboalkoxy, amino, nitro, or aryl groups,
193 or halogens;
194 b. With or without substitution at the ethylamine amino
195 moiety with alkyl, dialkyl, acetyl, or benzyl groups, whether or
196 not further substituted in the ring system;
197 c. With or without inclusion of the ethylamine amino
198 moiety in a cyclic structure;
199 d. With or without substitution of the benzyl ring; or
200 e. With or without replacement of the benzyl ring with an
Page 8 of 57
CODING: Words stricken are deletions; words underlined are additions.
hb309-00

F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
HB 309 2026
201 aromatic ring, including, but not limited to:
202 (I) Butonitazene.
203 (II) Clonitazene.
204 (III) Etodesnitazene.
205 (IV) Etonitazene.
206 (V) Flunitazene.
207 (VI) Isotodesnitazene.
208 (VII) Isotonitazene.
209 (VIII) Metodesnitazene.
210 (IX) Metonitazene.
211 (X) Nitazene.
212 (XI) N-Desethyl Etonitazene.
213 (XII) N-Desethyl Isotonitazene.
214 (XIII) N-Piperidino Etonitazene.
215 (XIV) N-Pyrrolidino Etonitazene.
216 (XV) Protonitazene.
217 (c) Unless specifically excepted or unless listed in
218 another schedule, any material, compound, mixture, or
219 preparation that contains any quantity of the following
220 hallucinogenic substances or that contains any of their salts,
221 isomers, including optical, positional, or geometric isomers,
222 homologues, nitrogen-heterocyclic analogs, esters, ethers, and
223 salts of isomers, homologues, nitrogen-heterocyclic analogs,
224 esters, or ethers, if the existence of such salts, isomers, and
225 salts of isomers is possible within the specific chemical
Page 9 of 57
CODING: Words stricken are deletions; words underlined are additions.
hb309-00

F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
HB 309 2026
226 designation or class description:
227 1. Alpha-Ethyltryptamine.
228 2. 4-Methylaminorex (2-Amino-4-methyl-5-phenyl-2-
229 oxazoline).
230 3. Aminorex (2-Amino-5-phenyl-2-oxazoline).
231 4. DOB (4-Bromo-2,5-dimethoxyamphetamine).
232 5. 2C-B (4-Bromo-2,5-dimethoxyphenethylamine).
233 6. Bufotenine.
234 7. Cannabis.
235 8. Cathinone.
236 9. DET (Diethyltryptamine).
237 10. 2,5-Dimethoxyamphetamine.
238 11. DOET (4-Ethyl-2,5-Dimethoxyamphetamine).
239 12. DMT (Dimethyltryptamine).
240 13. PCE (N-Ethyl-1-phenylcyclohexylamine) (Ethylamine
241 analog of phencyclidine).
242 14. JB-318 (N-Ethyl-3-piperidyl benzilate).
243 15. N-Ethylamphetamine.
244 16. Fenethylline.
245 17. 3,4-Methylenedioxy-N-hydroxyamphetamine.
246 18. Ibogaine.
247 19. LSD (Lysergic acid diethylamide).
248 20. Mescaline.
249 21. Methcathinone.
250 22. 5-Methoxy-3,4-methylenedioxyamphetamine.
Page 10 of 57
CODING: Words stricken are deletions; words underlined are additions.
hb309-00

F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
HB 309 2026
251 23. PMA (4-Methoxyamphetamine).
252 24. PMMA (4-Methoxymethamphetamine).
253 25. DOM (4-Methyl-2,5-dimethoxyamphetamine).
254 26. MDEA (3,4-Methylenedioxy-N-ethylamphetamine).
255 27. MDA (3,4-Methylenedioxyamphetamine).
256 28. JB-336 (N-Methyl-3-piperidyl benzilate).
257 29. N,N-Dimethylamphetamine.
258 30. Parahexyl.
259 31. Peyote.
260 32. PCPY (N-(1-Phenylcyclohexyl)-pyrrolidine) (Pyrrolidine
261 analog of phencyclidine).
262 33. Psilocybin.
263 34. Psilocyn.
264 35. Salvia divinorum, except for any drug product approved
265 by the United States Food and Drug Administration which contains
266 Salvia divinorum or its isomers, esters, ethers, salts, and
267 salts of isomers, esters, and ethers, if the existence of such
268 isomers, esters, ethers, and salts is possible within the
269 specific chemical designation.
270 36. Salvinorin A, except for any drug product approved by
271 the United States Food and Drug Administration which contains
272 Salvinorin A or its isomers, esters, ethers, salts, and salts of
273 isomers, esters, and ethers, if the existence of such isomers,
274 esters, ethers, and salts is possible within the specific
275 chemical designation.
Page 11 of 57
CODING: Words stricken are deletions; words underlined are additions.
hb309-00

F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
HB 309 2026
276 37. Xylazine, except for a xylazine animal drug product
277 approved by the United States Food and Drug Administration and
278 the use of which conforms to the approved application or is
279 authorized under 21 U.S.C. s. 360b(a)(4). The manufacture,
280 importation, distribution, prescribing, or sale of xylazine for
281 human use is not subject to this exception.
282 38. TCP (1-[1-(2-Thienyl)-cyclohexyl]-piperidine)
283 (Thiophene analog of phencyclidine).
284 39. 3,4,5-Trimethoxyamphetamine.
285 40. Methylone (3,4-Methylenedioxymethcathinone).
286 41. MDPV (3,4-Methylenedioxypyrovalerone).
287 42. Methylmethcathinone.
288 43. Methoxymethcathinone.
289 44. Fluoromethcathinone.
290 45. Methylethcathinone.
291 46. CP 47,497 (2-(3-Hydroxycyclohexyl)-5-(2-methyloctan-2-
292 yl)phenol) and its dimethyloctyl (C8) homologue.
293 47. HU-210 [(6aR,10aR)-9-(Hydroxymethyl)-6,6-dimethyl-3-
294 (2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-
295 ol].
296 48. JWH-018 (1-Pentyl-3-(1-naphthoyl)indole).
297 49. JWH-073 (1-Butyl-3-(1-naphthoyl)indole).
298 50. JWH-200 (1-[2-(4-Morpholinyl)ethyl]-3-(1-
299 naphthoyl)indole).
300 51. BZP (Benzylpiperazine).
Page 12 of 57
CODING: Words stricken are deletions; words underlined are additions.
hb309-00

F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
HB 309 2026
301 52. Fluorophenylpiperazine.
302 53. Methylphenylpiperazine.
303 54. Chlorophenylpiperazine.
304 55. Methoxyphenylpiperazine.
305 56. DBZP (1,4-Dibenzylpiperazine).
306 57. TFMPP (Trifluoromethylphenylpiperazine).
307 58. MBDB (Methylbenzodioxolylbutanamine) or (3,4-
308 Methylenedioxy-N-methylbutanamine).
309 59. 5-Hydroxy-AMT (5-Hydroxy-alpha-methyltryptamine).
310 60. 5-Hydroxy-N-methyltryptamine.
311 61. 5-MeO-MiPT (5-Methoxy-N-methyl-N-isopropyltryptamine).
312 62. 5-MeO-AMT (5-Methoxy-alpha-methyltryptamine).
313 63. Methyltryptamine.
314 64. 5-MeO-DMT (5-Methoxy-N,N-dimethyltryptamine).
315 65. 5-Me-DMT (5-Methyl-N,N-dimethyltryptamine).
316 66. Tyramine (4-Hydroxyphenethylamine).
317 67. 5-MeO-DiPT (5-Methoxy-N,N-Diisopropyltryptamine).
318 68. DiPT (N,N-Diisopropyltryptamine).
319 69. DPT (N,N-Dipropyltryptamine).
320 70. 4-Hydroxy-DiPT (4-Hydroxy-N,N-diisopropyltryptamine).
321 71. 5-MeO-DALT (5-Methoxy-N,N-Diallyltryptamine).
322 72. DOI (4-Iodo-2,5-dimethoxyamphetamine).
323 73. DOC (4-Chloro-2,5-dimethoxyamphetamine).
324 74. 2C-E (4-Ethyl-2,5-dimethoxyphenethylamine).
325 75. 2C-T-4 (4-Isopropylthio-2,5-dimethoxyphenethylamine).
Page 13 of 57
CODING: Words stricken are deletions; words underlined are additions.
hb309-00

F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
HB 309 2026
326 76. 2C-C (4-Chloro-2,5-dimethoxyphenethylamine).
327 77. 2C-T (4-Methylthio-2,5-dimethoxyphenethylamine).
328 78. 2C-T-2 (4-Ethylthio-2,5-dimethoxyphenethylamine).
329 79. 2C-T-7 (4-(n)-Propylthio-2,5-dimethoxyphenethylamine).
330 80. 2C-I (4-Iodo-2,5-dimethoxyphenethylamine).
331 81. Butylone (3,4-Methylenedioxy-alpha-
332 methylaminobutyrophenone).
333 82. Ethcathinone.
334 83. Ethylone (3,4-Methylenedioxy-N-ethylcathinone).
335 84. Naphyrone (Naphthylpyrovalerone).
336 85. Dimethylone (3,4-Methylenedioxy-N,N-
337 dimethylcathinone).
338 86. 3,4-Methylenedioxy-N,N-diethylcathinone.
339 87. 3,4-Methylenedioxy-propiophenone.
340 88. 3,4-Methylenedioxy-alpha-bromopropiophenone.
341 89. 3,4-Methylenedioxy-propiophenone-2-oxime.
342 90. 3,4-Methylenedioxy-N-acetylcathinone.
343 91. 3,4-Methylenedioxy-N-acetylmethcathinone.
344 92. 3,4-Methylenedioxy-N-acetylethcathinone.
345 93. Bromomethcathinone.
346 94. Buphedrone (alpha-Methylamino-butyrophenone).
347 95. Eutylone (3,4-Methylenedioxy-alpha-
348 ethylaminobutyrophenone).
349 96. Dimethylcathinone.
350 97. Dimethylmethcathinone.
Page 14 of 57
CODING: Words stricken are deletions; words underlined are additions.
hb309-00

F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
HB 309 2026
351 98. Pentylone (3,4-Methylenedioxy-alpha-
352 methylaminovalerophenone).
353 99. MDPPP (3,4-Methylenedioxy-alpha-
354 pyrrolidinopropiophenone).
355 100. MDPBP (3,4-Methylenedioxy-alpha-
356 pyrrolidinobutyrophenone).
357 101. MOPPP (Methoxy-alpha-pyrrolidinopropiophenone).
358 102. MPHP (Methyl-alpha-pyrrolidinohexanophenone).
359 103. BTCP (Benzothiophenylcyclohexylpiperidine) or BCP
360 (Benocyclidine).
361 104. F-MABP (Fluoromethylaminobutyrophenone).
362 105. MeO-PBP (Methoxypyrrolidinobutyrophenone).
363 106. Et-PBP (Ethylpyrrolidinobutyrophenone).
364 107. 3-Me-4-MeO-MCAT (3-Methyl-4-Methoxymethcathinone).
365 108. Me-EABP (Methylethylaminobutyrophenone).
366 109. Etizolam.
367 110. PPP (Pyrrolidinopropiophenone).
368 111. PBP (Pyrrolidinobutyrophenone).
369 112. PVP (Pyrrolidinovalerophenone) or
370 (Pyrrolidinopentiophenone).
371 113. MPPP (Methyl-alpha-pyrrolidinopropiophenone).
372 114. JWH-007 (1-Pentyl-2-methyl-3-(1-naphthoyl)indole).
373 115. JWH-015 (1-Propyl-2-methyl-3-(1-naphthoyl)indole).
374 116. JWH-019 (1-Hexyl-3-(1-naphthoyl)indole).
375 117. JWH-020 (1-Heptyl-3-(1-naphthoyl)indole).
Page 15 of 57
CODING: Words stricken are deletions; words underlined are additions.
hb309-00

F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
HB 309 2026
376 118. JWH-072 (1-Propyl-3-(1-naphthoyl)indole).
377 119. JWH-081 (1-Pentyl-3-(4-methoxy-1-naphthoyl)indole).
378 120. JWH-122 (1-Pentyl-3-(4-methyl-1-naphthoyl)indole).
379 121. JWH-133 ((6aR,10aR)-6,6,9-Trimethyl-3-(2-
380 methylpentan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromene).
381 122. JWH-175 (1-Pentyl-3-(1-naphthylmethyl)indole).
382 123. JWH-201 (1-Pentyl-3-(4-methoxyphenylacetyl)indole).
383 124. JWH-203 (1-Pentyl-3-(2-chlorophenylacetyl)indole).
384 125. JWH-210 (1-Pentyl-3-(4-ethyl-1-naphthoyl)indole).
385 126. JWH-250 (1-Pentyl-3-(2-methoxyphenylacetyl)indole).
386 127. JWH-251 (1-Pentyl-3-(2-methylphenylacetyl)indole).
387 128. JWH-302 (1-Pentyl-3-(3-methoxyphenylacetyl)indole).
388 129. JWH-398 (1-Pentyl-3-(4-chloro-1-naphthoyl)indole).
389 130. HU-211 ((6aS,10aS)-9-(Hydroxymethyl)-6,6-dimethyl-3-
390 (2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-
391 ol).
392 131. HU-308 ([(1R,2R,5R)-2-[2,6-Dimethoxy-4-(2-
393 methyloctan-2-yl)phenyl]-7,7-dimethyl-4-bicyclo[3.1.1]hept-3-
394 enyl] methanol).
395 132. HU-331 (3-Hydroxy-2-[(1R,6R)-3-methyl-6-(1-
396 methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-2,5-cyclohexadiene-
397 1,4-dione).
398 133. CB-13 (4-Pentyloxy-1-(1-naphthoyl)naphthalene).
399 134. CB-25 (N-Cyclopropyl-11-(3-hydroxy-5-pentylphenoxy)-
400 undecanamide).
Page 16 of 57
CODING: Words stricken are deletions; words underlined are additions.
hb309-00

F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
HB 309 2026
401 135. CB-52 (N-Cyclopropyl-11-(2-hexyl-5-hydroxyphenoxy)-
402 undecanamide).
403 136. CP 55,940 (2-[3-Hydroxy-6-propanol-cyclohexyl]-5-(2-
404 methyloctan-2-yl)phenol).
405 137. AM-694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl)indole).
406 138. AM-2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl)indole).
407 139. RCS-4 (1-Pentyl-3-(4-methoxybenzoyl)indole).
408 140. RCS-8 (1-(2-Cyclohexylethyl)-3-(2-
409 methoxyphenylacetyl)indole).
410 141. WIN55,212-2 ((R)-(+)-[2,3-Dihydro-5-methyl-3-(4-
411 morpholinylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]-1-
412 naphthalenylmethanone).
413 142. WIN55,212-3 ([(3S)-2,3-Dihydro-5-methyl-3-(4-
414 morpholinylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]-1-
415 naphthalenylmethanone).
416 143. Pentedrone (alpha-Methylaminovalerophenone).
417 144. Fluoroamphetamine.
418 145. Fluoromethamphetamine.
419 146. Methoxetamine.
420 147. Methiopropamine.
421 148. Methylbuphedrone (Methyl-alpha-
422 methylaminobutyrophenone).
423 149. APB ((2-Aminopropyl)benzofuran).
424 150. APDB ((2-Aminopropyl)-2,3-dihydrobenzofuran).
425 151. UR-144 (1-Pentyl-3-(2,2,3,3-
Page 17 of 57
CODING: Words stricken are deletions; words underlined are additions.
hb309-00

F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
HB 309 2026
426 tetramethylcyclopropanoyl)indole).
427 152. XLR11 (1-(5-Fluoropentyl)-3-(2,2,3,3-
428 tetramethylcyclopropanoyl)indole).
429 153. Chloro UR-144 (1-(Chloropentyl)-3-(2,2,3,3-
430 tetramethylcyclopropanoyl)indole).
431 154. AKB48 (N-Adamant-1-yl 1-pentylindazole-3-
432 carboxamide).
433 155. AM-2233(1-[(N-Methyl-2-piperidinyl)methyl]-3-(2-
434 iodobenzoyl)indole).
435 156. STS-135 (N-Adamant-1-yl 1-(5-fluoropentyl)indole-3-
436 carboxamide).
437 157. URB-597 ((3′-(Aminocarbonyl)[1,1′-biphenyl]-3-yl)-
438 cyclohexylcarbamate).
439 158. URB-602 ([1,1′-Biphenyl]-3-yl-carbamic acid,
440 cyclohexyl ester).
441 159. URB-754 (6-Methyl-2-[(4-methylphenyl)amino]-1-
442 benzoxazin-4-one).
443 160. 2C-D (4-Methyl-2,5-dimethoxyphenethylamine).
444 161. 2C-H (2,5-Dimethoxyphenethylamine).
445 162. 2C-N (4-Nitro-2,5-dimethoxyphenethylamine).
446 163. 2C-P (4-(n)-Propyl-2,5-dimethoxyphenethylamine).
447 164. 25I-NBOMe (4-Iodo-2,5-dimethoxy-[N-(2-
448 methoxybenzyl)]phenethylamine).
449 165. MDMA (3,4-Methylenedioxymethamphetamine).
450 166. PB-22 (8-Quinolinyl 1-pentylindole-3-carboxylate).
Page 18 of 57
CODING: Words stricken are deletions; words underlined are additions.
hb309-00

F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
HB 309 2026
451 167. Fluoro PB-22 (8-Quinolinyl 1-(fluoropentyl)indole-3-
452 carboxylate).
453 168. BB-22 (8-Quinolinyl 1-(cyclohexylmethyl)indole-3-
454 carboxylate).
455 169. Fluoro AKB48 (N-Adamant-1-yl 1-
456 (fluoropentyl)indazole-3-carboxamide).
457 170. AB-PINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-
458 pentylindazole-3-carboxamide).
459 171. AB-FUBINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-
460 (4-fluorobenzyl)indazole-3-carboxamide).
461 172. ADB-PINACA (N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-
462 1-pentylindazole-3-carboxamide).
463 173. Fluoro ADBICA (N-(1-Amino-3,3-dimethyl-1-oxobutan-2-
464 yl)-1-(fluoropentyl)indole-3-carboxamide).
465 174. 25B-NBOMe (4-Bromo-2,5-dimethoxy-[N-(2-
466 methoxybenzyl)]phenethylamine).
467 175. 25C-NBOMe (4-Chloro-2,5-dimethoxy-[N-(2-
468 methoxybenzyl)]phenethylamine).
469 176. AB-CHMINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-
470 (cyclohexylmethyl)indazole-3-carboxamide).
471 177. FUB-PB-22 (8-Quinolinyl 1-(4-fluorobenzyl)indole-3-
472 carboxylate).
473 178. Fluoro-NNEI (N-Naphthalen-1-yl 1-
474 (fluoropentyl)indole-3-carboxamide).
475 179. Fluoro-AMB (N-(1-Methoxy-3-methyl-1-oxobutan-2-yl)-1-
Page 19 of 57
CODING: Words stricken are deletions; words underlined are additions.
hb309-00

F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
HB 309 2026
476 (fluoropentyl)indazole-3-carboxamide).
477 180. THJ-2201 (1-(5-Fluoropentyl)-3-(1-
478 naphthoyl)indazole).
479 181. AM-855 ((4aR,12bR)-8-Hexyl-2,5,5-trimethyl-
480 1,4,4a,8,9,10,11,12b-octahydronaphtho[3,2-c]isochromen-12-ol).
481 182. AM-905 ((6aR,9R,10aR)-3-[(E)-Hept-1-enyl]-9-
482 (hydroxymethyl)-6,6-dimethyl-6a,7,8,9,10,10a-
483 hexahydrobenzo[c]chromen-1-ol).
484 183. AM-906 ((6aR,9R,10aR)-3-[(Z)-Hept-1-enyl]-9-
485 (hydroxymethyl)-6,6-dimethyl-6a,7,8,9,10,10a-
486 hexahydrobenzo[c]chromen-1-ol).
487 184. AM-2389 ((6aR,9R,10aR)-3-(1-Hexyl-cyclobut-1-yl)-
488 6a,7,8,9,10,10a-hexahydro-6,6-dimethyl-6H-dibenzo[b,d]pyran-1,9
489 diol).
490 185. HU-243 ((6aR,8S,9S,10aR)-9-(Hydroxymethyl)-6,6-
491 dimethyl-3-(2-methyloctan-2-yl)-8,9-ditritio-7,8,10,10a-
492 tetrahydro-6aH-benzo[c]chromen-1-ol).
493 186. HU-336 ((6aR,10aR)-6,6,9-Trimethyl-3-pentyl-
494 6a,7,10,10a-tetrahydro-1H-benzo[c]chromene-1,4(6H)-dione).
495 187. MAPB ((2-Methylaminopropyl)benzofuran).
496 188. 5-IT (2-(1H-Indol-5-yl)-1-methyl-ethylamine).
497 189. 6-IT (2-(1H-Indol-6-yl)-1-methyl-ethylamine).
498 190. Synthetic Cannabinoids.—Unless specifically excepted
499 or unless listed in another schedule or contained within a
500 pharmaceutical product approved by the United States Food and
Page 20 of 57
CODING: Words stricken are deletions; words underlined are additions.
hb309-00

F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
HB 309 2026
501 Drug Administration, any material, compound, mixture, or
502 preparation that contains any quantity of a synthetic
503 cannabinoid found to be in any of the following chemical class
504 descriptions, or homologues, nitrogen-heterocyclic analogs,
505 isomers (including optical, positional, or geometric), esters,
506 ethers, salts, and salts of homologues, nitrogen-heterocyclic
507 analogs, isomers, esters, or ethers, whenever the existence of
508 such homologues, nitrogen-heterocyclic analogs, isomers, esters,
509 ethers, salts, and salts of isomers, esters, or ethers is
510 possible within the specific chemical class or designation.
511 Since nomenclature of these synthetically produced cannabinoids
512 is not internationally standardized and may continually evolve,
513 these structures or the compounds of these structures shall be
514 included under this subparagraph, regardless of their specific
515 numerical designation of atomic positions covered, if it can be
516 determined through a recognized method of scientific testing or
517 analysis that the substance contains properties that fit within
518 one or more of the following categories:
519 a. Tetrahydrocannabinols.—Any tetrahydrocannabinols
520 naturally contained in a plant of the genus Cannabis, the
521 synthetic equivalents of the substances contained in the plant
522 or in the resinous extracts of the genus Cannabis, or synthetic
523 substances, derivatives, and their isomers with similar chemical
524 structure and pharmacological activity, including, but not
525 limited to, Delta 9 tetrahydrocannabinols and their optical
Page 21 of 57
CODING: Words stricken are deletions; words underlined are additions.
hb309-00

F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
HB 309 2026
526 isomers, Delta 8 tetrahydrocannabinols and their optical
527 isomers, Delta 6a,10a tetrahydrocannabinols and their optical
528 isomers, or any compound containing a tetrahydrobenzo[c]chromene
529 structure with substitution at either or both the 3-position or
530 9-position, with or without substitution at the 1-position with
531 hydroxyl or alkoxy groups, including, but not limited to:
532 (I) Tetrahydrocannabinol.
533 (II) HU-210 ((6aR,10aR)-9-(Hydroxymethyl)-6,6-dimethyl-3-
534 (2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-
535 ol).
536 (III) HU-211 ((6aS,10aS)-9-(Hydroxymethyl)-6,6-dimethyl-3-
537 (2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-
538 ol).
539 (IV) JWH-051 ((6aR,10aR)-9-(Hydroxymethyl)-6,6-dimethyl-3-
540 (2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromene).
541 (V) JWH-133 ((6aR,10aR)-6,6,9-Trimethyl-3-(2-methylpentan-
542 2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromene).
543 (VI) JWH-057 ((6aR,10aR)-6,6,9-Trimethyl-3-(2-methyloctan-
544 2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromene).
545 (VII) JWH-359 ((6aR,10aR)-1-Methoxy-6,6,9-trimethyl-3-
546 (2,3-dimethylpentan-2-yl)-6a,7,10,10a-
547 tetrahydrobenzo[c]chromene).
548 (VIII) AM-087 ((6aR,10aR)-3-(2-Methyl-6-bromohex-2-yl)-
549 6,6,9-trimethyl-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol).
550 (IX) AM-411 ((6aR,10aR)-3-(1-Adamantyl)-6,6,9-trimethyl-
Page 22 of 57
CODING: Words stricken are deletions; words underlined are additions.
hb309-00

F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
HB 309 2026
551 6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol).
552 (X) Parahexyl.
553 b. Naphthoylindoles, Naphthoylindazoles,
554 Naphthoylcarbazoles, Naphthylmethylindoles,
555 Naphthylmethylindazoles, and Naphthylmethylcarbazoles.—Any
556 compound containing a naphthoylindole, naphthoylindazole,
557 naphthoylcarbazole, naphthylmethylindole,
558 naphthylmethylindazole, or naphthylmethylcarbazole structure,
559 with or without substitution on the indole, indazole, or
560 carbazole ring to any extent, whether or not substituted on the
561 naphthyl ring to any extent, including, but not limited to:
562 (I) JWH-007 (1-Pentyl-2-methyl-3-(1-naphthoyl)indole).
563 (II) JWH-011 (1-(1-Methylhexyl)-2-methyl-3-(1-
564 naphthoyl)indole).
565 (III) JWH-015 (1-Propyl-2-methyl-3-(1-naphthoyl)indole).
566 (IV) JWH-016 (1-Butyl-2-methyl-3-(1-naphthoyl)indole).
567 (V) JWH-018 (1-Pentyl-3-(1-naphthoyl)indole).
568 (VI) JWH-019 (1-Hexyl-3-(1-naphthoyl)indole).
569 (VII) JWH-020 (1-Heptyl-3-(1-naphthoyl)indole).
570 (VIII) JWH-022 (1-(4-Pentenyl)-3-(1-naphthoyl)indole).
571 (IX) JWH-071 (1-Ethyl-3-(1-naphthoyl)indole).
572 (X) JWH-072 (1-Propyl-3-(1-naphthoyl)indole).
573 (XI) JWH-073 (1-Butyl-3-(1-naphthoyl)indole).
574 (XII) JWH-080 (1-Butyl-3-(4-methoxy-1-naphthoyl)indole).
575 (XIII) JWH-081 (1-Pentyl-3-(4-methoxy-1-naphthoyl)indole).
Page 23 of 57
CODING: Words stricken are deletions; words underlined are additions.
hb309-00

F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
HB 309 2026
576 (XIV) JWH-098 (1-Pentyl-2-methyl-3-(4-methoxy-1-
577 naphthoyl)indole).
578 (XV) JWH-116 (1-Pentyl-2-ethyl-3-(1-naphthoyl)indole).
579 (XVI) JWH-122 (1-Pentyl-3-(4-methyl-1-naphthoyl)indole).
580 (XVII) JWH-149 (1-Pentyl-2-methyl-3-(4-methyl-1-
581 naphthoyl)indole).
582 (XVIII) JWH-164 (1-Pentyl-3-(7-methoxy-1-
583 naphthoyl)indole).
584 (XIX) JWH-175 (1-Pentyl-3-(1-naphthylmethyl)indole).
585 (XX) JWH-180 (1-Propyl-3-(4-propyl-1-naphthoyl)indole).
586 (XXI) JWH-182 (1-Pentyl-3-(4-propyl-1-naphthoyl)indole).
587 (XXII) JWH-184 (1-Pentyl-3-[(4-methyl)-1-
588 naphthylmethyl]indole).
589 (XXIII) JWH-193 (1-[2-(4-Morpholinyl)ethyl]-3-(4-methyl-1-
590 naphthoyl)indole).
591 (XXIV) JWH-198 (1-[2-(4-Morpholinyl)ethyl]-3-(4-methoxy-1-
592 naphthoyl)indole).
593 (XXV) JWH-200 (1-[2-(4-Morpholinyl)ethyl]-3-(1-
594 naphthoyl)indole).
595 (XXVI) JWH-210 (1-Pentyl-3-(4-ethyl-1-naphthoyl)indole).
596 (XXVII) JWH-387 (1-Pentyl-3-(4-bromo-1-naphthoyl)indole).
597 (XXVIII) JWH-398 (1-Pentyl-3-(4-chloro-1-
598 naphthoyl)indole).
599 (XXIX) JWH-412 (1-Pentyl-3-(4-fluoro-1-naphthoyl)indole).
600 (XXX) JWH-424 (1-Pentyl-3-(8-bromo-1-naphthoyl)indole).
Page 24 of 57
CODING: Words stricken are deletions; words underlined are additions.
hb309-00

F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
HB 309 2026
601 (XXXI) AM-1220 (1-[(1-Methyl-2-piperidinyl)methyl]-3-(1-
602 naphthoyl)indole).
603 (XXXII) AM-1235 (1-(5-Fluoropentyl)-6-nitro-3-(1-
604 naphthoyl)indole).
605 (XXXIII) AM-2201 (1-(5-Fluoropentyl)-3-(1-
606 naphthoyl)indole).
607 (XXXIV) Chloro JWH-018 (1-(Chloropentyl)-3-(1-
608 naphthoyl)indole).
609 (XXXV) Bromo JWH-018 (1-(Bromopentyl)-3-(1-
610 naphthoyl)indole).
611 (XXXVI) AM-2232 (1-(4-Cyanobutyl)-3-(1-naphthoyl)indole).
612 (XXXVII) THJ-2201 (1-(5-Fluoropentyl)-3-(1-
613 naphthoyl)indazole).
614 (XXXVIII) MAM-2201 (1-(5-Fluoropentyl)-3-(4-methyl-1-
615 naphthoyl)indole).
616 (XXXIX) EAM-2201 (1-(5-Fluoropentyl)-3-(4-ethyl-1-
617 naphthoyl)indole).
618 (XL) EG-018 (9-Pentyl-3-(1-naphthoyl)carbazole).
619 (XLI) EG-2201 (9-(5-Fluoropentyl)-3-(1-
620 naphthoyl)carbazole).
621 c. Naphthoylpyrroles.—Any compound containing a
622 naphthoylpyrrole structure, with or without substitution on the
623 pyrrole ring to any extent, whether or not substituted on the
624 naphthyl ring to any extent, including, but not limited to:
625 (I) JWH-030 (1-Pentyl-3-(1-naphthoyl)pyrrole).
Page 25 of 57
CODING: Words stricken are deletions; words underlined are additions.
hb309-00

F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
HB 309 2026
626 (II) JWH-031 (1-Hexyl-3-(1-naphthoyl)pyrrole).
627 (III) JWH-145 (1-Pentyl-5-phenyl-3-(1-naphthoyl)pyrrole).
628 (IV) JWH-146 (1-Heptyl-5-phenyl-3-(1-naphthoyl)pyrrole).
629 (V) JWH-147 (1-Hexyl-5-phenyl-3-(1-naphthoyl)pyrrole).
630 (VI) JWH-307 (1-Pentyl-5-(2-fluorophenyl)-3-(1-
631 naphthoyl)pyrrole).
632 (VII) JWH-309 (1-Pentyl-5-(1-naphthalenyl)-3-(1-
633 naphthoyl)pyrrole).
634 (VIII) JWH-368 (1-Pentyl-5-(3-fluorophenyl)-3-(1-
635 naphthoyl)pyrrole).
636 (IX) JWH-369 (1-Pentyl-5-(2-chlorophenyl)-3-(1-
637 naphthoyl)pyrrole).
638 (X) JWH-370 (1-Pentyl-5-(2-methylphenyl)-3-(1-
639 naphthoyl)pyrrole).
640 d. Naphthylmethylenindenes.—Any compound containing a
641 naphthylmethylenindene structure, with or without substitution
642 at the 3-position of the indene ring to any extent, whether or
643 not substituted on the naphthyl ring to any extent, including,
644 but not limited to, JWH-176 (3-Pentyl-1-
645 (naphthylmethylene)indene).
646 e. Phenylacetylindoles and Phenylacetylindazoles.—Any
647 compound containing a phenylacetylindole or phenylacetylindazole
648 structure, with or without substitution on the indole or
649 indazole ring to any extent, whether or not substituted on the
650 phenyl ring to any extent, including, but not limited to:
Page 26 of 57
CODING: Words stricken are deletions; words underlined are additions.
hb309-00

F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
HB 309 2026
651 (I) JWH-167 (1-Pentyl-3-(phenylacetyl)indole).
652 (II) JWH-201 (1-Pentyl-3-(4-methoxyphenylacetyl)indole).
653 (III) JWH-203 (1-Pentyl-3-(2-chlorophenylacetyl)indole).
654 (IV) JWH-250 (1-Pentyl-3-(2-methoxyphenylacetyl)indole).
655 (V) JWH-251 (1-Pentyl-3-(2-methylphenylacetyl)indole).
656 (VI) JWH-302 (1-Pentyl-3-(3-methoxyphenylacetyl)indole).
657 (VII) Cannabipiperidiethanone.
658 (VIII) RCS-8 (1-(2-Cyclohexylethyl)-3-(2-
659 methoxyphenylacetyl)indole).
660 f. Cyclohexylphenols.—Any compound containing a
661 cyclohexylphenol structure, with or without substitution at the
662 5-position of the phenolic ring to any extent, whether or not
663 substituted on the cyclohexyl ring to any extent, including, but
664 not limited to:
665 (I) CP 47,497 (2-(3-Hydroxycyclohexyl)-5-(2-methyloctan-2-
666 yl)phenol).
667 (II) Cannabicyclohexanol (CP 47,497 dimethyloctyl (C8)
668 homologue).
669 (III) CP-55,940 (2-(3-Hydroxy-6-propanol-cyclohexyl)-5-(2-
670 methyloctan-2-yl)phenol).
671 g. Benzoylindoles and Benzoylindazoles.—Any compound
672 containing a benzoylindole or benzoylindazole structure, with or
673 without substitution on the indole or indazole ring to any
674 extent, whether or not substituted on the phenyl ring to any
675 extent, including, but not limited to:
Page 27 of 57
CODING: Words stricken are deletions; words underlined are additions.
hb309-00

F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
HB 309 2026
676 (I) AM-679 (1-Pentyl-3-(2-iodobenzoyl)indole).
677 (II) AM-694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl)indole).
678 (III) AM-1241 (1-[(N-Methyl-2-piperidinyl)methyl]-3-(2-
679 iodo-5-nitrobenzoyl)indole).
680 (IV) Pravadoline (1-[2-(4-Morpholinyl)ethyl]-2-methyl-3-
681 (4-methoxybenzoyl)indole).
682 (V) AM-2233 (1-[(N-Methyl-2-piperidinyl)methyl]-3-(2-
683 iodobenzoyl)indole).
684 (VI) RCS-4 (1-Pentyl-3-(4-methoxybenzoyl)indole).
685 (VII) RCS-4 C4 homologue (1-Butyl-3-(4-
686 methoxybenzoyl)indole).
687 (VIII) AM-630 (1-[2-(4-Morpholinyl)ethyl]-2-methyl-6-iodo-
688 3-(4-methoxybenzoyl)indole).
689 h. Tetramethylcyclopropanoylindoles and
690 Tetramethylcyclopropanoylindazoles.—Any compound containing a
691 tetramethylcyclopropanoylindole or
692 tetramethylcyclopropanoylindazole structure, with or without
693 substitution on the indole or indazole ring to any extent,
694 whether or not substituted on the tetramethylcyclopropyl group
695 to any extent, including, but not limited to:
696 (I) UR-144 (1-Pentyl-3-(2,2,3,3-
697 tetramethylcyclopropanoyl)indole).
698 (II) XLR11 (1-(5-Fluoropentyl)-3-(2,2,3,3-
699 tetramethylcyclopropanoyl)indole).
700 (III) Chloro UR-144 (1-(Chloropentyl)-3-(2,2,3,3-
Page 28 of 57
CODING: Words stricken are deletions; words underlined are additions.
hb309-00

F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
HB 309 2026
701 tetramethylcyclopropanoyl)indole).
702 (IV) A-796,260 (1-[2-(4-Morpholinyl)ethyl]-3-(2,2,3,3-
703 tetramethylcyclopropanoyl)indole).
704 (V) A-834,735 (1-[4-(Tetrahydropyranyl)methyl]-3-(2,2,3,3-
705 tetramethylcyclopropanoyl)indole).
706 (VI) M-144 (1-(5-Fluoropentyl)-2-methyl-3-(2,2,3,3-
707 tetramethylcyclopropanoyl)indole).
708 (VII) FUB-144 (1-(4-Fluorobenzyl)-3-(2,2,3,3-
709 tetramethylcyclopropanoyl)indole).
710 (VIII) FAB-144 (1-(5-Fluoropentyl)-3-(2,2,3,3-
711 tetramethylcyclopropanoyl)indazole).
712 (IX) XLR12 (1-(4,4,4-Trifluorobutyl)-3-(2,2,3,3-
713 tetramethylcyclopropanoyl)indole).
714 (X) AB-005 (1-[(1-Methyl-2-piperidinyl)methyl]-3-(2,2,3,3-
715 tetramethylcyclopropanoyl)indole).
716 i. Adamantoylindoles, Adamantoylindazoles, Adamantylindole
717 carboxamides, and Adamantylindazole carboxamides.—Any compound
718 containing an adamantoyl indole, adamantoyl indazole, adamantyl
719 indole carboxamide, or adamantyl indazole carboxamide structure,
720 with or without substitution on the indole or indazole ring to
721 any extent, whether or not substituted on the adamantyl ring to
722 any extent, including, but not limited to:
723 (I) AKB48 (N-Adamant-1-yl 1-pentylindazole-3-carboxamide).
724 (II) Fluoro AKB48 (N-Adamant-1-yl 1-
725 (fluoropentyl)indazole-3-carboxamide).
Page 29 of 57
CODING: Words stricken are deletions; words underlined are additions.
hb309-00

F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
HB 309 2026
726 (III) STS-135 (N-Adamant-1-yl 1-(5-fluoropentyl)indole-3-
727 carboxamide).
728 (IV) AM-1248 (1-(1-Methylpiperidine)methyl-3-(1-
729 adamantoyl)indole).
730 (V) AB-001 (1-Pentyl-3-(1-adamantoyl)indole).
731 (VI) APICA (N-Adamant-1-yl 1-pentylindole-3-carboxamide).
732 (VII) Fluoro AB-001 (1-(Fluoropentyl)-3-(1-
733 adamantoyl)indole).
734 j. Quinolinylindolecarboxylates,
735 Quinolinylindazolecarboxylates, Quinolinylindolecarboxamides,
736 and Quinolinylindazolecarboxamides.—Any compound containing a
737 quinolinylindole carboxylate, quinolinylindazole carboxylate,
738 isoquinolinylindole carboxylate, isoquinolinylindazole
739 carboxylate, quinolinylindole carboxamide, quinolinylindazole
740 carboxamide, isoquinolinylindole carboxamide, or
741 isoquinolinylindazole carboxamide structure, with or without
742 substitution on the indole or indazole ring to any extent,
743 whether or not substituted on the quinoline or isoquinoline ring
744 to any extent, including, but not limited to:
745 (I) PB-22 (8-Quinolinyl 1-pentylindole-3-carboxylate).
746 (II) Fluoro PB-22 (8-Quinolinyl 1-(fluoropentyl)indole-3-
747 carboxylate).
748 (III) BB-22 (8-Quinolinyl 1-(cyclohexylmethyl)indole-3-
749 carboxylate).
750 (IV) FUB-PB-22 (8-Quinolinyl 1-(4-fluorobenzyl)indole-3-
Page 30 of 57
CODING: Words stricken are deletions; words underlined are additions.
hb309-00

F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
HB 309 2026
751 carboxylate).
752 (V) NPB-22 (8-Quinolinyl 1-pentylindazole-3-carboxylate).
753 (VI) Fluoro NPB-22 (8-Quinolinyl 1-(fluoropentyl)indazole-
754 3-carboxylate).
755 (VII) FUB-NPB-22 (8-Quinolinyl 1-(4-fluorobenzyl)indazole-
756 3-carboxylate).
757 (VIII) THJ (8-Quinolinyl 1-pentylindazole-3-carboxamide).
758 (IX) Fluoro THJ (8-Quinolinyl 1-(fluoropentyl)indazole-3-
759 carboxamide).
760 k. Naphthylindolecarboxylates and
761 Naphthylindazolecarboxylates.—Any compound containing a
762 naphthylindole carboxylate or naphthylindazole carboxylate
763 structure, with or without substitution on the indole or
764 indazole ring to any extent, whether or not substituted on the
765 naphthyl ring to any extent, including, but not limited to:
766 (I) NM-2201 (1-Naphthalenyl 1-(5-fluoropentyl)indole-3-
767 carboxylate).
768 (II) SDB-005 (1-Naphthalenyl 1-pentylindazole-3-
769 carboxylate).
770 (III) Fluoro SDB-005 (1-Naphthalenyl 1-
771 (fluoropentyl)indazole-3-carboxylate).
772 (IV) FDU-PB-22 (1-Naphthalenyl 1-(4-fluorobenzyl)indole-3-
773 carboxylate).
774 (V) 3-CAF (2-Naphthalenyl 1-(2-fluorophenyl)indazole-3-
775 carboxylate).
Page 31 of 57
CODING: Words stricken are deletions; words underlined are additions.
hb309-00

F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
HB 309 2026
776 l. Naphthylindole carboxamides and Naphthylindazole
777 carboxamides.—Any compound containing a naphthylindole
778 carboxamide or naphthylindazole carboxamide structure, with or
779 without substitution on the indole or indazole ring to any
780 extent, whether or not substituted on the naphthyl ring to any
781 extent, including, but not limited to:
782 (I) NNEI (N-Naphthalen-1-yl 1-pentylindole-3-carboxamide).
783 (II) Fluoro-NNEI (N-Naphthalen-1-yl 1-
784 (fluoropentyl)indole-3-carboxamide).
785 (III) Chloro-NNEI (N-Naphthalen-1-yl 1-
786 (chloropentyl)indole-3-carboxamide).
787 (IV) MN-18 (N-Naphthalen-1-yl 1-pentylindazole-3-
788 carboxamide).
789 (V) Fluoro MN-18 (N-Naphthalen-1-yl 1-
790 (fluoropentyl)indazole-3-carboxamide).
791 m. Alkylcarbonyl indole carboxamides, Alkylcarbonyl
792 indazole carboxamides, Alkylcarbonyl indole carboxylates, and
793 Alkylcarbonyl indazole carboxylates.—Any compound containing an
794 alkylcarbonyl group, including 1-amino-3-methyl-1-oxobutan-2-yl,
795 1-methoxy-3-methyl-1-oxobutan-2-yl, 1-amino-1-oxo-3-
796 phenylpropan-2-yl, 1-methoxy-1-oxo-3-phenylpropan-2-yl, with an
797 indole carboxamide, indazole carboxamide, indole carboxylate, or
798 indazole carboxylate, with or without substitution on the indole
799 or indazole ring to any extent, whether or not substituted on
800 the alkylcarbonyl group to any extent, including, but not
Page 32 of 57
CODING: Words stricken are deletions; words underlined are additions.
hb309-00

F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
HB 309 2026
801 limited to:
802 (I) ADBICA, (N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-
803 pentylindole-3-carboxamide).
804 (II) Fluoro ADBICA (N-(1-Amino-3,3-dimethyl-1-oxobutan-2-
805 yl)-1-(fluoropentyl)indole-3-carboxamide).
806 (III) Fluoro ABICA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-
807 1-(fluoropentyl)indole-3-carboxamide).
808 (IV) AB-PINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-
809 pentylindazole-3-carboxamide).
810 (V) Fluoro AB-PINACA (N-(1-Amino-3-methyl-1-oxobutan-2-
811 yl)-1-(fluoropentyl)indazole-3-carboxamide).
812 (VI) ADB-PINACA (N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-
813 1-pentylindazole-3-carboxamide).
814 (VII) Fluoro ADB-PINACA (N-(1-Amino-3,3-dimethyl-1-
815 oxobutan-2-yl)-1-(fluoropentyl)indazole-3-carboxamide).
816 (VIII) AB-FUBINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-
817 1-(4-fluorobenzyl)indazole-3-carboxamide).
818 (IX) ADB-FUBINACA (N-(1-Amino-3,3-dimethyl-1-oxobutan-2-
819 yl)-1-(4-fluorobenzyl)indazole-3-carboxamide).
820 (X) AB-CHMINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-
821 (cyclohexylmethyl)indazole-3-carboxamide).
822 (XI) MA-CHMINACA (N-(1-Methoxy-3-methyl-1-oxobutan-2-yl)-
823 1-(cyclohexylmethyl)indazole-3-carboxamide).
824 (XII) MAB-CHMINACA (N-(1-Amino-3,3-dimethyl-1-oxobutan-2-
825 yl)-1-(cyclohexylmethyl)indazole-3-carboxamide).
Page 33 of 57
CODING: Words stricken are deletions; words underlined are additions.
hb309-00

F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
HB 309 2026
826 (XIII) AMB (N-(1-Methoxy-3-methyl-1-oxobutan-2-yl)-1-
827 pentylindazole-3-carboxamide).
828 (XIV) Fluoro-AMB (N-(1-Methoxy-3-methyl-1-oxobutan-2-yl)-
829 1-(fluoropentyl)indazole-3-carboxamide).
830 (XV) FUB-AMB (N-(1-Methoxy-3-methyl-1-oxobutan-2-yl)-1-(4-
831 fluorobenzyl)indazole-3-carboxamide).
832 (XVI) MDMB-CHMINACA (N-(1-Methoxy-3,3-dimethyl-1-oxobutan-
833 2-yl)-1-(cyclohexylmethyl)indazole-3-carboxamide).
834 (XVII) MDMB-FUBINACA (N-(1-Methoxy-3,3-dimethyl-1-
835 oxobutan-2-yl)-1-(4-fluorobenzyl)indazole-3-carboxamide).
836 (XVIII) MDMB-CHMICA (N-(1-Methoxy-3,3-dimethyl-1-oxobutan-
837 2-yl)-1-(cyclohexylmethyl)indole-3-carboxamide).
838 (XIX) PX-1 (N-(1-Amino-1-oxo-3-phenylpropan-2-yl)-1-(5-
839 fluoropentyl)indole-3-carboxamide).
840 (XX) PX-2 (N-(1-Amino-1-oxo-3-phenylpropan-2-yl)-1-(5-
841 fluoropentyl)indazole-3-carboxamide).
842 (XXI) PX-3 (N-(1-Amino-1-oxo-3-phenylpropan-2-yl)-1-
843 (cyclohexylmethyl)indazole-3-carboxamide).
844 (XXII) PX-4 (N-(1-Amino-1-oxo-3-phenylpropan-2-yl)-1-(4-
845 fluorobenzyl)indazole-3-carboxamide).
846 (XXIII) MO-CHMINACA (N-(1-Methoxy-3,3-dimethyl-1-oxobutan-
847 2-yl)-1-(cyclohexylmethyl)indazole-3-carboxylate).
848 n. Cumylindolecarboxamides and Cumylindazolecarboxamides.—
849 Any compound containing a N-(2-phenylpropan-2-yl) indole
850 carboxamide or N-(2-phenylpropan-2-yl) indazole carboxamide
Page 34 of 57
CODING: Words stricken are deletions; words underlined are additions.
hb309-00

F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
HB 309 2026
851 structure, with or without substitution on the indole or
852 indazole ring to any extent, whether or not substituted on the
853 phenyl ring of the cumyl group to any extent, including, but not
854 limited to:
855 (I) CUMYL-PICA (N-(2-Phenylpropan-2-yl)-1-pentylindole-3-
856 carboxamide).
857 (II) Fluoro CUMYL-PICA (N-(2-Phenylpropan-2-yl)-1-
858 (fluoropentyl)indole-3-carboxamide).
859 o. Other Synthetic Cannabinoids.—Any material, compound,
860 mixture, or preparation that contains any quantity of a
861 Synthetic Cannabinoid, as described in sub-subparagraphs a.-n.:
862 (I) With or without modification or replacement of a
863 carbonyl, carboxamide, alkylene, alkyl, or carboxylate linkage
864 between either two core rings, or linkage between a core ring
865 and group structure, with or without the addition of a carbon or
866 replacement of a carbon;
867 (II) With or without replacement of a core ring or group
868 structure, whether or not substituted on the ring or group
869 structures to any extent; and
870 (III) Is a cannabinoid receptor agonist, unless
871 specifically excepted or unless listed in another schedule or
872 contained within a pharmaceutical product approved by the United
873 States Food and Drug Administration.
874 191. Substituted Cathinones.—Unless specifically excepted,
875 listed in another schedule, or contained within a pharmaceutical
Page 35 of 57
CODING: Words stricken are deletions; words underlined are additions.
hb309-00

F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
HB 309 2026
876 product approved by the United States Food and Drug
877 Administration, any material, compound, mixture, or preparation,
878 including its salts, isomers, esters, or ethers, and salts of
879 isomers, esters, or ethers, whenever the existence of such salts
880 is possible within any of the following specific chemical
881 designations:
882 a. Any compound containing a 2-amino-1-phenyl-1-propanone
883 structure;
884 b. Any compound containing a 2-amino-1-naphthyl-1-
885 propanone structure; or
886 c. Any compound containing a 2-amino-1-thiophenyl-1-
887 propanone structure, whether or not the compound is further
888 modified:
889 (I) With or without substitution on the ring system to any
890 extent with alkyl, alkylthio, thio, fused alkylenedioxy, alkoxy,
891 haloalkyl, hydroxyl, nitro, fused furan, fused benzofuran, fused
892 dihydrofuran, fused tetrahydropyran, fused alkyl ring, or halide
893 substituents;
894 (II) With or without substitution at the 3-propanone
895 position with an alkyl substituent or removal of the methyl
896 group at the 3-propanone position;
897 (III) With or without substitution at the 2-amino nitrogen
898 atom with alkyl, dialkyl, acetyl, or benzyl groups, whether or
899 not further substituted in the ring system; or
900 (IV) With or without inclusion of the 2-amino nitrogen
Page 36 of 57
CODING: Words stricken are deletions; words underlined are additions.
hb309-00

F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
HB 309 2026
901 atom in a cyclic structure, including, but not limited to:
902 (A) Methcathinone.
903 (B) Ethcathinone.
904 (C) Methylone (3,4-Methylenedioxymethcathinone).
905 (D) 2,3-Methylenedioxymethcathinone.
906 (E) MDPV (3,4-Methylenedioxypyrovalerone).
907 (F) Methylmethcathinone.
908 (G) Methoxymethcathinone.
909 (H) Fluoromethcathinone.
910 (I) Methylethcathinone.
911 (J) Butylone (3,4-Methylenedioxy-alpha-
912 methylaminobutyrophenone).
913 (K) Ethylone (3,4-Methylenedioxy-N-ethylcathinone).
914 (L) BMDP (3,4-Methylenedioxy-N-benzylcathinone).
915 (M) Naphyrone (Naphthylpyrovalerone).
916 (N) Bromomethcathinone.
917 (O) Buphedrone (alpha-Methylaminobutyrophenone).
918 (P) Eutylone (3,4-Methylenedioxy-alpha-
919 ethylaminobutyrophenone).
920 (Q) Dimethylcathinone.
921 (R) Dimethylmethcathinone.
922 (S) Pentylone (3,4-Methylenedioxy-alpha-
923 methylaminovalerophenone).
924 (T) Pentedrone (alpha-Methylaminovalerophenone).
925 (U) MDPPP (3,4-Methylenedioxy-alpha-
Page 37 of 57
CODING: Words stricken are deletions; words underlined are additions.
hb309-00

F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
HB 309 2026
926 pyrrolidinopropiophenone).
927 (V) MDPBP (3,4-Methylenedioxy-alpha-
928 pyrrolidinobutyrophenone).
929 (W) MPPP (Methyl-alpha-pyrrolidinopropiophenone).
930 (X) PPP (Pyrrolidinopropiophenone).
931 (Y) PVP (Pyrrolidinovalerophenone) or
932 (Pyrrolidinopentiophenone).
933 (Z) MOPPP (Methoxy-alpha-pyrrolidinopropiophenone).
934 (AA) MPHP (Methyl-alpha-pyrrolidinohexanophenone).
935 (BB) F-MABP (Fluoromethylaminobutyrophenone).
936 (CC) Me-EABP (Methylethylaminobutyrophenone).
937 (DD) PBP (Pyrrolidinobutyrophenone).
938 (EE) MeO-PBP (Methoxypyrrolidinobutyrophenone).
939 (FF) Et-PBP (Ethylpyrrolidinobutyrophenone).
940 (GG) 3-Me-4-MeO-MCAT (3-Methyl-4-Methoxymethcathinone).
941 (HH) Dimethylone (3,4-Methylenedioxy-N,N-
942 dimethylcathinone).
943 (II) 3,4-Methylenedioxy-N,N-diethylcathinone.
944 (JJ) 3,4-Methylenedioxy-N-acetylcathinone.
945 (KK) 3,4-Methylenedioxy-N-acetylmethcathinone.
946 (LL) 3,4-Methylenedioxy-N-acetylethcathinone.
947 (MM) Methylbuphedrone (Methyl-alpha-
948 methylaminobutyrophenone).
949 (NN) Methyl-alpha-methylaminohexanophenone.
950 (OO) N-Ethyl-N-methylcathinone.
Page 38 of 57
CODING: Words stricken are deletions; words underlined are additions.
hb309-00

F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
HB 309 2026
951 (PP) PHP (Pyrrolidinohexanophenone).
952 (QQ) PV8 (Pyrrolidinoheptanophenone).
953 (RR) Chloromethcathinone.
954 (SS) 4-Bromo-2,5-dimethoxy-alpha-aminoacetophenone.
955 192. Substituted Phenethylamines.—Unless specifically
956 excepted or unless listed in another schedule, or contained
957 within a pharmaceutical product approved by the United States
958 Food and Drug Administration, any material, compound, mixture,
959 or preparation, including its salts, isomers, esters, or ethers,
960 and salts of isomers, esters, or ethers, whenever the existence
961 of such salts is possible within any of the following specific
962 chemical designations, any compound containing a phenethylamine
963 structure, without a beta-keto group, and without a benzyl group
964 attached to the amine group, whether or not the compound is
965 further modified with or without substitution on the phenyl ring
966 to any extent with alkyl, alkylthio, nitro, alkoxy, thio,
967 halide, fused alkylenedioxy, fused furan, fused benzofuran,
968 fused dihydrofuran, or fused tetrahydropyran substituents,
969 whether or not further substituted on a ring to any extent, with
970 or without substitution at the alpha or beta position by any
971 alkyl substituent, with or without substitution at the nitrogen
972 atom, and with or without inclusion of the 2-amino nitrogen atom
973 in a cyclic structure, including, but not limited to:
974 a. 2C-B (4-Bromo-2,5-dimethoxyphenethylamine).
975 b. 2C-E (4-Ethyl-2,5-dimethoxyphenethylamine).
Page 39 of 57
CODING: Words stricken are deletions; words underlined are additions.
hb309-00

F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
HB 309 2026
976 c. 2C-T-4 (4-Isopropylthio-2,5-dimethoxyphenethylamine).
977 d. 2C-C (4-Chloro-2,5-dimethoxyphenethylamine).
978 e. 2C-T (4-Methylthio-2,5-dimethoxyphenethylamine).
979 f. 2C-T-2 (4-Ethylthio-2,5-dimethoxyphenethylamine).
980 g. 2C-T-7 (4-(n)-Propylthio-2,5-dimethoxyphenethylamine).
981 h. 2C-I (4-Iodo-2,5-dimethoxyphenethylamine).
982 i. 2C-D (4-Methyl-2,5-dimethoxyphenethylamine).
983 j. 2C-H (2,5-Dimethoxyphenethylamine).
984 k. 2C-N (4-Nitro-2,5-dimethoxyphenethylamine).
985 l. 2C-P (4-(n)-Propyl-2,5-dimethoxyphenethylamine).
986 m. MDMA (3,4-Methylenedioxymethamphetamine).
987 n. MBDB (Methylbenzodioxolylbutanamine) or (3,4-
988 Methylenedioxy-N-methylbutanamine).
989 o. MDA (3,4-Methylenedioxyamphetamine).
990 p. 2,5-Dimethoxyamphetamine.
991 q. Fluoroamphetamine.
992 r. Fluoromethamphetamine.
993 s. MDEA (3,4-Methylenedioxy-N-ethylamphetamine).
994 t. DOB (4-Bromo-2,5-dimethoxyamphetamine).
995 u. DOC (4-Chloro-2,5-dimethoxyamphetamine).
996 v. DOET (4-Ethyl-2,5-dimethoxyamphetamine).
997 w. DOI (4-Iodo-2,5-dimethoxyamphetamine).
998 x. DOM (4-Methyl-2,5-dimethoxyamphetamine).
999 y. PMA (4-Methoxyamphetamine).
1000 z. N-Ethylamphetamine.
Page 40 of 57
CODING: Words stricken are deletions; words underlined are additions.
hb309-00

F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
HB 309 2026
1001 aa. 3,4-Methylenedioxy-N-hydroxyamphetamine.
1002 bb. 5-Methoxy-3,4-methylenedioxyamphetamine.
1003 cc. PMMA (4-Methoxymethamphetamine).
1004 dd. N,N-Dimethylamphetamine.
1005 ee. 3,4,5-Trimethoxyamphetamine.
1006 ff. 4-APB (4-(2-Aminopropyl)benzofuran).
1007 gg. 5-APB (5-(2-Aminopropyl)benzofuran).
1008 hh. 6-APB (6-(2-Aminopropyl)benzofuran).
1009 ii. 7-APB (7-(2-Aminopropyl)benzofuran).
1010 jj. 4-APDB (4-(2-Aminopropyl)-2,3-dihydrobenzofuran).
1011 kk. 5-APDB (5-(2-Aminopropyl)-2,3-dihydrobenzofuran).
1012 ll. 6-APDB (6-(2-Aminopropyl)-2,3-dihydrobenzofuran).
1013 mm. 7-APDB (7-(2-Aminopropyl)-2,3-dihydrobenzofuran).
1014 nn. 4-MAPB (4-(2-Methylaminopropyl)benzofuran).
1015 oo. 5-MAPB (5-(2-Methylaminopropyl)benzofuran).
1016 pp. 6-MAPB (6-(2-Methylaminopropyl)benzofuran).
1017 qq. 7-MAPB (7-(2-Methylaminopropyl)benzofuran).
1018 rr. 5-EAPB (5-(2-Ethylaminopropyl)benzofuran).
1019 ss. 5-MAPDB (5-(2-Methylaminopropyl)-2,3-
1020 dihydrobenzofuran),
1021
1022 which does not include phenethylamine, mescaline as described in
1023 subparagraph 20., substituted cathinones as described in
1024 subparagraph 191., N-Benzyl phenethylamine compounds as
1025 described in subparagraph 193., or methamphetamine as described
Page 41 of 57
CODING: Words stricken are deletions; words underlined are additions.
hb309-00

F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
HB 309 2026
1026 in subparagraph (2)(c)5.
1027 193. N-Benzyl Phenethylamine Compounds.—Unless
1028 specifically excepted or unless listed in another schedule, or
1029 contained within a pharmaceutical product approved by the United
1030 States Food and Drug Administration, any material, compound,
1031 mixture, or preparation, including its salts, isomers, esters,
1032 or ethers, and salts of isomers, esters, or ethers, whenever the
1033 existence of such salts is possible within any of the following
1034 specific chemical designations, any compound containing a
1035 phenethylamine structure without a beta-keto group, with
1036 substitution on the nitrogen atom of the amino group with a
1037 benzyl substituent, with or without substitution on the phenyl
1038 or benzyl ring to any extent with alkyl, alkoxy, thio,
1039 alkylthio, halide, fused alkylenedioxy, fused furan, fused
1040 benzofuran, or fused tetrahydropyran substituents, whether or
1041 not further substituted on a ring to any extent, with or without
1042 substitution at the alpha position by any alkyl substituent,
1043 including, but not limited to:
1044 a. 25B-NBOMe (4-Bromo-2,5-dimethoxy-[N-(2-
1045 methoxybenzyl)]phenethylamine).
1046 b. 25B-NBOH (4-Bromo-2,5-dimethoxy-[N-(2-
1047 hydroxybenzyl)]phenethylamine).
1048 c. 25B-NBF (4-Bromo-2,5-dimethoxy-[N-(2-
1049 fluorobenzyl)]phenethylamine).
1050 d. 25B-NBMD (4-Bromo-2,5-dimethoxy-[N-(2,3-
Page 42 of 57
CODING: Words stricken are deletions; words underlined are additions.
hb309-00

F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
HB 309 2026
1051 methylenedioxybenzyl)]phenethylamine).
1052 e. 25I-NBOMe (4-Iodo-2,5-dimethoxy-[N-(2-
1053 methoxybenzyl)]phenethylamine).
1054 f. 25I-NBOH (4-Iodo-2,5-dimethoxy-[N-(2-
1055 hydroxybenzyl)]phenethylamine).
1056 g. 25I-NBF (4-Iodo-2,5-dimethoxy-[N-(2-
1057 fluorobenzyl)]phenethylamine).
1058 h. 25I-NBMD (4-Iodo-2,5-dimethoxy-[N-(2,3-
1059 methylenedioxybenzyl)]phenethylamine).
1060 i. 25T2-NBOMe (4-Methylthio-2,5-dimethoxy-[N-(2-
1061 methoxybenzyl)]phenethylamine).
1062 j. 25T4-NBOMe (4-Isopropylthio-2,5-dimethoxy-[N-(2-
1063 methoxybenzyl)]phenethylamine).
1064 k. 25T7-NBOMe (4-(n)-Propylthio-2,5-dimethoxy-[N-(2-
1065 methoxybenzyl)]phenethylamine).
1066 l. 25C-NBOMe (4-Chloro-2,5-dimethoxy-[N-(2-
1067 methoxybenzyl)]phenethylamine).
1068 m. 25C-NBOH (4-Chloro-2,5-dimethoxy-[N-(2-
1069 hydroxybenzyl)]phenethylamine).
1070 n. 25C-NBF (4-Chloro-2,5-dimethoxy-[N-(2-
1071 fluorobenzyl)]phenethylamine).
1072 o. 25C-NBMD (4-Chloro-2,5-dimethoxy-[N-(2,3-
1073 methylenedioxybenzyl)]phenethylamine).
1074 p. 25H-NBOMe (2,5-Dimethoxy-[N-(2-
1075 methoxybenzyl)]phenethylamine).
Page 43 of 57
CODING: Words stricken are deletions; words underlined are additions.
hb309-00

F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
HB 309 2026
1076 q. 25H-NBOH (2,5-Dimethoxy-[N-(2-
1077 hydroxybenzyl)]phenethylamine).
1078 r. 25H-NBF (2,5-Dimethoxy-[N-(2-
1079 fluorobenzyl)]phenethylamine).
1080 s. 25D-NBOMe (4-Methyl-2,5-dimethoxy-[N-(2-
1081 methoxybenzyl)]phenethylamine),
1082
1083 which does not include substituted cathinones as described in
1084 subparagraph 191.
1085 194. Substituted Tryptamines.—Unless specifically excepted
1086 or unless listed in another schedule, or contained within a
1087 pharmaceutical product approved by the United States Food and
1088 Drug Administration, any material, compound, mixture, or
1089 preparation containing a 2-(1H-indol-3-yl)ethanamine, for
1090 example tryptamine, structure with or without mono- or di-
1091 substitution of the amine nitrogen with alkyl or alkenyl groups,
1092 or by inclusion of the amino nitrogen atom in a cyclic
1093 structure, whether or not substituted at the alpha position with
1094 an alkyl group, whether or not substituted on the indole ring to
1095 any extent with any alkyl, alkoxy, halo, hydroxyl, or acetoxy
1096 groups, including, but not limited to:
1097 a. Alpha-Ethyltryptamine.
1098 b. Bufotenine.
1099 c. DET (Diethyltryptamine).
1100 d. DMT (Dimethyltryptamine).
Page 44 of 57
CODING: Words stricken are deletions; words underlined are additions.
hb309-00

F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
HB 309 2026
1101 e. MET (N-Methyl-N-ethyltryptamine).
1102 f. DALT (N,N-Diallyltryptamine).
1103 g. EiPT (N-Ethyl-N-isopropyltryptamine).
1104 h. MiPT (N-Methyl-N-isopropyltryptamine).
1105 i. 5-Hydroxy-AMT (5-Hydroxy-alpha-methyltryptamine).
1106 j. 5-Hydroxy-N-methyltryptamine.
1107 k. 5-MeO-MiPT (5-Methoxy-N-methyl-N-isopropyltryptamine).
1108 l. 5-MeO-AMT (5-Methoxy-alpha-methyltryptamine).
1109 m. Methyltryptamine.
1110 n. 5-MeO-DMT (5-Methoxy-N,N-dimethyltryptamine).
1111 o. 5-Me-DMT (5-Methyl-N,N-dimethyltryptamine).
1112 p. 5-MeO-DiPT (5-Methoxy-N,N-Diisopropyltryptamine).
1113 q. DiPT (N,N-Diisopropyltryptamine).
1114 r. DPT (N,N-Dipropyltryptamine).
1115 s. 4-Hydroxy-DiPT (4-Hydroxy-N,N-diisopropyltryptamine).
1116 t. 5-MeO-DALT (5-Methoxy-N,N-Diallyltryptamine).
1117 u. 4-AcO-DMT (4-Acetoxy-N,N-dimethyltryptamine).
1118 v. 4-AcO-DiPT (4-Acetoxy-N,N-diisopropyltryptamine).
1119 w. 4-Hydroxy-DET (4-Hydroxy-N,N-diethyltryptamine).
1120 x. 4-Hydroxy-MET (4-Hydroxy-N-methyl-N-ethyltryptamine).
1121 y. 4-Hydroxy-MiPT (4-Hydroxy-N-methyl-N-
1122 isopropyltryptamine).
1123 z. Methyl-alpha-ethyltryptamine.
1124 aa. Bromo-DALT (Bromo-N,N-diallyltryptamine),
1125
Page 45 of 57
CODING: Words stricken are deletions; words underlined are additions.
hb309-00

F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
HB 309 2026
1126 which does not include tryptamine, psilocyn as described in
1127 subparagraph 34., or psilocybin as described in subparagraph 33.
1128 195. Substituted Phenylcyclohexylamines.—Unless
1129 specifically excepted or unless listed in another schedule, or
1130 contained within a pharmaceutical product approved by the United
1131 States Food and Drug Administration, any material, compound,
1132 mixture, or preparation containing a phenylcyclohexylamine
1133 structure, with or without any substitution on the phenyl ring,
1134 any substitution on the cyclohexyl ring, any replacement of the
1135 phenyl ring with a thiophenyl or benzothiophenyl ring, with or
1136 without substitution on the amine with alkyl, dialkyl, or alkoxy
1137 substituents, inclusion of the nitrogen in a cyclic structure,
1138 or any combination of the above, including, but not limited to:
1139 a. BTCP (Benzothiophenylcyclohexylpiperidine) or BCP
1140 (Benocyclidine).
1141 b. PCE (N-Ethyl-1-phenylcyclohexylamine)(Ethylamine analog
1142 of phencyclidine).
1143 c. PCPY (N-(1-Phenylcyclohexyl)-pyrrolidine)(Pyrrolidine
1144 analog of phencyclidine).
1145 d. PCPr (Phenylcyclohexylpropylamine).
1146 e. TCP (1-[1-(2-Thienyl)-cyclohexyl]-piperidine)(Thiophene
1147 analog of phencyclidine).
1148 f. PCEEA (Phenylcyclohexyl(ethoxyethylamine)).
1149 g. PCMPA (Phenylcyclohexyl(methoxypropylamine)).
1150 h. Methoxetamine.
Page 46 of 57
CODING: Words stricken are deletions; words underlined are additions.
hb309-00

F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
HB 309 2026
1151 i. 3-Methoxy-PCE ((3-Methoxyphenyl)cyclohexylethylamine).
1152 j. Bromo-PCP ((Bromophenyl)cyclohexylpiperidine).
1153 k. Chloro-PCP ((Chlorophenyl)cyclohexylpiperidine).
1154 l. Fluoro-PCP ((Fluorophenyl)cyclohexylpiperidine).
1155 m. Hydroxy-PCP ((Hydroxyphenyl)cyclohexylpiperidine).
1156 n. Methoxy-PCP ((Methoxyphenyl)cyclohexylpiperidine).
1157 o. Methyl-PCP ((Methylphenyl)cyclohexylpiperidine).
1158 p. Nitro-PCP ((Nitrophenyl)cyclohexylpiperidine).
1159 q. Oxo-PCP ((Oxophenyl)cyclohexylpiperidine).
1160 r. Amino-PCP ((Aminophenyl)cyclohexylpiperidine).
1161 196. W-15, 4-chloro-N-[1-(2-phenylethyl)-2-
1162 piperidinylidene]-benzenesulfonamide.
1163 197. W-18, 4-chloro-N-[1-[2-(4-nitrophenyl)ethyl]-2-
1164 piperidinylidene]-benzenesulfonamide.
1165 198. AH-7921, 3,4-dichloro-N-[[1-
1166 (dimethylamino)cyclohexyl]methyl]-benzamide.
1167 199. U47700, trans-3,4-dichloro-N-[2-
1168 (dimethylamino)cyclohexyl]-N-methyl-benzamide.
1169 200. MT-45, 1-cyclohexyl-4-(1,2-diphenylethyl)-piperazine,
1170 dihydrochloride.
1171 Section 2. Paragraph (i) of subsection (1) of section
1172 893.13, Florida Statutes, is amended to read:
1173 893.13 Prohibited acts; penalties.—
1174 (1)
1175 (i) Except as authorized by this chapter, a person commits
Page 47 of 57
CODING: Words stricken are deletions; words underlined are additions.
hb309-00

F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
HB 309 2026
1176 a felony of the first degree, punishable as provided in s.
1177 775.082, s. 775.083, or s. 775.084, and must be sentenced to a
1178 mandatory minimum term of imprisonment of 3 years, if:
1179 1. The person sells, manufactures, or delivers, or
1180 possesses with intent to sell, manufacture, or deliver, any of
1181 the following:
1182 a. Alfentanil, as described in s. 893.03(2)(b)1.;
1183 b. Carfentanil, as described in s. 893.03(2)(b)6.;
1184 c. Fentanyl, as described in s. 893.03(2)(b)9.;
1185 d. Sufentanil, as described in s. 893.03(2)(b)30.;
1186 e. A fentanyl derivative, as described in s.
1187 893.03(1)(a)64. s. 893.03(1)(a)63.;
1188 f. Xylazine, as described in s. 893.03(1)(c)37.;
1189 g.f. A controlled substance analog, as described in s.
1190 893.0356, of any substance described in sub-subparagraphs a.-f.
1191 sub-subparagraphs a.-e.; or
1192 h.g. A mixture containing any substance described in sub-
1193 subparagraphs a.-g. sub-subparagraphs a.-f.; and
1194 2. The substance or mixture listed in subparagraph 1. is
1195 in a form that resembles, or is mixed, granulated, absorbed,
1196 spray-dried, or aerosolized as or onto, coated on, in whole or
1197 in part, or solubilized with or into, a product, when such
1198 product or its packaging further has at least one of the
1199 following attributes:
1200 a. Resembles the trade dress of a branded food product,
Page 48 of 57
CODING: Words stricken are deletions; words underlined are additions.
hb309-00

F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
HB 309 2026
1201 consumer food product, or logo food product;
1202 b. Incorporates an actual or fake registered copyright,
1203 service mark, or trademark;
1204 c. Resembles candy, cereal, a gummy, a vitamin, or a
1205 chewable product, such as a gum or gelatin-based product; or
1206 d. Contains a cartoon character imprint.
1207 Section 3. Paragraph (a) of subsection (2) of section
1208 893.131, Florida Statutes, is amended to read:
1209 893.131 Distribution of controlled substances resulting in
1210 overdose or serious bodily injury.—
1211 (2)(a) Except as provided in paragraph (b), a person 18
1212 years of age or older who unlawfully distributes:
1213 1. Heroin, as described in s. 893.03(1)(b)11.;
1214 2. Alfentanil, as described in s. 893.03(2)(b)1.;
1215 3. Carfentanil, as described in s. 893.03(2)(b)6.;
1216 4. Fentanyl, as described in s. 893.03(2)(b)9.;
1217 5. Sufentanil, as described in s. 893.03(2)(b)30.;
1218 6. Fentanyl derivatives, as described in s.
1219 893.03(1)(a)64. s. 893.03(1)(a)63.;
1220 7. A controlled substance analog, as described in s.
1221 893.0356, of any substance specified in subparagraphs 1.-6.; or
1222 8. A mixture containing any substance specified in
1223 subparagraphs 1.-7.,
1224
1225 and an overdose or serious bodily injury of the user results,
Page 49 of 57
CODING: Words stricken are deletions; words underlined are additions.
hb309-00

F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
HB 309 2026
1226 commits a felony of the second degree, punishable as provided in
1227 s. 775.082, s. 775.083, or s. 775.084, when such substance or
1228 mixture is proven to have caused or been a substantial factor in
1229 causing the overdose or serious bodily injury of the user.
1230 Section 4. Paragraph (c) of subsection (1) of section
1231 893.135, Florida Statutes, is amended to read:
1232 893.135 Trafficking; mandatory sentences; suspension or
1233 reduction of sentences; conspiracy to engage in trafficking.—
1234 (1) Except as authorized in this chapter or in chapter 499
1235 and notwithstanding the provisions of s. 893.13:
1236 (c)1. A person who knowingly sells, purchases,
1237 manufactures, delivers, or brings into this state, or who is
1238 knowingly in actual or constructive possession of, 4 grams or
1239 more of any morphine, opium, hydromorphone, or any salt,
1240 derivative, isomer, or salt of an isomer thereof, including
1241 heroin, as described in s. 893.03(1)(b), (2)(a), (3)(c)3., or
1242 (3)(c)4., or 4 grams or more of any mixture containing any such
1243 substance, but less than 30 kilograms of such substance or
1244 mixture, commits a felony of the first degree, which felony
1245 shall be known as "trafficking in illegal drugs," punishable as
1246 provided in s. 775.082, s. 775.083, or s. 775.084. If the
1247 quantity involved:
1248 a. Is 4 grams or more, but less than 14 grams, such person
1249 shall be sentenced to a mandatory minimum term of imprisonment
1250 of 3 years and shall be ordered to pay a fine of $50,000.
Page 50 of 57
CODING: Words stricken are deletions; words underlined are additions.
hb309-00

F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
HB 309 2026
1251 b. Is 14 grams or more, but less than 28 grams, such
1252 person shall be sentenced to a mandatory minimum term of
1253 imprisonment of 15 years and shall be ordered to pay a fine of
1254 $100,000.
1255 c. Is 28 grams or more, but less than 30 kilograms, such
1256 person shall be sentenced to a mandatory minimum term of
1257 imprisonment of 25 years and shall be ordered to pay a fine of
1258 $500,000.
1259 2. A person who knowingly sells, purchases, manufactures,
1260 delivers, or brings into this state, or who is knowingly in
1261 actual or constructive possession of, 28 grams or more of
1262 hydrocodone, as described in s. 893.03(2)(a)1.k., codeine, as
1263 described in s. 893.03(2)(a)1.g., or any salt thereof, or 28
1264 grams or more of any mixture containing any such substance,
1265 commits a felony of the first degree, which felony shall be
1266 known as "trafficking in hydrocodone," punishable as provided in
1267 s. 775.082, s. 775.083, or s. 775.084. If the quantity involved:
1268 a. Is 28 grams or more, but less than 50 grams, such
1269 person shall be sentenced to a mandatory minimum term of
1270 imprisonment of 3 years and shall be ordered to pay a fine of
1271 $50,000.
1272 b. Is 50 grams or more, but less than 100 grams, such
1273 person shall be sentenced to a mandatory minimum term of
1274 imprisonment of 7 years and shall be ordered to pay a fine of
1275 $100,000.
Page 51 of 57
CODING: Words stricken are deletions; words underlined are additions.
hb309-00

F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
HB 309 2026
1276 c. Is 100 grams or more, but less than 300 grams, such
1277 person shall be sentenced to a mandatory minimum term of
1278 imprisonment of 15 years and shall be ordered to pay a fine of
1279 $500,000.
1280 d. Is 300 grams or more, but less than 30 kilograms, such
1281 person shall be sentenced to a mandatory minimum term of
1282 imprisonment of 25 years and shall be ordered to pay a fine of
1283 $750,000.
1284 3. A person who knowingly sells, purchases, manufactures,
1285 delivers, or brings into this state, or who is knowingly in
1286 actual or constructive possession of, 7 grams or more of
1287 oxycodone, as described in s. 893.03(2)(a)1.q., or any salt
1288 thereof, or 7 grams or more of any mixture containing any such
1289 substance, commits a felony of the first degree, which felony
1290 shall be known as "trafficking in oxycodone," punishable as
1291 provided in s. 775.082, s. 775.083, or s. 775.084. If the
1292 quantity involved:
1293 a. Is 7 grams or more, but less than 14 grams, such person
1294 shall be sentenced to a mandatory minimum term of imprisonment
1295 of 3 years and shall be ordered to pay a fine of $50,000.
1296 b. Is 14 grams or more, but less than 25 grams, such
1297 person shall be sentenced to a mandatory minimum term of
1298 imprisonment of 7 years and shall be ordered to pay a fine of
1299 $100,000.
1300 c. Is 25 grams or more, but less than 100 grams, such
Page 52 of 57
CODING: Words stricken are deletions; words underlined are additions.
hb309-00

F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
HB 309 2026
1301 person shall be sentenced to a mandatory minimum term of
1302 imprisonment of 15 years and shall be ordered to pay a fine of
1303 $500,000.
1304 d. Is 100 grams or more, but less than 30 kilograms, such
1305 person shall be sentenced to a mandatory minimum term of
1306 imprisonment of 25 years and shall be ordered to pay a fine of
1307 $750,000.
1308 4.a. A person who knowingly sells, purchases,
1309 manufactures, delivers, or brings into this state, or who is
1310 knowingly in actual or constructive possession of, 4 grams or
1311 more of:
1312 (I) Alfentanil, as described in s. 893.03(2)(b)1.;
1313 (II) Carfentanil, as described in s. 893.03(2)(b)6.;
1314 (III) Fentanyl, as described in s. 893.03(2)(b)9.;
1315 (IV) Sufentanil, as described in s. 893.03(2)(b)30.;
1316 (V) A fentanyl derivative, as described in s.
1317 893.03(1)(a)64. s. 893.03(1)(a)63.;
1318 (VI) A controlled substance analog, as described in s.
1319 893.0356, of any substance described in sub-sub-subparagraphs
1320 (I)-(V); or
1321 (VII) A mixture containing any substance described in sub-
1322 sub-subparagraphs (I)-(VI),
1323
1324 commits a felony of the first degree, which felony shall be
1325 known as "trafficking in dangerous fentanyl or fentanyl
Page 53 of 57
CODING: Words stricken are deletions; words underlined are additions.
hb309-00

F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
HB 309 2026
1326 analogues," punishable as provided in s. 775.082, s. 775.083, or
1327 s. 775.084.
1328 b. If the quantity involved under sub-subparagraph a.:
1329 (I) Is 4 grams or more, but less than 14 grams, such
1330 person shall be sentenced to a mandatory minimum term of
1331 imprisonment of 7 years, and shall be ordered to pay a fine of
1332 $50,000.
1333 (II) Is 14 grams or more, but less than 28 grams, such
1334 person shall be sentenced to a mandatory minimum term of
1335 imprisonment of 20 years, and shall be ordered to pay a fine of
1336 $100,000.
1337 (III) Is 28 grams or more, such person shall be sentenced
1338 to a mandatory minimum term of imprisonment of 25 years, and
1339 shall be ordered to pay a fine of $500,000.
1340 c. A person 18 years of age or older who violates sub-
1341 subparagraph a. by knowingly selling or delivering to a minor at
1342 least 4 grams of a substance or mixture listed in sub-
1343 subparagraph a. shall be sentenced to a mandatory minimum term
1344 of not less than 25 years and not exceeding life imprisonment,
1345 and shall be ordered to pay a fine of $1 million if the
1346 substance or mixture listed in sub-subparagraph a. is in a form
1347 that resembles, or is mixed, granulated, absorbed, spray-dried,
1348 or aerosolized as or onto, coated on, in whole or in part, or
1349 solubilized with or into, a product, when such product or its
1350 packaging further has at least one of the following attributes:
Page 54 of 57
CODING: Words stricken are deletions; words underlined are additions.
hb309-00

F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
HB 309 2026
1351 (I) Resembles the trade dress of a branded food product,
1352 consumer food product, or logo food product;
1353 (II) Incorporates an actual or fake registered copyright,
1354 service mark, or trademark;
1355 (III) Resembles candy, cereal, a gummy, a vitamin, or a
1356 chewable product, such as a gum or gelatin-based product; or
1357 (IV) Contains a cartoon character imprint.
1358 5. A person who knowingly sells, purchases, manufactures,
1359 delivers, or brings into this state, or who is knowingly in
1360 actual or constructive possession of, 30 kilograms or more of
1361 any morphine, opium, oxycodone, hydrocodone, codeine,
1362 hydromorphone, or any salt, derivative, isomer, or salt of an
1363 isomer thereof, including heroin, as described in s.
1364 893.03(1)(b), (2)(a), (3)(c)3., or (3)(c)4., or 30 kilograms or
1365 more of any mixture containing any such substance, commits the
1366 first degree felony of trafficking in illegal drugs. A person
1367 who has been convicted of the first degree felony of trafficking
1368 in illegal drugs under this subparagraph shall be punished by
1369 life imprisonment and is ineligible for any form of
1370 discretionary early release except pardon or executive clemency
1371 or conditional medical release under s. 947.149. However, if the
1372 court determines that, in addition to committing any act
1373 specified in this paragraph:
1374 a. The person intentionally killed an individual or
1375 counseled, commanded, induced, procured, or caused the
Page 55 of 57
CODING: Words stricken are deletions; words underlined are additions.
hb309-00

F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
HB 309 2026
1376 intentional killing of an individual and such killing was the
1377 result; or
1378 b. The person's conduct in committing that act led to a
1379 natural, though not inevitable, lethal result,
1380
1381 such person commits the capital felony of trafficking in illegal
1382 drugs, punishable as provided in ss. 775.082 and 921.142. A
1383 person sentenced for a capital felony under this paragraph shall
1384 also be sentenced to pay the maximum fine provided under
1385 subparagraph 1.
1386 6. A person who knowingly brings into this state 60
1387 kilograms or more of any morphine, opium, oxycodone,
1388 hydrocodone, codeine, hydromorphone, or any salt, derivative,
1389 isomer, or salt of an isomer thereof, including heroin, as
1390 described in s. 893.03(1)(b), (2)(a), (3)(c)3., or (3)(c)4., or
1391 60 kilograms or more of any mixture containing any such
1392 substance, and who knows that the probable result of such
1393 importation would be the death of a person, commits capital
1394 importation of illegal drugs, a capital felony punishable as
1395 provided in ss. 775.082 and 921.142. A person sentenced for a
1396 capital felony under this paragraph shall also be sentenced to
1397 pay the maximum fine provided under subparagraph 1.
1398 7. A person who knowingly sells, purchases, manufactures,
1399 delivers, or brings into this state, or who is knowingly in
1400 actual or constructive possession of, 28 grams or more of
Page 56 of 57
CODING: Words stricken are deletions; words underlined are additions.
hb309-00

F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
HB 309 2026
1401 xylazine, as described in s. 893.03(1)(c)37., or any salt
1402 thereof, or 28 grams or more of any mixture containing any such
1403 substance, commits a felony of the first degree, which felony
1404 shall be known as "trafficking in xylazine," punishable as
1405 provided in s. 775.082, s. 775.083, or s. 775.084. If the
1406 quantity involved:
1407 a. Is 28 grams or more, but less than 100 grams, such
1408 person shall be sentenced to a mandatory minimum term of
1409 imprisonment of 3 years and shall be ordered to pay a fine of
1410 $50,000.
1411 b. Is 100 grams or more, but less than 200 grams, such
1412 person shall be sentenced to a mandatory minimum term of
1413 imprisonment of 7 years and shall be ordered to pay a fine of
1414 $100,000.
1415 c. Is 200 grams or more, such person shall be sentenced to
1416 a mandatory minimum term of imprisonment of 25 years and shall
1417 be ordered to pay a fine of $500,000.
1418 Section 5. Except as otherwise expressly provided in this
1419 act and except for this section, which shall take effect upon
1420 this act becoming a law, this act shall take effect October 1,
1421 2026.
Page 57 of 57
CODING: Words stricken are deletions; words underlined are additions.
hb309-00

[DELETED:  92 LORIDA HOUSE OF REPRESENTATIVES A A 8 c c a S a F p p i d m F 8 x m o i  B S]
[DELETED:  92 LORIDA HOUSE OF REPRESENTATIVES   8 i s a c t s w S P P A  ( p t s f  ( a t e e c  1]
[DELETED:  92 LORIDA HOUSE OF REPRESENTATIVES  2  3  4 a o  5  6 e (  7  8  9  1  1  1  1  1  1  1  1  1  1  2  2  2]
[DELETED:  92 LORIDA HOUSE OF REPRESENTATIVES  2  2  2  2  2  2  2  3  3  3 p  3  3  3  3  3 P  3 p  3  4  4  4  4  4]
[DELETED:  92 LORIDA HOUSE OF REPRESENTATIVES  4  4  4  4  4  5 A  5  5  5  5  5  5  5  5  5  6  6  6  6  6 l p A i]
[DELETED:  92 LORIDA HOUSE OF REPRESENTATIVES i i d  a a m d s  b m h c r  c p c g  d a a  e p g  f a]
[DELETED:  92 LORIDA HOUSE OF REPRESENTATIVES  g a e i  (  ( e (  (  (  (  (  ( p  (  (  (  (  (  (  (  (  (  (  (]
[DELETED:  92 LORIDA HOUSE OF REPRESENTATIVES  (  (  (  (  (  6 l p A i i i d s t  a w o  b m n  c m  d  e]
[DELETED:  92 LORIDA HOUSE OF REPRESENTATIVES a  (  (  (  (  (  (  (  (  (  (  (  (  (  (  (  ( a p h i h s e s]
[DELETED:  92 LORIDA HOUSE OF REPRESENTATIVES d  1  2 o  3  4  5  6  7  8  9  1  1  1  1 a  1  1  1  1  1  1  2  2  2]
[DELETED:  92 LORIDA HOUSE OF REPRESENTATIVES  2  2  2  2  2  2  2  3  3  3 a  3  3  3 b S s i s  3 t S i e c]
[DELETED:  92 LORIDA HOUSE OF REPRESENTATIVES  3 a t a i h  3 (  3  4  4  4  4  4  4  4 y  4 ( o  4  4  5 n  5]
[DELETED:  92 LORIDA HOUSE OF REPRESENTATIVES  5  5  5  5  5  5  5 M  5  6  6  6  6  6  6  6  6  6  6  7  7  7  7  7  7]
[DELETED:  92 LORIDA HOUSE OF REPRESENTATIVES  7  7  7  7  8  8 m  8  8  8  8 d  8  8  8  8  9  9  9  9  9  9 e  9  9]
[DELETED:  92 LORIDA HOUSE OF REPRESENTATIVES  9 m  9 p  1 p  1  1  1 (  1  1  1  1  1  1  1  1  1 (  1  1  1  1  1]
[DELETED:  92 LORIDA HOUSE OF REPRESENTATIVES  1  1  1  1 m  1  1  1  1  1  1  1  1  1 ( o  1 m e  1 m 1  1  1 u]
[DELETED:  92 LORIDA HOUSE OF REPRESENTATIVES  1 u  1 m  1  1  1  1 m  1 m n  1 m n  1  1  1  1  1  1 m  1  1  1]
[DELETED:  92 LORIDA HOUSE OF REPRESENTATIVES t  1 t  1 t  1 c  1 i  1 c  1 c  1 c  1 b  1  1  1  1  1 m  1  1]
[DELETED:  92 LORIDA HOUSE OF REPRESENTATIVES  1 c  1 c  1 (  1 p  1 (  1 1  1 y  1 m  1 m  1 (  1 c  1 (  1]
[DELETED:  92 LORIDA HOUSE OF REPRESENTATIVES (  1 n  1 1  1 ( h  1 ( h  1 6 d  1 d t  1 6  1  1  1  1 o p]
[DELETED:  92 LORIDA HOUSE OF REPRESENTATIVES D p c d i e a s e p S i t i n d a o  a n s o s s l]
[DELETED:  92 LORIDA HOUSE OF REPRESENTATIVES i i i s 9 h  (  ( ( o  ( ( o  ( (  ( 2  ( 2  ( ( t  ( 6  (]
[DELETED:  92 LORIDA HOUSE OF REPRESENTATIVES 6  (  b N N c n n w c n  (  ( n  (  (  (  (  (  (  (  (  (  (  (]
[DELETED:  92 LORIDA HOUSE OF REPRESENTATIVES  ( n  (  (  ( n  ( n  (  (  (  ( n  ( n  ( n  ( n  (  (  ( n  (  (]
[DELETED:  92 LORIDA HOUSE OF REPRESENTATIVES  ( n  ( n  ( n  ( n  ( n  (  ( n  ( n  ( n  (  ( n  c n p n  (]
[DELETED:  92 LORIDA HOUSE OF REPRESENTATIVES  (  (  (  (  ( n  ( n  ( n  ( n  ( n  d n a n b (  e c s i p]
[DELETED:  92 LORIDA HOUSE OF REPRESENTATIVES  (  (  (  (  (  (  (  ( m  f c 5 s n  ( y  ( h  ( m  g c w e e]
[DELETED:  92 LORIDA HOUSE OF REPRESENTATIVES  (  (  ( i  ( (  ( i  (  ( m  ( 3  h T t t s w t  ( t  ( t  (]
[DELETED:  92 LORIDA HOUSE OF REPRESENTATIVES t  ( t  ( t  ( t  ( t  ( t  ( t  ( t  i c c i w a a  (  ( (]
[DELETED:  92 LORIDA HOUSE OF REPRESENTATIVES  ( c  ( a  (  (  ( a  j Q a q i c c i s w t  (  ( c  ( c  (]
[DELETED:  92 LORIDA HOUSE OF REPRESENTATIVES c  (  ( 3  ( 3  (  ( c  k N n s i n  ( c  ( c  ( (  ( c  ( c]
[DELETED:  92 LORIDA HOUSE OF REPRESENTATIVES  l c c w e e  (  ( (  ( (  ( c  ( (  m i A a 1 p i i o t]
[DELETED:  92 LORIDA HOUSE OF REPRESENTATIVES l  ( p  ( y  ( 1  ( p  ( y  ( 1  ( o  ( 1  ( y  ( (  ( 1  ( y]
[DELETED:  92 LORIDA HOUSE OF REPRESENTATIVES  ( p  ( 1  ( f  ( 2  ( o  ( 2  ( f  ( f  ( (  ( f  ( 2  n A c]
[DELETED:  92 LORIDA HOUSE OF REPRESENTATIVES s i p l  ( c  ( (  o m S  ( c b a r  ( s s  ( s c S  1 l]
[DELETED:  92 LORIDA HOUSE OF REPRESENTATIVES p A i i i d  a s  b p  c p m  ( e h d s  ( p g  ( a n  (]
[DELETED:  92 LORIDA HOUSE OF REPRESENTATIVES a  (  (  (  (  (  (  (  (  (  ( m  (  (  (  (  (  ( e  (  (  ( m  (  (]
[DELETED:  92 LORIDA HOUSE OF REPRESENTATIVES p  ( p  (  (  ( (  (  (  (  (  (  (  (  (  ( d  (  (  (  (  ( m  (  (]
[DELETED:  92 LORIDA HOUSE OF REPRESENTATIVES  (  (  (  (  1 e w F o a o c s a f t h f w o a a i  a  b]
[DELETED:  92 LORIDA HOUSE OF REPRESENTATIVES  c  d  e  f  g  h  i  j  k  l  m  n M  o  p  q  r  s  t  u  v  w  x  y  z]
[DELETED:  92 LORIDA HOUSE OF REPRESENTATIVES  a  b  c  d  e  f  g  h  i  j  k  l  m  n  o  p  q  r  s d  w s s d]
[DELETED:  92 LORIDA HOUSE OF REPRESENTATIVES i  1 s c S m o e s p s b o a b n s i  a m  b h  c f  d]
[DELETED:  92 LORIDA HOUSE OF REPRESENTATIVES m  e m  f h  g f  h m  i m  j m  k m  l m  m h  n f  o m  p m]
[DELETED:  92 LORIDA HOUSE OF REPRESENTATIVES  q h  r f  s m  w s  1 o p D p e s o s a a g  a  b  c  d]
[DELETED:  92 LORIDA HOUSE OF REPRESENTATIVES  e  f  g  h  i  j  k  l  m  n  o  p  q  r  s  t  u  v  w  x  y i  z  a ]
[DELETED:  92 LORIDA HOUSE OF REPRESENTATIVES w s  1 s c S m s a p w s o  a (  b o  c a  d  e a  f  g  h]
[DELETED:  92 LORIDA HOUSE OF REPRESENTATIVES  i  j  k  l  m  n  o  p  q  r  1 p  1 p  1 (  1 (  2 dS   8  (  (]
[DELETED:  92 LORIDA HOUSE OF REPRESENTATIVES a 7 m  1 p t  a  b  c  d  e 8  f  g 8 s  h s  2 i s i p f  a]
[DELETED:  92 LORIDA HOUSE OF REPRESENTATIVES c  b s  c c  dS   8 o  ( y  1  2  3  4  5  6 8  7 8  8 s  a]
[DELETED:  92 LORIDA HOUSE OF REPRESENTATIVES c s m cS   8 r  ( a  ( m k m d h ( s m s p q  a s o]
[DELETED:  92 LORIDA HOUSE OF REPRESENTATIVES  b p i $  c p i $  2 d a h d g c k s  a p i $  b p i $]
[DELETED:  92 LORIDA HOUSE OF REPRESENTATIVES  c p i $  d p i $  3 d a o t s s p q  a s o  b p i $  c]
[DELETED:  92 LORIDA HOUSE OF REPRESENTATIVES p i $  d p i $  4 m k m  (  (  (  (  ( 8  ( 8 (  ( s  c k]
[DELETED:  92 LORIDA HOUSE OF REPRESENTATIVES a s  b  ( p i $  ( p i $  ( t s  c s l s o a s t o s p]
[DELETED:  92 LORIDA HOUSE OF REPRESENTATIVES  ( c  ( s  ( c  (  5 d a a h i 8 m f w i l d o c s  a c]
[DELETED:  92 LORIDA HOUSE OF REPRESENTATIVES i r  b n  s d p a s  6 k h i d 6 s i i p c p  7 d a]
[DELETED:  92 LORIDA HOUSE OF REPRESENTATIVES x t s s p q  a p i $  b p i $  c a bS   a t 2]